"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A1,WO 2017/141185 A1,178-845-587-413-429,2017-08-24,2017,IB 2017050876 W,2017-02-16,US 201662295749 P,2016-02-16,METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS,"The current disclosure provides methods and compositions for treating atherosclerosis, and is based on inhibiting anti-angiogenesis in vivo. Aspects relate to a method for treating atherosclerosis in a subject comprising: administering a surgical treatment to a subject determined to have one or more of: increased levels of HGF, decreased levels of VEGF165a, increased levels of VEGFR1, increased levels of endostatin, and/or increased levels of angiostatin.",UNIV CALIFORNIA,GONZALEZ NESTOR RAUL,,https://lens.org/178-845-587-413-429,Patent Application,yes,1,1,1,1,0,A61P9/10;;G01N33/6893,C12Q1/68;;A61P9/10;;G01N33/50;;G01N33/53;;G01N33/68,,2,1,132-051-234-034-227,pmc3929590;;10.1007/s10143-012-0432-z;;23097149,"G ONZALEZ ET AL.: ""Intracranial arterial stenoses: current viewpoints, novel approaches, and surgical perspectives"", NEUROSURG REV., vol. 36, no. 2, April 2013 (2013-04-01), pages 175 - 185;;GONZALEZ ET AL.: ""Abstract TMP15: Circulating Antiangiogenic Profile Predicts Lower Degrees of Neovascularization After Indirect Revascularization With Encephaloduroarteriosynangiosis (EDAS"", PATIENTS WITH INTRACRANIAL ATHEROSCLEROSIS (ICAS, vol. 47, no. 1, February 2016 (2016-02-01), Retrieved from the Internet <URL:http://stroke.ahajournals.org/content/47/Suppl_1/ATMP15.short> [retrieved on 20170707]",PENDING
2,US,A1,US 2017/0282949 A1,071-435-748-636-278,2017-10-05,2017,US 201715471499 A,2017-03-28,US 201715471499 A;;US 201662314487 P,2016-03-29,COMPONENT CART ASSEMBLY,"A cart assembly includes a base with wheels, a shelf support structure orthogonally arranged with respect to the base, one or more shelves supported by the support structure, and a swivel mechanism. The swivel mechanism is coupled to the base and the shelf support structure to provide an axis of rotation, such that the shelf support structure and the shelf or shelves are selectively rotatable with respect to the axis. The swivel mechanism may include a race that defines a socket on a circumference of the race. A pin is selectively engageable with the socket to prevent rotation of the race and the support structure. The shelf may include a thermoformed plastic tray, or three shelves arranged at three different levels of the shelf support structure. Some of the shelves may fold against and secure to the shelf support structure.",FIVES CINETIC CORP,GONZALEZ GILBERTO;;REYNA NESTOR,,https://lens.org/071-435-748-636-278,Patent Application,yes,0,2,1,1,0,B62B5/049;;B62B2202/90;;B62B2203/071;;B62B2205/33;;B62B2301/12;;B62B3/005;;B62B3/003;;B62B3/004;;B62B5/061;;B62B3/005;;B62B3/003;;B62B3/004;;B62B5/061;;B62B2203/071;;B62B5/049;;B62B2202/90;;B62B2205/33;;B62B2301/12,B62B3/02;;B62B3/00,,0,0,,,,DISCONTINUED
3,ES,Y,ES 1065397 Y,130-515-543-633-004,2007-11-01,2007,ES 200700926 U,2007-04-30,ES 200700926 U,2007-04-30,SISTEMA PARA SUJETAR MODULOS PARA CERRAMIENTOS,,GONZALEZ VALLE JOAQUIN NESTOR,GONZALEZ VALLE JOAQUIN NESTOR,,https://lens.org/130-515-543-633-004,Limited Patent,no,0,0,2,2,0,,E04H17/14,,0,0,,,,EXPIRED
4,ES,U,ES 1060974 U,061-832-472-969-835,2005-12-01,2005,ES 200502010 U,2005-09-08,ES 200502010 U,2005-09-08,"Planter with automatic irrigation. (Machine-translation by Google Translate, not legally binding)","Planter with automatic irrigation, comprising a buoy (1), a hose (2), and a tray (3), characterized in that the pots (4) are deposited on the tray (3), so that the buoy (1) of the pot allows a metered and reduced passage through the hose (2) of water contained in a container (5) outside the container, pouring the water that passes through it into the tray (3) and remaining the water distributed in its horizontal extension, thus behaving that the pots (4) placed in the tray (3) are adequately watered by the water distributed in the tray (3). (Machine-translation by Google Translate, not legally binding)",GONZALEZ VALLE JOAQUIN NESTOR,GONZALEZ VALLE JOAQUIN NESTOR,,https://lens.org/061-832-472-969-835,Patent Application,no,0,0,2,2,0,,A01G27/02,,0,0,,,,EXPIRED
5,ES,U,ES 1065397 U,122-387-071-094-001,2007-08-01,2007,ES 200700926 U,2007-04-30,ES 200700926 U,2007-04-30,"System for holding modules for closures (Machine-translation by Google Translate, not legally binding)","System for fastening modules for enclosures consisting of a solution that connects the support posts (1) of the fence enclosures of farms, with the stringers (4) linking consecutive posts, characterized in that the support posts ( 1) preferably metallic, prismatic, square section, or any other, has welded together metal profiles (2), each of which is attached, also by welding, or by gluing, a nut (3), inserted into each of the profiles (2) the end of a stringer (4), preferably metallic, prismatic, square or rectangular section, with an open tear hole (5) and another, also tear closed (6) by which is introduced a screw (7) that pressing through a washer (8) is screwed on the nut (3) immobilizing the beam (4) on the profile (2) of the support post (1). (Machine-translation by Google Translate, not legally binding)",GONZALEZ VALLE JOAQUIN NESTOR,GONZALEZ VALLE JOAQUIN NESTOR,,https://lens.org/122-387-071-094-001,Patent Application,no,0,0,2,2,0,,E04H17/14,,0,0,,,,EXPIRED
6,US,A1,US 2021/0189490 A1,048-530-251-017-30X,2021-06-24,2021,US 202117193637 A,2021-03-05,US 202117193637 A;;US 2019/0054143 W;;US 201862739680 P,2018-10-01,MicroRNA Transcriptional Signature (miR-TS) Evaluation of Stem Cells,"Aspects of the present disclosure include methods of evaluating stem cells. Aspects of the methods include obtaining a microRNA transcriptional signature (miR-TS), i.e., a microRNA transcriptional phenotype, for a stem cell and using the obtained miR-TS to evaluate the stem cell. Also provided are kits and compositions for practicing the subject methods. The methods and compositions find use in a variety of different applications, including diagnostic applications, therapeutic applications, research applications, and the like.",LUNDQUIST INST FOR BIOMEDICAL INNOVATION AT HARBOR UCLA MEDICAL CENTER,GONZALEZ-CADAVID NESTOR F,LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER (2019-10-28),https://lens.org/048-530-251-017-30X,Patent Application,yes,0,0,2,2,0,C12Q1/6881;;C12Q1/6881;;C12Q1/6883;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;C12Q2600/178;;C12Q2600/178,C12Q1/6881;;C12Q1/6883,,0,0,,,,PENDING
7,ES,Y,ES 1060974 Y,130-276-765-744-492,2006-03-16,2006,ES 200502010 U,2005-09-08,ES 200502010 U,2005-09-08,MACETERO CON RIEGO AUTOMATICO.,,GONZALEZ VALLE JOAQUIN NESTOR,GONZALEZ VALLE JOAQUIN NESTOR,,https://lens.org/130-276-765-744-492,Limited Patent,no,0,0,2,2,0,,A01G27/02,,0,0,,,,EXPIRED
8,WO,A1,WO 2020/072545 A1,176-484-816-774-84X,2020-04-09,2020,US 2019/0054143 W,2019-10-01,US 201862739680 P,2018-10-01,MicroRNA TRANSCRIPTIONAL SIGNATURE (miR-TS) EVALUATION OF STEM CELLS,"Aspects of the present disclosure include methods of evaluating stem cells. Aspects of the methods include obtaining a microRNA transcriptional signature (miR-TS), i.e., a microRNA transcriptional phenotype, for a stem cell and using the obtained miR-TS to evaluate the stem cell. Also provided are kits and compositions for practicing the subject methods. The methods and compositions find use in a variety of different applications, including diagnostic applications, therapeutic applications, research applications, and the like.",LUNDQUIST INST FOR BIOMEDICAL INNOVATION AT HARBOR UCLA MEDICAL CENTER,GONZALEZ-CADAVID NESTOR F,,https://lens.org/176-484-816-774-84X,Patent Application,yes,1,0,2,2,0,C12Q1/6881;;C12Q1/6881;;C12Q1/6883;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;C12Q2600/178;;C12Q2600/178,C12Q1/68;;C40B30/04,,2,2,135-019-327-544-487;;039-750-893-621-582,10.1002/jcb.25814;;27918077;;22504138;;10.1038/leu.2012.106,"REZABAKHSH ET AL.: ""Type 2 Diabetes Inhibited Human Mesenchymal Stem Cells Angiogenic Response by Over-Activity of Autophagic Pathway"", JOURNAL OF CELLULAR BIOCHEMISTRY, vol. 118, no. 6, 5 December 2016 (2016-12-05), pages 1518 - 1530, XP055701465;;GRASEDIECK ET AL.: ""Impact of serum storage conditions on microRNA stability"", LEUKEMIA, vol. 26, 16 April 2012 (2012-04-16), pages 2414 - 2416, XP055701466",PENDING
9,ES,Y,ES 1186733 Y,004-649-533-577-921,2017-09-27,2017,ES 201730717 U,2017-06-15,ES 201730717 U,2017-06-15,Percha calefactora,,GONZALEZ VEGA JAVIER;;TOLOSA ECHEPARE NESTOR,GONZALEZ VEGA JAVIER;;TOLOSA ECHEPARE NESTOR,GOVE GESTION S.L (2021-12-30),https://lens.org/004-649-533-577-921,Limited Patent,no,0,0,4,4,0,A47G25/14;;A47G2025/1485;;D06F59/02;;D06F59/02,D06F59/00;;A47G25/14,,0,0,,,,ACTIVE
10,US,A1,US 2020/0000811 A1,069-216-948-146-044,2020-01-02,2020,US 201916269047 A,2019-02-06,US 201916269047 A;;US 201715832918 A;;US 77906904 A,2004-02-13,"METHODS OF USE OF INHIBITORS OF PHOSPHODIESTERASES AND MODULATORS OF NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND METALLOPROTEINASES IN THE TREATMENT OF PEYRONIE'S DISEASE, ARTERIOSCLEROSIS AND OTHER FIBROTIC DISEASES","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, a PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity.",LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/069-216-948-146-044,Patent Application,yes,0,2,8,8,0,A61K31/53;;A61K31/53;;A61K9/0053;;A61K31/00;;A61K31/00;;A61K31/4985;;A61K31/4985;;A61K31/519;;A61K31/519;;A61K48/00;;A61K48/00;;A61K48/005;;A61K48/005;;A61P15/00;;C12N15/86;;C12N15/86;;C12N2710/10343;;C12N2710/10343;;C12N2830/008;;C12N2830/008;;C12N2830/85;;C12N2830/85,A61K31/53;;A61K9/00;;A61K31/00;;A61K31/4985;;A61K31/519;;A61K48/00;;C12N15/86;;C12N15/861,,0,0,,,,DISCONTINUED
11,US,A1,US 2014/0200219 A1,089-131-175-262-010,2014-07-17,2014,US 201414215444 A,2014-03-17,US 201414215444 A;;US 0333400 W;;US 201213372094 A;;US 77906904 A;;US 42028102 P,2002-10-22,"Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, a PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity.",LOS ANGELES BIOMED RES INST;;LOS ANGELES BIOMED RES INST,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/089-131-175-262-010,Patent Application,yes,0,0,8,8,0,A61K31/53;;A61K31/53;;A61K9/0053;;A61K31/00;;A61K31/00;;A61K31/4985;;A61K31/4985;;A61K31/519;;A61K31/519;;A61K48/00;;A61K48/00;;A61K48/005;;A61K48/005;;A61P15/00;;C12N15/86;;C12N15/86;;C12N2710/10343;;C12N2710/10343;;C12N2830/008;;C12N2830/008;;C12N2830/85;;C12N2830/85,A61K31/519;;A61K31/00;;A61K48/00;;C12N15/861,514/243;;514/252.16;;514/250;;544/262;;544/343;;544/184,0,0,,,,DISCONTINUED
12,AU,B2,AU 693621 B2,178-822-605-299-569,1998-07-02,1998,AU 1996/042336 A,1995-11-09,US 33735794 A;;US 9514588 W,1994-11-10,"Amelioration of human erectile dysfunction by treatment with iNOS, and related NOS agents",,NIREC INC,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/178-822-605-299-569,Granted Patent,no,0,0,8,8,0,A61K9/0034;;A61K9/0034;;A61K38/00;;A61K38/00;;A61K38/191;;A61K38/191;;A61K38/2006;;A61K38/2006;;A61K38/217;;A61K38/217;;A61K48/00;;A61K48/00;;A61P13/02;;A61P15/00;;C12N9/0075;;C12N9/0075;;C12Y114/13039;;C12Y114/13039,C12N15/09;;A61K31/715;;A61K35/74;;A61K38/00;;A61K38/19;;A61K38/20;;A61K38/21;;A61K38/43;;A61K38/44;;A61K48/00;;A61P13/02;;A61P15/00;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/02;;C12R1/19,,0,0,,,,EXPIRED
13,AU,A1,AU 2003/286555 A1,033-762-455-802-324,2004-05-13,2004,AU 2003/286555 A,2003-10-21,US 42028102 P;;US 0333400 W,2002-10-22,"METHODS OF USE OF INHIBITORS OF PHOSPHODIESTERASES AND MODULATORS OF NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND METALLOPROTEINASES IN THE TREATMENT OF PEYRONIE'S DISEASE, ARTERIOSCLEROSIS AND OTHER FIBROTIC DISEASES",,HARBOR UCLA RES & EDUCATION,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/033-762-455-802-324,Patent Application,no,0,0,4,4,0,A61K31/58;;A61K31/519,A61K/;;A61K31/519;;A61K31/58,,0,0,,,,DISCONTINUED
14,US,A1,US 2014/0350021 A1,071-724-103-729-929,2014-11-27,2014,US 201414453543 A,2014-08-06,US 201414453543 A;;US 3340003 A;;US 201213372094 A;;US 77906904 A;;US 42028102 P,2002-10-22,"Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, a PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity.",LOS ANGELES BIOMED RES INST,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/071-724-103-729-929,Patent Application,yes,1,1,8,8,0,A61K31/53;;A61K31/53;;A61K9/0053;;A61K31/00;;A61K31/00;;A61K31/4985;;A61K31/4985;;A61K31/519;;A61K31/519;;A61K48/00;;A61K48/00;;A61K48/005;;A61K48/005;;A61P15/00;;C12N15/86;;C12N15/86;;C12N2710/10343;;C12N2710/10343;;C12N2830/008;;C12N2830/008;;C12N2830/85;;C12N2830/85,A61K31/4985;;A61K31/00;;A61K31/519;;A61K31/53;;A61K48/00;;C12N15/861,514/243;;514/252.16;;514/250,1,1,040-475-708-072-692,26558095;;10.1016/j.aju.2013.05.004;;pmc4443017,"Egydio et al (Arab Journal of Urology (2013) 11, 294-298)",DISCONTINUED
15,AU,A,AU 1996/042336 A,068-211-247-366-125,1996-06-06,1996,AU 1996/042336 A,1995-11-09,US 33735794 A;;US 9514588 W,1994-11-10,"Amelioration of human erectile dysfunction by treatment with inos, and related nos agents",,NIREC INC,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/068-211-247-366-125,Patent Application,no,0,0,8,8,0,A61K9/0034;;A61K9/0034;;A61K38/00;;A61K38/00;;A61K38/191;;A61K38/191;;A61K38/2006;;A61K38/2006;;A61K38/217;;A61K38/217;;A61K48/00;;A61K48/00;;A61P13/02;;A61P15/00;;C12N9/0075;;C12N9/0075;;C12Y114/13039;;C12Y114/13039,C12N15/09;;A61K31/715;;A61K35/74;;A61K38/00;;A61K38/19;;A61K38/20;;A61K38/21;;A61K38/43;;A61K38/44;;A61K48/00;;A61P13/02;;A61P15/00;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/02;;C12R1/19,,0,0,,,,EXPIRED
16,US,A,US 6133281 A,197-152-743-417-972,2000-10-17,2000,US 95690797 A,1997-10-23,US 95690797 A;;US 2925096 P,1996-10-24,NMDA receptor blockers in the therapy of urogenital disease,"Methods are presented for the treatment of benign prostatic hyperplasia. The methods provide for administration to a person at least one compound identified generically as antagonists of N-methyl-D-aspartate receptors. These compounds are selected from the group consisting of memantidine, amantidine, dextromethorphan and ketamine.",HARBOR UCLA RES & EDUCATION,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,HARBOR-UCLA RESEARCH AND EDUCATION INSTITUTE (1998-02-04),https://lens.org/197-152-743-417-972,Granted Patent,yes,2,17,1,1,0,A61K31/13;;A61K31/135;;A61K31/485;;A61K31/13;;A61K31/485;;A61K31/135,A61K31/13;;A61K31/135;;A61K31/485,514/289;;514/579;;514/647,64,57,005-984-580-695-116;;026-628-411-837-786;;043-046-732-728-544;;010-564-035-399-602;;023-969-091-487-081;;062-377-508-955-908;;040-059-899-068-57X;;037-142-540-646-58X;;178-307-590-221-729;;015-248-675-234-811;;132-020-767-826-76X;;006-198-885-987-097;;019-004-200-342-231;;030-315-928-188-106;;061-788-759-351-009;;054-332-332-530-949;;026-183-552-056-976;;001-095-025-479-427;;009-452-272-500-549;;022-461-121-359-651;;066-587-750-222-834;;010-503-722-948-029;;016-521-862-976-416;;038-673-729-314-262;;066-205-901-952-003;;036-267-180-134-777;;054-834-881-199-806;;065-461-511-880-08X;;003-968-765-223-331;;076-727-041-298-742;;117-837-926-300-726;;026-533-466-308-409;;028-144-500-848-016;;069-431-705-901-078;;171-467-404-561-526;;004-459-012-379-64X;;106-152-533-780-254;;030-110-591-572-954;;111-708-675-666-686;;019-269-864-010-620;;009-243-438-691-509;;081-138-348-549-572;;048-908-383-898-964;;118-719-669-531-45X;;148-251-505-844-342;;056-779-410-628-575;;012-831-342-698-553;;120-166-005-832-633;;036-443-292-251-679;;065-724-978-136-766;;081-707-235-215-573;;013-690-347-600-308;;022-850-079-263-216;;057-755-792-709-935;;029-886-034-777-036;;042-388-934-235-047;;008-423-772-277-647,10.1177/009127009203200605;;1353083;;10.1111/j.1749-6632.1995.tb16582.x;;10.1016/0169-328x(93)90190-z;;7684481;;8276955;;10.1093/humrep/8.suppl_2.18;;7907400;;10.1159/000126607;;7880240;;10.1056/nejm199410133311507;;7789739;;10.1016/0306-3623(94)00211-5;;10.1073/pnas.81.3.935;;6583688;;pmc344954;;7482387;;7483132;;10.1016/s0094-0143(21)00697-2;;8254833;;10.1016/s0022-5347(17)34871-1;;10.1095/biolreprod53.6.1365;;8562693;;7530924;;10.1152/ajpheart.1995.268.1.h467;;9096878;;10.1095/biolreprod56.4.954;;7752918;;10.1016/0026-0495(95)90127-2;;10.1046/j.1471-4159.1996.66062239.x;;8632144;;7647968;;10.1111/j.1476-5381.1995.tb16331.x;;pmc1908749;;14959705;;10.1016/s0021-9258(18)53849-7;;8428958;;10.1159/000474321;;7505224;;7884411;;7901242;;7705129;;10.1378/chest.107.4.1152;;10.1056/nejm199608223350801;;8684407;;8596569;;10.1056/nejm199604043341401;;10.1210/en.136.4.1495;;7534702;;10.1210/endo.136.4.7534702;;8770031;;10.1152/ajpendo.1996.271.2.e354;;10.1006/bbrc.1996.1324;;8806605;;10.1016/0304-3940(94)11114-x;;7746488;;10.1016/s0531-5565(96)00154-4;;9315447;;8632355;;10.1097/00000441-199502000-00008;;7847449;;10.1056/nejm199501123320207;;7527494;;10.1095/biolreprod55.3.567;;8862773;;1422571;;pmc1907619;;10.1111/j.1476-5381.1992.tb14483.x;;10.1016/0014-2999(93)90507-e;;8405085;;10.1210/en.138.9.3925;;9275083;;10.1210/endo.138.9.5402;;1309211;;10.1056/nejm199201093260203;;7617171;;10.1016/0306-4522(95)00021-a;;10.1002/1520-6777(1994)13:3<297::aid-nau1930130311>3.0.co;2-y;;7920686;;10.1016/s0022-5347(17)35683-5;;8102184;;10.1002/nau.1930120610;;7508779;;1352681;;10.1016/0006-291x(92)91701-q;;8270370;;7879335;;10.1016/s0090-4295(99)80013-2;;8667184;;7594165;;10.1111/j.1532-5415.1995.tb07407.x;;8700797;;8592646;;10.1016/0304-3940(95)11966-z;;7518769;;10.1111/j.1528-1157.1994.tb05972.x;;10.1016/s0028-3908(96)00049-4;;8887974;;10.1016/0028-3908(96)84636-3;;7588327;;10.1210/en.136.12.5709;;10.1210/endo.136.12.7588327;;10.1056/nejm199608223350809;;8678937;;8561325;;10.1097/00000539-199602000-00009;;9072555;;10.1097/00005392-199703000-00118;;10.1016/s0022-5347(01)65153-x;;8666029;;10.1016/0014-2999(95)00615-7;;10.1097/00001756-199512290-00010;;8742413;;10.1097/00001756-199512000-00010,"Achari R, Laddu A (1993) Terazosin: A New Alpha Adrenoceptor Blocking Drug. J. Clin Pharmacol 32:520 523.;;Albers GW, et al., (1995) Safety, Tolerability and Pharmacokinetics of the N Methyl D Aspartate Antagonist Ro 01 6794/706 in Patients with Acute Ischemic Stroke. Annals NY Academy of Sciences :250 261.;;Bessho Y, et al., (1993) Glutamate receptor agonists enhance the expression of BDNF mRNA in cultured cerebellar granule cells. Brain Res Mol Brain Res 18:201 208.;;Bourguignon JP, et al., (1993) Control of pulsatile secretion of gonadotrophin releasing hormone from hypothalamic explants. Human Reproduction 2:18 22.;;Brann DW, et al., (1993) Steroid Hormone Effects on NMDA Receptor Binding and NMDA Receptor mRNA Levels in the Hypothalamus and Cerebral Cortex of the Adult Rat. Neuroendocrinology 58:666 672.;;Catalona WJ (1994) Management of Cancer of the Prostate. New England Journal of Medicine 331:996 1004.;;Dehpour AR, et al., (1995) Different Calcium Dependencies of Contractile Activity of Prostatic and Epididymal Portions of Rat Vas Deferens. Gen. Pharmac. 26:633 639.;;D Ercole AJ, et al., (1994) Tissue concentrations of somatomedin C: Further evidence for mlutiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935 939.;;Doble, A (1995) Excitatory amino acid receptors and neurodegeneration. Therapie 50:319 337.;;Fallon, B (1995) Intracavernous Injection Therapy for Male Erectile Dysfunction. Urologic Clinics of North America 22:883 845.;;Feldman HA, et al., (1994) Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study. The Journal of Urology 151:54 61.;;Garban H, et al., (1995) Restoration of Normal Adult Penile Erectile Response in Aged Rats by Long Term Treatment with Androgens. Biology of Reproduction 53:1365 1372.;;Garb a n H, et al., (1995) Effect of aging on nitric oxide mediated penile erection in rats. American Journal of Physiology 268:H467 H475.;;Garb a n H, et al., (1997) Cloning of Rat and Human Inducible Penile Nitric Oxide Synthase. Application for Gene Therapy of Erectile Dysfunction. Biology of Reproduction 56:954 963.;;Giorda C, et al., (1995) Alpha 1 Blocker Doxazosin Improves Peripheral Insulin Sensitivity in Diabetic Hypertensive Patients. Metabolism 44:673 676.;;Grimwood S, et al., (1996) Generation and Characterisation of Stable Cell Lines Expressing Recombinant Human N Methyl D Aspartate Receptor Subtypes. Journal of Neurochemistry 66:2239 2247.;;Guh J H, et al., (1995) Characterization of Alpha 1 adrenoceptor subtypes in tension response of human prostate to electrical field stimulation. J Pharmacol 115:142 146.;;Hung A, et al., (1995) Expression of Inducible Nitric Oxide Synthase in Smooth Muscle Cells From Rat Penile Corpora Cavernosa. J Androl 16:469 481.;;Ishii T, et al., (1993) Molecular Characterization of the Family of the N Methl D Aspartate Receptor Subunits. The Journal of Biological Chemistry 268:2836 2843.;;Janknegt RA, et al., (1993) Efficacy and Safety of the Alpha 1 Blocker Doxazosin in the Treatment of Benign Prostatic Hyperplasia. Eur Urol 24:319 326.;;Kornhuber J, et al., (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm 43:91 104.;;Kyncl JJ (1993) Pharmacology of Terazosin: An Alpha 1 Selective Blocker. J Clin Pharmacol 33:866 899.;;Lee T S, Hou X (1995) Vasoactive Effects of Ketamine on Isolated Rabbit Pulmonary Arteries. Chest 107:1152 1155.;;Lepor H, et al., (1996) The Efficacy of Terazosin, Finasteride, or both in Benign Prostatic Hyperplasia. New England Journal of Medicine 335:533 539.;;Levsin (hyoscyamine sulfate USP) (1997). Physician s Desk Reference , pp. 2405 2406.;;Linet OI, et al., (1996) Efficacy and safety of intracavernosal Alprostad; 1 in men with erectile dysfunction. New England Journal of Medicine 334:873 877.;;Lugg JA, et al., (1995) Dihydrotestosterone is the Active Androgen in the Maintenance of Nitric Oxide Mediated Penile Erection in the Rat. Endocrinology 136:1495 1501.;;Lugg JA, et al., (1996) Cavernosal nerve stimulation in the rat reverses castration induced decrease in penile NOS activity. Am J Physiol 34:354 361.;;Magee T, et al., (1996) Cloning of a Novel Neuronal Nitric Oxide Synthase Expressed in Penis and Lower Urinary Tract. Biochemical and Biophysical Research Communications 226:141 151.;;Matsumoto G, et al., (1995) Role of glutamate and NMDA receptors in the descencing limb of the spinobulbospinal micturition reflex pathway of the rat. Neuroscience Letters 183:58 61.;;McCann SM (1997) The Nitric Oxide Hypothesis of Brain Aging. Experimental Gerontology 32:431 440.;;Munir H, et al., (1996) Pharmacological and Immunological Characterization of N methyl D aspartate Receptors in HumN Nt2 N Neurons. Journal of Pharmacology and Experimental Therapeutics 276:819 828.;;Murray F, et al., (1995) Evaluation and Treatment of Erectile Dysfunction. American Journal of the Medicial Sciences 309:99 109.;;Osterling JE (1995) Benign Prostatic Hyperplasia. Medical and Minimally Invasive Treatment Options. Drug Therapy 332:99 109.;;Osterling JE, et al., (1994) A new reality for urology: Drugs that alleviate BPH symptoms. Contemporary Urology 6:2 10.;;Penson DF, et al., (1996) Androgen and Pituitary Control of Penile Nitric Oxide Synthase and Erectile Function in the Rat. Biology of Reproduction 55: 567 574.;;Persson K, et al., (1992) Effects of inhibition in the L arginine/nitric oxide pathway in the rat lower urinary tract in vivo and in vitro. Br I Pharmacol 107:178 184.;;Pedersen CM, et al., (1993) Smooth muscle relaxant effects of propofol and ketamine in isolated guinea pig trachea. European Journal of Pharmacology 238:75 80.;;Penson DF, et al., (1997) Adrenal Control of Erectile Function and Nitric Oxide Synthase in the Rat Penis. Endocrinology , 138(9), 1 8.;;Rajfer J, et al., (1992) Nitric Oxide as a Mediator or Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission. New England Journal of Medicine 326:90 94.;;Said SI, (1995) N Methyl D Aspartate Receptors Outside The Central Nervous System: Activation Causes Acute Lung Injury That is Mediated by Nitric Oxide Synthesis and Prevented by Vasoactive Intestinal Peptide. Neuroscience 65:943 946.;;Saito M, et al., (1994) Effect of Partial Outflow Obstruction on Rat Detrusor Contractility and Intracellular Free Calcium Concentration. Neurourology and Urodynamics 13:297 305.;;Saito M, et al., (1993) Effects of Partial Outlet Obstruction of the Rat Urinary Bladder on Micturition Characteristics, DNA Synthesis and the Contractile Response to Field Stimulation and Pharmacological Agents. The Journal of Urology 150:1045 1051.;;Saito M, et al., (1993) Effect of Partial Outlet Obstruction on Contractility: Comparison Between Severe and Mild Obstruction. Neurourology and Urodynamics 12:573 583.;;Steers WD (1993) Physiology of the Urinary Bladder. In Campbells Urology , pp. 142 176.;;Sugihara H, et al., (1992) Structures and Properties of Seven Isoforms of the NMDA Receptor Generated by Alternative Splicing. Biochemical and Biophysical Research Communications 185:862 832.;;Szabo L, et al., (1993) Voiding Disorders and Unstable Bladder in Children. International Urology and Nephrology 25:431 437.;;Takeda M, et al., (1994) Effects of Nitric Oxide on Human and Canine Prostates. Adult Urology 45:440 446.;;Testa S, et al., (1996) Functional Antagonistic Activity of REC 15/2739, a Novel Alpha 1 Antagonist Selective for;;Thomas RJ (1995) Excitatory Amino Acids in Health and Disease. J Am Geriatr Soc 43:1279 1289.;;Thornberg SA, et al., (1996) A Review of NMDA Receptors and the Phencyclidine Model of Schizophrenia. Pharmacotherapy 16:82 93.;;Tortella FC, et al., (1995) Dextromethorphan analogs are neuroprotective in vitro and block glutamate induced excitotoxic calcium signals in neurons. Neuroscience Letters 198:79 82.;;Trube G, et al., (1994) Dextromethorphan: Cellular Effects Reducing Neuronal Hyperactivity. Epilepsia 35:S62 S67.;;Urwyler S, et al., (1996) Biphenyl derivatives of 2 Amino 7 phosphono heptonoic Acid, a Novel Class of Potent Competitive N Methyl D aspartate Receptor Antagonists. I. Pharmacological Characterization in Vitro. Neuropharmacology 35:643 654.;;Vernet D, et al., (1995) Reduction of Penile Nitric Oxide Synthase in Diabetic BB/WOR dp (Type I) and BBZ/WOR dp (Type II) Rats with Erectile Dysfunction. Endocrinology 136:5709 5717.;;Walsh PC (1996) Treatment of Benign Prostatic Hyperplasia. New England Journal of Medicine 335:586 587.;;Wein AJ (1993) Pharmacologic Management of Non BPH Induced Voiding Dysfunction. Monographs in Urology 14:68 86.;;Wendling WW, et al., (1996) The Effects of N Methyl D Aspartate Agonists and Antagonists on Isolated Vocine Cerebral Arteries. J Neurosurgical Anesthesia 82:264 268.;;Xie Y, et al., (1997) Effect of Long Term Passive Smoking on Erectile Function and Penile Nitric Oxide Synthase in the Rat. The Journal of Urology 157:1121 1126.;;Yoshiyama M, et al., (1995) Interactions between NMDA and AMPA/kainate receptors in the control of micturition in the rat. European Journal of Pharmacology 287:73 78.;;Wenzel A, et al., (1995) Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain. Neurochemistry 7:45 48.;;Hirota et al., Acta Anaesthesiologica Scandinavica, 39(2), 175 8 (abstract), Feb. 1995.;;Hytrin, Physicians Desk Reference, pp. 430 433 (1995).;;Prinzide, Physicians Desk Reference, pp. 1740 1744 (1995).",EXPIRED
17,WO,A2,WO 2004/037183 A2,003-763-129-685-851,2004-05-06,2004,US 0333400 W,2003-10-21,US 42028102 P,2002-10-22,"METHODS OF USE OF INHIBITORS OF PHOSPHODIESTERASES AND MODULATORS OF NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND METALLOPROTEINASES IN THE TREATMENT OF PEYRONIE'S DISEASE, ARTERIOSCLEROSIS AND OTHER FIBROTIC DISEASES","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie&apos;s disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren&apos;s disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation,general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity. In certain embodiments, the composition may be a gene therapy vector.",HARBOR UCLA RES & EDUCATION;;GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/003-763-129-685-851,Patent Application,yes,0,25,4,4,0,A61K31/58;;A61K31/519,A61K/;;A61K31/519;;A61K31/58,,0,0,,,,PENDING
18,US,B2,US 8133903 B2,094-866-764-156-521,2012-03-13,2012,US 77906904 A,2004-02-13,US 77906904 A;;US 0333400 W,2003-10-21,"Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, a PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity.",GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB;;LOS ANGELES BIOMED RES INST,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (2004-05-05),https://lens.org/094-866-764-156-521,Granted Patent,yes,25,3,8,8,0,A61K31/53;;A61K31/53;;A61K9/0053;;A61K31/00;;A61K31/00;;A61K31/4985;;A61K31/4985;;A61K31/519;;A61K31/519;;A61K48/00;;A61K48/00;;A61K48/005;;A61K48/005;;A61P15/00;;C12N15/86;;C12N15/86;;C12N2710/10343;;C12N2710/10343;;C12N2830/008;;C12N2830/008;;C12N2830/85;;C12N2830/85,A01N43/42;;A61K31/00;;A61K31/519;;A61K48/00;;C12N15/861,514/310,101,100,073-346-702-977-34X;;042-253-944-050-718;;008-973-360-555-504;;036-548-175-241-253;;016-206-066-841-924;;055-959-571-480-438;;006-274-638-703-976;;113-611-409-014-134;;123-839-451-905-428;;040-911-181-960-084;;182-361-007-739-363;;037-323-951-508-002;;008-266-745-986-652;;064-669-590-564-128;;045-232-488-340-047;;013-984-467-826-540;;008-004-654-791-85X;;014-918-986-911-350;;019-779-279-237-402;;041-638-530-875-251;;121-000-635-035-82X;;096-862-091-422-606;;023-731-155-768-510;;102-559-801-229-40X;;049-509-756-926-330;;018-816-065-362-893;;034-479-970-680-969;;030-150-440-569-658;;063-284-412-958-411;;020-263-025-813-527;;014-120-797-420-867;;021-374-346-316-618;;018-809-879-063-344;;002-568-670-746-501;;012-796-286-224-706;;075-336-878-901-318;;005-768-977-528-918;;000-934-863-533-523;;016-764-733-619-961;;035-226-322-167-033;;050-398-026-357-056;;018-891-443-837-56X;;047-569-197-884-657;;045-050-707-322-440;;007-449-072-589-841;;019-962-941-391-726;;160-466-850-175-314;;009-183-188-486-665;;023-117-528-730-495;;045-050-070-551-501;;077-083-360-838-246;;068-056-158-668-108;;019-857-370-048-89X;;033-084-956-716-619;;137-468-922-516-727;;019-509-163-565-404;;003-647-606-987-724;;019-588-188-955-183;;005-098-991-186-870;;114-790-754-521-113;;091-785-423-738-546;;019-497-120-547-876;;014-777-203-827-034;;160-579-593-529-134;;054-669-009-939-916;;030-315-928-188-106;;019-004-200-342-231;;091-771-773-514-190;;066-956-335-595-722;;149-591-406-846-163;;040-124-652-147-469;;007-795-967-504-054;;096-256-165-804-990;;061-994-930-210-837;;122-115-438-985-005;;029-093-319-431-784;;000-083-690-854-675;;049-159-010-072-263;;052-212-215-348-196;;001-743-024-078-501;;124-644-872-728-112;;018-900-400-358-43X;;176-121-996-089-950;;113-723-708-301-244;;098-495-718-002-279;;076-886-137-479-706;;059-810-081-151-260;;093-072-368-098-891;;042-930-616-481-32X;;008-300-652-338-361;;117-605-104-227-600;;142-710-772-082-567;;004-310-826-245-792;;001-095-025-479-427;;003-549-958-688-278;;156-697-761-608-070;;005-687-231-735-270;;001-501-136-089-756;;000-932-458-818-171;;025-022-310-172-241,15502109;;10.1164/rccm.200409-1164oc;;19552848;;12376817;;10.1007/s00467-002-0941-z;;10.1038/sj.ijir.3900558;;11002396;;10915630;;10.1152/ajpgi.2000.279.2.g245;;10845863;;10.1161/01.atv.20.6.1493;;10.1016/s0363-5023(96)80102-x;;8683048;;11730265;;10.1152/ajpcell.1996.271.5.c1424;;8944624;;10961969;;10.1161/01.cir.102.9.1033;;10196019;;10.1016/s0272-6386(99)70229-5;;11224701;;10.1097/00041552-200103000-00014;;12443711;;10.1006/jsre.2002.6523;;12505874;;10.1152/ajpheart.00770.2002;;10799245;;10.1097/00005392-200006000-00108;;10.1016/s0022-5347(05)67616-1;;10.1161/01.cir.100.18.1901;;10545435;;10.1161/01.cir.98.18.1842;;9799202;;10.1016/s0014-5793(99)00323-3;;10217399;;10.1161/01.res.87.10.840;;11073878;;pmc1218431;;9164871;;10.1042/bj3240305;;10.1002/hep.510250218;;9021948;;10.1053/jhep.1997.v25.pm0009021948;;9705871;;10.1006/bbrc.1998.9130;;11849431;;10.1046/j.1523-1755.2002.00226.x;;9710120;;10.1161/01.res.83.3.279;;11895925;;9637712;;10.1172/jci2132;;pmc508869;;10329205;;10.1006/jmcc.1998.0910;;9852090;;10.1074/jbc.273.51.34263;;10713731;;10.1038/sj.cdd.4400605;;10.1161/01.hyp.31.2.643;;9461235;;10.1007/s429-001-8002-0;;11876531;;10.1016/s0190-9622(99)70415-9;;10411420;;10318772;;10.1074/jbc.274.20.13729;;10.2337/diab.46.4.671;;10.2337/diabetes.46.4.671;;9075810;;12065318;;10.1161/01.res.0000020401.61826.ea;;10.1016/s0022-1759(02)00070-4;;12072178;;8958389;;10.1097/00001721-199610000-00003;;10.1002/path.1074;;12081196;;10.1046/j.1464-410x.2003.04224.x;;12780843;;10468656;;10.1046/j.1365-201x.1999.00552.x;;7640660;;10.1006/cbir.1995.1090;;10.1016/s0168-8278(99)80192-5;;10207803;;10.1097/00005392-199701000-00098;;8976281;;10.1016/s0022-5347(01)65361-8;;10.1097/00005392-199701000-00101;;10.1016/s0022-5347(01)65364-3;;8976284;;10.4049/jimmunol.164.4.2110;;10657665;;1651559;;10.3109/00365599109024539;;11065343;;10.1016/s0022-5347(01)65368-0;;8976288;;10.1097/00005392-199701000-00105;;10330038;;10.1152/ajplung.1999.276.5.l814;;10.1016/s0022-5347(05)68868-4;;10.1097/00005392-199906000-00078;;10332485;;9523668;;10.1046/j.1464-410x.1998.00529.x;;10.1016/s0022-5347(01)68236-3;;9366377;;10.1097/00005392-199710000-00019;;9302128;;10.1016/s0022-5347(01)64223-x;;11692087;;10.1067/mai.2001.119555;;11729239;;10.1681/asn.v12122701;;10745022;;10.1165/ajrcmb.22.4.3857;;10068108;;10.1016/s0168-8278(99)80074-9;;11207215;;10.1095/biolreprod64.3.974;;11435753;;10.1159/000054665;;12577322;;10.1002/cne.10543;;10.1006/niox.2001.0421;;12009846;;11174136;;10215613;;pmc1220210;;10.1042/0264-6021:3390729;;10.1042/bj3390729;;10.1161/01.atv.12.9.1008;;1356019;;9657518;;10.1096/fasebj.12.10.773;;9096878;;10.1095/biolreprod56.4.954;;7530924;;10.1152/ajpheart.1995.268.1.h467;;10.1016/s0022-5347(17)42617-6;;3352034;;10.1023/a:1005940202801;;9544420;;9537291;;10.1016/s0008-6363(02)00327-9;;12123764;;10.1097/01.ju.0000053800.62741.fe;;12629334;;10.1006/bbrc.2000.4180;;11162610;;10904020;;10.1161/01.hyp.36.1.103;;10851306;;10.1038/sj.ijir.3900873;;12454687;;10.1159/000058447;;12053029;;10.1177/002215540205000501;;11967271;;10.1016/s0021-9975(05)80113-6;;7962729;;12082014;;10.1093/carcin/23.6.929;;10819440;;11330651;;10467729;;10.1016/s1357-2725(99)00032-1;;9919591;;10.1016/s0076-6879(99)01106-4;;10.1002/jemt.10114;;12112420;;11092532;;10.1038/labinvest.3780182;;10769198;;10.1242/jcs.113.10.1671;;10.1016/s0002-9440(10)65700-8;;pmc1866342;;9846976;;10816057;;10.1080/14017430050142369;;11331455;;10.1067/msy.2001.113039;;10.1016/s0014-2999(99)00559-2;;10556498;;11311852;;10.1016/s1357-2725(00)00087-x;;11978733;;10.1096/fj.01-0713com;;14959705;;11369002;;10.1016/s0021-9150(00)00636-5;;10.1111/j.1440-1681.1997.tb01199.x;;9143785;;10.1161/01.hyp.36.3.312;;10988257;;10.1161/hy09t1.096249;;11566935;;1553006;;10.1159/000186740;;9076940;;10.1016/s1357-2725(96)00118-5,"Burdick et al, CXCL11 Attenuates Bleomycin-induced Pulmonary Fibrosis via Inhibition of Vascular Remodeling, American Journal of Respiratory and Critical Care Medicine vol. 171, pp. 261-268, printed pp. 1-5, especially page 1.;;Ma et al. (Therapeutic effect of phosphodiesterase-5 inhibitor on pathological changes of tunica albuginea in erectile dysfunction: experiment with rats), Zhonghua Yi Xue Za Zhi. Feb. 3, 2009; 89(4): 276-9.;;Alves, M.A., et al.: L-Arginine effects on blood pressure and renal function of intrauterine restricted rats. Pediatr Nephro (2002) 17:856-862.;;Anderson, MS, et al.: Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents. Int J Impot Res (2000) 12 Suppl 3, S25-31.;;Arthur, MJ.: Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol. Soc. (2000) 279: G245-G249.;;Asai, K, et al.: Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol. (2000) 20(6):1493-1499.;;Badalamente, MA, et al.: The role of transforming growth factor beta in Dupuytren's disease. Journal of Hand Surg (1996) 21A(2): 210-215.;;Becker, GJ, et al.: Pharmacological intervention in renal fibrosis and vascular sclerosis. J. Nephrol. (2001) 14:332-339.;;Beckmann, JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol (1996) 271:C1424-C1437.;;Behr-Roussel, D, et al.: Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethy-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation 2000; 102:1033-1038.;;Benigni, A, et al.: Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model. Am J Kidney Dis (1999) 33(4):746-53.;;Berry, C, et al.: Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens. (2001) 10:247-255.;;Bing, W, et al.: L-arginine impacts pulmonary vascular structure in rats with an aortocaval shunt. J Surg Res (2002)108:20-31.;;Bivalacqua, TJ, et al.: Gene transfer of extracellular SOD to the penis reduces O2-. and improves erectile function in aged rats. Am J Physiol Heart Circ Physiol. (2003) 284:H1408-1421.;;Bivalacqua, TJ et al.: A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. Jour Urol (2000) 163:1992-1998.;;Boffa, JJ, et al.: Angiotensin II activates collagen type I in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism. Circulation (1999) 100(18):1901-1908.;;Boger, RH, et al.: Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation (1998) 98:1842-1847.;;Bugno, M, et al.: Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett (1999) 448(1):9-14.;;Cai, H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. (2000) 87:840-844.;;Cao, M, et al.: Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 324:305-310.;;Casini, A, et al.: Neutrophil-derived superoxide anion induces lipid peroxidation and stimulations collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology (1997) 25(2):361-367.;;Catani, MV, et al.: Inhibition of clotting factor XIII activity by nitric oxide. Biochem Biophys Res Comm (1998) 249:275-278.;;Cattell, V: Nitric oxide and glomerulonephritis. Kidney Int (2002) 61(3):816-21.;;Cernadas, MR, et al.: Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res. (1998) 83:279-286.;;Chan, DC, et al.: Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors. Clin Cancer Res (2002) 8(3):904-912.;;Chatziantoniou, C, et al.: Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin. J Clin Invest (1998) 101(12):2780-2789.;;Chen, YM, Wu KD, Tsai TJ, Hsieh BS: Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells, J Mol Cell Cardiol (1999) 31(4):773-783.;;Chiche JD, et al.: Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J Biol Chem (1998) 273(51):34263-34271.;;Chipe, CC, et al.: Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro, Cell Death & Differ (2000) 7(2)166-176.;;Chou, T, et. al.: Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension. (1998) 31:643-648.;;Connat, JL, et al.: Modification of the rat aortic wall during ageing; possible relation with decrease of peptidergic innervation. Anat Embryol. (2001) 204:455-468.;;Connelly TJ: Development of Peyronie's and Dupuytren's diseases in an individual after single episodes of trauma: a case report and review of the literature. J Am Acad Dermatol (1999) 41(1):106-108.;;Corbin, JD, Francis SH: Cyclic GMP phosphodiesterase-5: target of sildenafil. J Bio Chem (1999) 274(20):13729-13732.;;Craven, PA, et al.: Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells. Diabetes (1997) 46:671-681.;;Csiszar, A, et al.: Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. (2002) 90:1159-1166.;;Curtin, JF, Donovan M, Cotter TG: Regulation and measurement of oxidative stress in apoptosis. J Immunnol Methods (2002) 265:49-72.;;Dambisya, YM, et al: A thromboelastography study on the in vitro effects of L-arginine and L-NG-nitro arginine methyl ester on human whole blood coagulation and fibrinolysis. Blood Coagul Fibrinol (1996) 7:678-683.;;Darby, IA, et al.: Skin flap-induced regression of granulation tissue correlates with reduced growth factor and increased metalloproteinase expression. J Pathol, (2002) 197(1):117-127.;;Davila, HH, et al.: Gene transfer of antisense PIN (protein inhibitor of NOS) cDNA on erectile dysfunction in aged rats. American Urological Association Meeting, Chicago, IL 2003.;;Dávila, M, et al.: Fibrin as an inducer of fibrosis in the tunica albuginea the rate: a new animal model for Peyronie's disease. Br. J. Urol. (2003) 91:830-838.;;Demaree, SR, et al.: Ageing alters aortic antioxidants enzyme activites in Fischer-344 rats. Acta Physiol Scand. (1999) 166:203-208.;;Desmoulière, A: Factors influencing myofibroblasts differentiation lduring would healing and fibrosis, Cell Biol Interntl (1995) 19(5):471-476.;;Desmouliere, A, et al.: Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells. J Hepatol (1999) 30(4): 621-631.;;Devine, CJ Jr, et al.: Proposal: trauma as the cause of the peyronie's lesion. J Urol (1997) 157(1):285-290.;;Diegelmann, RF: Cellular and biochemical aspects of normal and abnormal wound healing: an overview. J Urol (1997) 157:298-302.;;Duffield, JS, et al.: Activated macrophages direct apoptosis and suppress mitosis of mesangial cells. J Immunol (2000) 164(4):2110-2119.;;Duncan, MR, et al.: Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol (1991) 25(2):89-94.;;Dussaule, JC, et al.: Mechanisms mediating the renal profibrotic actions of vasoactive peptides in transgenic mice. J Am Soc Nepbrol Suppl (2000) 11(16):S124-8.;;Ehrlich, HP: Scar contracture: cellular and connective tissue aspects in yronie's disease. J Urol (1997) 157:316-319.;;Eickelberg, O, et al.: Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol. (1999) 276(5 Pt 1): L814-24.;;El-Sakka, AI, et al.: The effects of colchicine on a Peyronie's-like condition in an animal model. J Urol (1999) 161:1980-1983.;;El-Sakka, AI, et al.: Histological and ultrastructural alterations in an animal model of Peyronie's disease, British J Urol (1998) 81:445-452.;;El-Sakka, AI, et al.: An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol (1997) 158:2284-2290.;;El-Sakka, AI, et al.: Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol (1997) 158:1391-4.;;Essayan, DM: Cyclic nucleotide phosphodiesterases, J. Allergy Clin. Immunol. (2001) 108:671-680.;;Fakhouri, F, et al.: Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta. J Am Soc Nephrol (2001) 12(12):2701-10.;;Fan, J, et al.: Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol (2000) 22(4):412-21.;;Faouzi, S, et al.: Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellolar carcinoma: an in vivo and in vitro study. J Hepatol (1999) 30:275-284.;;Ferrini, M, et al.: Aging-telated expression of inducible nitric oxide sunthase (iNOS) and cytotoxicity markers in the rat penis. Biol Reprod (2001) 64:974-982.;;Ferrini, M, et al.: Aging-related expression of inducible nitric oxide synthase (iNOS) and cytotoxicity markers in rat hypothalamic regions associated with male reproductive function. Neuroendocr (2001) 74:1-11.;;Ferrini, MG, et al.: Penile neuronal nitric oxide synthase (PnNOS) and its regulatory proteins are present in hypothalamic and spinal cord regions involved in the control of penile erection. J Compar Neurol, (2003) 458:46-61.;;Ferrini, MG, et al.: Antifibrotic role of inducible nitric oxide synthase (iNOS). Nitric Oxide (2002) 6(3):283-294.;;Fischer, M, et al.: Crux medicorum ulcerated radiation-induced fibrosis-successful therapy with pentoxifylline and vitamin E. Eur J Dermatol (2001) 11(1): 38-40.;;Foresti, R, et al.: Peroxynitrite induces haemoxygenase-1 in vascular endothelial cells: a link to apoptosis. Br Biochem J (1999) 339:729-736.;;Fornieri, C, et al.: Role of the extracellular matrix in age-related modifications of the rat aorta. Ultrastructural, morphometric, and enzymatic evaluations. Arterioscler Thromb. (1992) 12(9):1008-1016.;;Forstermann, U, et al.: Expressional control of the ""constitutive"" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J (1998) 12:773-790.;;Garban, H, et al.: Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biol Reprod (1997) 56:954-963.;;Garban, H, et al.: Effect of aging on nitric oxide-mediated penile erection in the rat. Amer. J. Physiol. (1995) 268:H467-H475.;;Gelbard, MK: Dystrophic penile calcification in Peyronie's disease. J Urol (1988) 139(4)738-40.;;Geller, DA, Billiar TR: Molecular biology of nitric oxide synthases. Cancer Metast Rev (1998) 17:7-23.;;Gelman, J, et al.: Transforming growth factor -beta1 (TGF-beta1) in penile and prostate growth in the rat during sexual maturation. J Androl (1998) 19(1):50-57.;;Gewaltig, MT, Kojda G: Vasoprotection by nitric oxide: mechanisms and therapeutic protential. Cardivasc Res. (2002) 55:250-260.;;Gholami, SS, et al.: Peyronie's Disease: A review. J Urol, (2003) 169:1234-1241.;;Goettsch, W, et al: Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem Biophys Res Commun. (2001) 280:908-913.;;Gonzalez, W, et al.: Molecular plastiscity of vascular wall during N(G)-nitro-L-arginine methylester-induced hypertension: modulation of proinflamatory signals. Hypertension (2000) 36:103-109.;;González-Cadavid, NF, et al.: Nitric oxide and the cyclic GMP system in the penis. Mol Urol. (1999) 3(2):51-59.;;Gonzalez-Cadavid, NF, et al.: Gene expression in Peyronie's disease. Int. J. Impot. Res. (2002) 14:361-374.;;Grein, U, et al.: Arteriosclerosis of penile arteries: histolgical findings and their significance in the treatment of erectile dysfunction. Urol. Int. (2002) 68:261-264.;;Grounds, MD, et al.: The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem (2002) 50(5):589-610.;;Haig, DM, Thomson, Percival A: The in-vitro detection and quantitation of ovine bone marrow precursors of multipotential colony-forming cells. J Comp Path. (1994) 111(1):73-85.;;Heigold, S, et al.: Nitric oxide mediates apotosis induction selectively in transformed fibroblast compared to nontransformed fibroblasts. Carcinogenesis (2002) 23(6):929-941.;;Hellstrom, WJ, Bivalacqua TJ: Peyronie's disease: etiology, medical, and surgical therapy. J Androl (2000) 21(3):347-354.;;Hellstrom, WJG, Bivalacqua J, Champion, HC, et al.: Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat. J Androl (2001) 22(3):497-508.;;Herrick, S, et al.: Fibrinogen. Int J Biochem Cell Biol (1999) 31(7):741-6.;;Higuchi, H, et al.: Assay of antioxidant and anti-flammatory activity of nitric oxide in vivo. Meth Enzymol (1999) 301:424-436.;;Hildebrand, KA, et al.: Response of donor and recipient cells after transplantation of cells to the ligament and tendon. Microsc. Res. Tech. (2002) 58(1):34-38.;;Hochberg, D, et al.: Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase. Lab Invest (200) 80(11):1721-1728.;;Hofmann, F, et al.: Rising behind NO: cCMP-dependent protein kinases. J Cell Sci (2000) 113:1671-6.;;Hoaboam, CM, et al.: Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition. Am J Pathol (1998) 153(6):1861-1872.;;Holm, AM, et al.: Effects of L-arginine on vascular smooth muscle cell proliferation and apoptosis after balloon injury. Scand.Cardiovasc J. (2000) 34:28-32.;;Holmdahl, L, et al.: Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment. Surgery (2001) 129(5)626-632.;;Horio, T, et al.: Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts. Eur J Pharmacol (1999) 382(1):1-9.;;Huff, T, et al.: beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol (2001) 33(3): 205-220.;;Huff, T, et al.: Thymosin beta4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen. FASEB J. (2002) 16(7):691-696.;;Hung, A, et al.: Expression of the inducible nitric oxide synthase in smooth muscle cells from the rat penile corpora cavernosa. J Androl (1995) 16(6):469-481.;;Ihrig, M, et al.: Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas. Atherosclerosis. (2001) 156:103-107.;;Ikeda, K, et al.: Nitric oxide deficiency induces myocardial infarction in hypercholesterolemic stroke-prone spontaneously hypertensive rats. Clin Exptl Pharmacol Physiol (1997) 24:344-8.;;Intengan, HD, Schiffrin EL: Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension. (2000) 36:312-318.;;Intengan, HD, Schiffrin EL: Vascular remodeling in hypertension. Roles of apoptosis, inflammation, and fibrosis. Hypertension. (2001) 38[part 2]: 581-587.;;Ito, S, et al.: Induction of glomerular injury by singlet oxygen. Nephron (1992) 60(2):204-9.;;Iredale, JP: Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol (1997) 29(1):43-54.",ACTIVE
19,EP,A1,EP 0808104 A1,181-542-548-079-974,1997-11-26,1997,EP 95940665 A,1995-11-09,US 9514588 W;;US 33735794 A,1994-11-10,"AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS",,NIREC INC,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/181-542-548-079-974,Patent Application,yes,0,0,8,8,0,A61K9/0034;;A61K9/0034;;A61K38/00;;A61K38/00;;A61K38/191;;A61K38/191;;A61K38/2006;;A61K38/2006;;A61K38/217;;A61K38/217;;A61K48/00;;A61K48/00;;A61P13/02;;A61P15/00;;C12N9/0075;;C12N9/0075;;C12Y114/13039;;C12Y114/13039,C12N15/09;;A61K31/715;;A61K35/74;;A61K38/00;;A61K38/19;;A61K38/20;;A61K38/21;;A61K38/43;;A61K38/44;;A61K48/00;;A61P13/02;;A61P15/00;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/02;;C12R1/19,,1,0,,,See references of WO 9614748A1,DISCONTINUED
20,AU,A,AU 1997/029338 A,192-034-131-885-960,1997-12-05,1997,AU 1997/029338 A,1997-05-09,US 1737396 P;;US 9707643 W,1996-05-10,Amelioration of erectile dysfunction,,JACOB RAJFER;;NESTOR F GONZALEZ CADAVID,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/192-034-131-885-960,Patent Application,no,0,0,2,2,0,A61K9/0034;;A61K31/711;;A61K31/739;;A61K38/00;;A61K38/191;;A61K38/2006;;A61K38/217;;A61K48/00;;C12N9/0075;;C12Y114/13039,A61K35/74;;A61K38/00;;A61K38/19;;A61K38/20;;A61K38/21;;A61K48/00;;C12N9/02,,0,0,,,,PENDING
21,US,A1,US 2017/0239257 A1,002-971-098-573-346,2017-08-24,2017,US 201615277550 A,2016-09-27,US 201615277550 A;;US 0333400 W;;US 201414453543 A;;US 201213372094 A;;US 77906904 A;;US 42028102 P,2002-10-22,"Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, a PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity.",LOS ANGELES BIOMEDICAL RES INST AT HARBOR- UCLA MEDICAL CENTER,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/002-971-098-573-346,Patent Application,yes,0,0,8,8,0,A61K31/53;;A61K31/53;;A61K9/0053;;A61K31/00;;A61K31/00;;A61K31/4985;;A61K31/4985;;A61K31/519;;A61K31/519;;A61K48/00;;A61K48/00;;A61K48/005;;A61K48/005;;A61P15/00;;C12N15/86;;C12N15/86;;C12N2710/10343;;C12N2710/10343;;C12N2830/008;;C12N2830/008;;C12N2830/85;;C12N2830/85,A61K31/53;;A61K9/00;;A61K31/00;;A61K31/4985;;A61K31/519;;A61K48/00;;C12N15/861,,0,0,,,,DISCONTINUED
22,US,A1,US 2012/0141454 A1,116-389-222-932-132,2012-06-07,2012,US 201213372094 A,2012-02-13,US 201213372094 A;;US 0333400 W;;US 77906904 A,2003-10-21,"Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, a PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity.",GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB;;LOS ANGELES BIOMED RES INST,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/116-389-222-932-132,Patent Application,yes,0,0,8,8,0,A61K31/53;;A61K31/53;;A61K9/0053;;A61K31/00;;A61K31/00;;A61K31/4985;;A61K31/4985;;A61K31/519;;A61K31/519;;A61K48/00;;A61K48/00;;A61K48/005;;A61K48/005;;A61P15/00;;C12N15/86;;C12N15/86;;C12N2710/10343;;C12N2710/10343;;C12N2830/008;;C12N2830/008;;C12N2830/85;;C12N2830/85,A61K31/4985;;A61K31/00;;A61K31/519;;A61K31/53;;A61K38/48;;A61K48/00;;A61P15/00;;C12N15/861,424/94.67;;514/252.16;;514/250;;514/243,0,0,,,,DISCONTINUED
23,MX,A,MX 2008015749 A,169-323-310-590-559,2010-06-08,2010,MX 2008015749 A,2008-12-09,MX 2008015749 A,2008-12-09,TWO-STROKE INNER COMBUSTION ENGINE.,"The present invention refers to a two-stroke inner combustion engine, where the pistons are actuated by a camshaft, and the mechanism of the exhaust valves allow the aperture thereof to be speed up or slow down, providing the following advantages: 1) A better use of the fuel. 2) Elimination of noise from the exhaust system upon equalling the pressure in the combustion chamber and the atmospheric pressure. 3) Elimination of detonation noise. 4) A higher power upon using the whole expansive wave of the combustion. 5) The same power upon modifying the compression ratio and maintaining the same air volume at different heights.",HEIRAS ESTEBAN GONZALEZ,HEIRAS ESTEBAN GONZALEZ;;LOPEZ NESTOR BAEZA,,https://lens.org/169-323-310-590-559,Patent Application,no,0,0,1,1,0,,F02B1/00,,0,0,,,,PENDING
24,WO,A1,WO 1996/014748 A1,083-634-917-167-562,1996-05-23,1996,US 9514588 W,1995-11-09,US 33735794 A,1994-11-10,"AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS","Treatment of erectile dysfunction comprising administering to a patient, inducible Nitric Oxide Synthase (iNOS) agents, including penile iNOS, inducers of penile iNOS, iNOS cDNA, or penile smooth muscle cells or corpora cavernosa with iNOS cDNA. Typical in vivo treatment involves delivery of these agents to the penile tissue of a patient by constant or intermittent implanted or external infusion pump, pellets, intrauretheral administration, injection or other related procedures. The genetically engineered cells or penile tissue from the patient hyperexpressing iNOS is implanted in microcapsules, pellets, or other methods, or directly by surgical inoculation into the corpora cavernosa. In certain cases, an oral or injectable systemic route of administration is applicable. Also disclosed are methods of treatment involving in vitro induction of iNOS in cultured smooth muscle cells and thereofter delivery of purified or recombinant iNOS enzyme, production of iNOS cDNA and genetic transformation with iNOS cDNA, followed by delivery thereof to the penis of a patient. The methods of this invention include hyperexpression and/or biological modulation of other endogenous and exogenous NOS isoforms in the penis, for the treatment of erectile dysfunction.",NIREC INC;;GONZALEZ CADAVID NESTOR F;;RAJFER JACOB,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/083-634-917-167-562,Patent Application,yes,0,16,8,8,0,A61K9/0034;;A61K9/0034;;A61K38/00;;A61K38/00;;A61K38/191;;A61K38/191;;A61K38/2006;;A61K38/2006;;A61K38/217;;A61K38/217;;A61K48/00;;A61K48/00;;A61P13/02;;A61P15/00;;C12N9/0075;;C12N9/0075;;C12Y114/13039;;C12Y114/13039,C12N15/09;;A61K31/715;;A61K35/74;;A61K38/00;;A61K38/19;;A61K38/20;;A61K38/21;;A61K38/43;;A61K38/44;;A61K48/00;;A61P13/02;;A61P15/00;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/02;;C12R1/19,,1,0,,,"CHEMICAL ABSTRACTS, issued 1994, EHREN et al., ""Nitric Oxide Synthase Activity in the Human Urogenital Tract"", Abstract No. 122:259288.",PENDING
25,US,A1,US 2020/0032450 A1,158-768-662-471-118,2020-01-30,2020,US 201816004366 A,2018-06-09,ES 201730717 U,2017-06-15,HEATING HANGER,"A heating hanger. The hanger includes a casing, having a lower and upper grills. The casing further includes a heating ensemble, which provides heat employing resistive heating elements, and a fan. A cycle commutator controls the operation of the heating ensemble and fan to provide heated forced airflow to a garment hanging on the hanger.",VEGA JAVIER GONZALEZ;;ECHEPARE NESTOR TOLOSA,VEGA JAVIER GONZALEZ;;ECHEPARE NESTOR TOLOSA,,https://lens.org/158-768-662-471-118,Patent Application,yes,10,1,4,4,0,A47G25/14;;A47G2025/1485;;D06F59/02;;D06F59/02,D06F59/02,,0,0,,,,DISCONTINUED
26,WO,A1,WO 1997/042965 A1,155-193-864-498-008,1997-11-20,1997,US 9707643 W,1997-05-09,US 1737396 P,1996-05-10,AMELIORATION OF ERECTILE DYSFUNCTION,"Methods of treatment of erectile dysfunction are disclosed. In these methods, a medicament is introduced into the penile tissue of a patient. This medicament preferably is one which induces cavernosal smooth muscle relaxation, and/or produces an increase in the level of nitric oxide synthetase (NOS) in tissue. This treatment includes the transfer of cDNAs to the penis, wherein these cDNAs encode proteins that induce the relaxation of the corpora cavernosa smooth muscle. An isolated sequence encoding human penile inducible nitric oxide synthetase is also disclosed.",GONZALEZ CADAVID NESTOR F;;RAJFER JACOB,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/155-193-864-498-008,Patent Application,yes,1,0,2,2,0,A61K9/0034;;A61K31/711;;A61K31/739;;A61K38/00;;A61K38/191;;A61K38/2006;;A61K38/217;;A61K48/00;;C12N9/0075;;C12Y114/13039,A61K35/74;;A61K38/00;;A61K38/19;;A61K38/20;;A61K38/21;;A61K48/00;;C12N9/02,,2,2,001-095-025-479-427;;046-759-373-855-603,14959705;;10.1126/science.270.5235.404;;7569994,"J. ANDROLOGY, November/December 1995, Vol. 16, No. 6, HUNG et al., ""Expression of Inducible Nitric Oxide Synthethase in Smooth Muscle Cells from Rat Penile Corpora Cavernosa"", pages 469-481.;;SCIENCE, 20 October 1995, Vol. 270, CRYSTAL et al., ""Transfer of Genes to Humans: Early Lessons and Obstacles to Success"", pages 404-410.",PENDING
27,AU,A,AU 1997/018509 A,022-294-625-246-153,1997-09-02,1997,AU 1997/018509 A,1997-02-13,US 1170796 P;;US 1737196 P;;US 3155096 P;;US 9701565 W,1996-02-15,Novel penile neuronal nitric oxide synthase (pnnos) and applications for diagnosis and treatment of urogenital disorders,,NESTOR F GONZALEZ CADAVID;;JACOB RAJFER,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/022-294-625-246-153,Patent Application,no,0,0,2,2,0,A61K48/00;;C12N9/0075,A61K48/00;;C12N9/02,,0,0,,,,DISCONTINUED
28,AU,A8,AU 2003/286555 A8,097-040-032-007-342,2004-05-13,2004,AU 2003/286555 A,2003-10-21,US 42028102 P;;US 0333400 W,2002-10-22,"Phosphodiester inhibitors and nitric oxide modulators for treating peyronie's disease, arteriosclerosis and other fibrotic diseases",,HARBOR UCLA RES & EDUCATION,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/097-040-032-007-342,Patent Application,no,0,0,4,4,0,A61K31/58;;A61K31/519,A61K/;;A61K31/519;;A61K31/58,,0,0,,,,DISCONTINUED
29,CA,A1,CA 2204886 A1,070-191-185-732-439,1996-05-23,1996,CA 2204886 A,1995-11-09,US 33735794 A,1994-11-10,"AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH INOS, AND RELATED NOS AGENTS","Treatment of erectile dysfunction comprising administering to a patient, inducible Nitric Oxide Synthase (iNOS) agents, including penile iNOS, inducers of penile iNOS, iNOS cDNA, or penile smooth muscle cells or corpora cavernosa with iNOS cDNA. Typical in vivo treatment involves delivery of these agents to the penile tissue of a patient by constant or intermittent implanted or external infusion pump, pellets, intrauretheral administration, injection or other related procedures. The genetically engineered cells or penile tissue from the patient hyperexpressing iNOS is implanted in microcapsules, pellets, or other methods, or directly by surgical inoculation into the corpora cavernosa. In certain cases, an oral or injectable systemic route of administration is applicable. Also disclosed are methods of treatment involving in vitro induction of iNOS in cultured smooth muscle cells and thereofter delivery of purified or recombinant iNOS enzyme, production of iNOS cDNA and genetic transformation with iNOS cDNA, followed by delivery thereof to the penis of a patient. The methods of this invention include hyperexpression and/or biological modulation of other endogenous and exogenous NOS isoforms in the penis, for the treatment of erectile dysfunction.",NIREC INC,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/070-191-185-732-439,Patent Application,no,0,0,8,8,0,A61K9/0034;;A61K9/0034;;A61K38/00;;A61K38/00;;A61K38/191;;A61K38/191;;A61K38/2006;;A61K38/2006;;A61K38/217;;A61K38/217;;A61K48/00;;A61K48/00;;A61P13/02;;A61P15/00;;C12N9/0075;;C12N9/0075;;C12Y114/13039;;C12Y114/13039,C12N15/09;;A61K31/715;;A61K35/74;;A61K38/00;;A61K38/19;;A61K38/20;;A61K38/21;;A61K38/43;;A61K38/44;;A61K48/00;;A61P13/02;;A61P15/00;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/02;;C12R1/19,,0,0,,,,DISCONTINUED
30,US,A1,US 2005/0085486 A1,141-364-817-032-753,2005-04-21,2005,US 77906904 A,2004-02-13,US 77906904 A;;US 0333400 W,2003-10-21,"Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, a PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity.",GONZALEZ-CADAVID NESTOR F.;;RAJFER JACOB,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (2004-05-05),https://lens.org/141-364-817-032-753,Patent Application,yes,15,46,8,8,0,A61K31/53;;A61K31/53;;A61K9/0053;;A61K31/00;;A61K31/00;;A61K31/4985;;A61K31/4985;;A61K31/519;;A61K31/519;;A61K48/00;;A61K48/00;;A61K48/005;;A61K48/005;;A61P15/00;;C12N15/86;;C12N15/86;;C12N2710/10343;;C12N2710/10343;;C12N2830/008;;C12N2830/008;;C12N2830/85;;C12N2830/85,A61K31/00;;A61K31/519;;A61K48/00;;C12N15/861,514/252.16;;514/262.1,0,0,,,,EXPIRED
31,WO,A3,WO 2004/037183 A3,051-366-801-580-751,2004-08-05,2004,US 0333400 W,2003-10-21,US 42028102 P,2002-10-22,"PHOSPHODIESTER INHIBITORS AND NITRIC OXIDE MODULATORS FOR TREATING PEYRONIE'S DISEASE, ARTERIOSCLEROSIS AND OTHER FIBROTIC DISEASES","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie&apos;s disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren&apos;s disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation,general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity. In certain embodiments, the composition may be a gene therapy vector.",HARBOR UCLA RES & EDUCATION;;GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/051-366-801-580-751,Search Report,yes,3,0,4,4,0,A61K31/58;;A61K31/519,A61K/;;A61K31/519;;A61K31/58,,0,0,,,,PENDING
32,US,A1,US 2019/0391321 A1,113-344-395-512-699,2019-12-26,2019,US 201916451769 A,2019-06-25,EP 18382475 A,2018-06-26,LIGHTING DEVICE AND METHOD FOR MANUFACTURING SAID LIGHTING DEVICE,"The lighting device comprises a light guide comprising two or more layers; and a light source that illuminates the light guide. The two or more layers define at least one surface between two adjacent layers. Geometric motives are formed in the at least one surface. The method for manufacturing the lighting device includes the step of providing one layer. Geometric motives are then formed in the one layer. After this formation, another layer is injected directly to the geometric motives, thus defining a surface between the layers that provides a better homogenous illuminance and a better photometric performance.",FICOMIRRORS S A U,ORTEGA NESTOR RUIZ;;TIL GONZALEZ MADORRAN,FICOMIRRORS S.A.U (2019-07-29),https://lens.org/113-344-395-512-699,Patent Application,yes,3,1,2,2,0,F21S43/239;;F21K9/237;;F21S43/14;;F21S43/245;;F21S43/50;;G02B6/0065;;G02B6/0055;;G02B6/006;;G02B6/0073;;G02B6/0076;;G02B6/3668,F21V8/00;;G02B6/36,,0,0,,,,DISCONTINUED
33,US,A1,US 2018/0318307 A1,175-834-188-760-332,2018-11-08,2018,US 201715832918 A,2017-12-06,US 201715832918 A;;US 0333400 W;;US 201615277550 A;;US 201414453543 A;;US 201213372094 A;;US 77906904 A,2003-10-21,"METHODS OF USE OF INHIBITORS OF PHOSPHODIESTERASES AND MODULATORS OF NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND METALLOPROTEINASES IN THE TREATMENT OF PEYRONIE'S DISEASE, ARTERIOSCLEROSIS AND OTHER FIBROTIC DISEASES","The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, a PDE-5 inhibitor, a compound that elevates cGMP and/or PKG, a stimulator of guanylyl cyclase and/or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity.",LOS ANGELES BIOMEDICAL RES INSTITUTE AT HARBO,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/175-834-188-760-332,Patent Application,yes,0,1,8,8,0,A61K31/53;;A61K31/53;;A61K9/0053;;A61K31/00;;A61K31/00;;A61K31/4985;;A61K31/4985;;A61K31/519;;A61K31/519;;A61K48/00;;A61K48/00;;A61K48/005;;A61K48/005;;A61P15/00;;C12N15/86;;C12N15/86;;C12N2710/10343;;C12N2710/10343;;C12N2830/008;;C12N2830/008;;C12N2830/85;;C12N2830/85,A61K31/53;;A61K9/00;;A61K31/00;;A61K31/4985;;A61K31/519;;A61K48/00;;C12N15/86;;C12N15/861,,0,0,,,,DISCONTINUED
34,WO,A1,WO 1997/030066 A1,180-681-200-251-239,1997-08-21,1997,US 9701565 W,1997-02-13,US 1170796 P;;US 1737196 P;;US 3155096 P,1996-02-15,NOVEL PENILE NEURONAL NITRIC OXIDE SYNTHASE (PnNOS) AND APPLICATIONS FOR DIAGNOSIS AND TREATMENT OF UROGENITAL DISORDERS,"A rat tissue nitric oxide synthase designated RPnNOS and the cDNA are disclosed. It is expressed in pelvic plexus, bladder, skeletal muscle, liver, cerebellum as well as penile tissue.",GONZALEZ CADAVID NESTOR F;;RAJFER JACOB,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,,https://lens.org/180-681-200-251-239,Patent Application,yes,3,2,2,2,0,A61K48/00;;C12N9/0075,A61K48/00;;C12N9/02,,7,7,007-464-222-018-08X;;001-095-025-479-427;;017-789-760-651-614;;001-605-762-113-211;;002-417-005-384-178;;020-256-906-675-974;;065-461-511-880-08X,1712077;;10.1038/351714a0;;14959705;;7528745;;10.1016/s0021-9258(20)30099-5;;10.1046/j.1471-4159.1994.63010140.x;;7515942;;10.1016/0014-5793(93)81210-q;;7678401;;7686743;;10.1006/bbrc.1993.1726;;10.1006/bbrc.1996.1324;;8806605,"NATURE, 27 June 1991, Vol. 351, BREDT et al., ""Cloned and Expressed Nitric Oxide Synthase Structurally Resembles Cytochrome P-450 Reductase"", pages 714-718.;;J. ANDROL., November/December 1995, Vol. 16, No. 6, HUNG et al., ""Expression of Inducible Nitric Oxide Synthase in Smooth Muscle Cells from Rat Penile Corpora Cavernosa"", pages 469-481.;;J. BIOL. CHEM., 30 December 1994, Vol. 269, No. 52, HALL et al., ""Structural Organization of the Human Neuronal Nitric Oxide Synthase Gene (NOS1)"", pages 33082-33090.;;J. NEUROCHEM., July 1994, Vol. 63, No. 1, FUJISAWA et al., ""Expression of Two Types of Nitric Oxide Synthase mRNA in Human Neuroblastoma Cell Lines"", pages 140-145.;;FEBS LETT., January 1993, Vol. 316, No. 2, NAKANE et al., ""Cloned Human Brain Nitric Oxide Synthase is Highly Expressed in Skeletal Muscle"", pages 175-180.;;BIOCHEM. BIOPHYS. RES. COMMUN., 30 June 1993, Vol. 193, No. 3, OGURA et al., ""Structural Diversity of Neuronal Nitric Oxide Synthase mRNA in the Nervous System"", pages 1014-1022.;;BIOCHEM. BIOPHYS. RES. COMMUN., 04 September 1996, Vol. 226, No. 1, MAGEE et al., ""Cloning of a Novel Neuronal Nitric Oxide Synthase Expressed in Penis and Lower Urinary Tract"", pages 145-151.",PENDING
35,US,A,US 5594032 A,133-855-407-380-452,1997-01-14,1997,US 33735794 A,1994-11-10,US 33735794 A,1994-11-10,"Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA","Treatment of erectile dysfunction comprising administering to a patient, inducible Nitric Oxide Synthase (iNOS) agents, including penile iNOS, inducers of penile iNOS, iNOS cDNA, or penile smooth muscle cells transformed with iNOS cDNA. Typical in vivo treatment involves delivery of these agents to the penile tissue of a patient by constant or intermittent implanted or external infusion pump, by implantation of time-release microcapsules or introduction of the genetically-engineered cells as by injection. Also disclosed are methods of treatment involving in vitro induction of iNOS in cultured smooth muscle cells and thereafter delivery of purified or recombinant iNOS enzyme, production of iNOS cDNA and genetic transformation with iNOS cDNA, followed by delivery thereof to the penis of a patient.",GONZALEZ-CADAVID; NESTOR F.;;RAJFER; JACOB,GONZALEZ-CADAVID NESTOR F;;RAJFER JACOB,NIREC INC (1995-01-17),https://lens.org/133-855-407-380-452,Granted Patent,yes,8,61,8,8,0,A61K9/0034;;A61K9/0034;;A61K38/00;;A61K38/00;;A61K38/191;;A61K38/191;;A61K38/2006;;A61K38/2006;;A61K38/217;;A61K38/217;;A61K48/00;;A61K48/00;;A61P13/02;;A61P15/00;;C12N9/0075;;C12N9/0075;;C12Y114/13039;;C12Y114/13039,C12N15/09;;A61K31/715;;A61K35/74;;A61K38/00;;A61K38/19;;A61K38/20;;A61K38/21;;A61K38/43;;A61K38/44;;A61K48/00;;A61P13/02;;A61P15/00;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/02;;C12R1/19,514/645;;514/740;;435/195;;435/212;;435/226;;435/228;;530/395,0,0,,,,EXPIRED
36,ES,U,ES 1186733 U,182-282-108-886-826,2017-07-04,2017,ES 201730717 U,2017-06-15,ES 201730717 U,2017-06-15,"Heating hanger (Machine-translation by Google Translate, not legally binding)","Heating mantle, characterized in that, in relation to its arms (8) in which the hanging garment is arranged, it consists of: a) a casing (1) in which a lower grid (2) and an upper grid (3) associated, respectively, are attached to a heating assembly (4) and a fan (5); and b) a cycle switch (6) which, connected via cable (7) to an external power supply, controls the switching on and off of both the heating assembly (4) and the fan (5) thanks to at least one switch (9) (Machine-translation by Google Translate, not legally binding)",GONZALEZ VEGA JAVIER;;TOLOSA ECHEPARE NESTOR,GONZALEZ VEGA JAVIER;;TOLOSA ECHEPARE NESTOR,GOVE GESTION S.L (2021-12-30),https://lens.org/182-282-108-886-826,Patent Application,no,0,0,4,4,0,A47G25/14;;A47G2025/1485;;D06F59/02;;D06F59/02,D06F59/00;;A47G25/14,,0,0,,,,ACTIVE
37,US,A1,US 2015/0328249 A1,152-468-793-984-324,2015-11-19,2015,US 201314651616 A,2013-12-11,US 201314651616 A;;US 201261735953 P;;US 2013/0074467 W,2012-12-11,"MODULATION OF MYOFIBER REPAIR BY ANTI-MYOSTATIN STRATEGIES AND/OR PPAR GAMMA LIGANDS, ALONE OR IN COMBINATION WITH STEM CELLS, FOR THE THERAPY OF CRITICAL LIMB ISCHEMIA AND OTHER ISCHEMIC PROCESSES AFFECTING THE SKELETAL MUSCLE",Treating or inhibiting an ischemic condition affecting the skeletal muscle comprising administering an agent having a property to inhibit an activity or a protein expression of myostatin or growth differentiation factor 8 (GDF-8) according to a regimen to treat or inhibit the ischemic condition. Treating or inhibiting an ischemic condition affecting the skeletal muscle including administering an effective amount of a thiazolidenedione or other PPAR gamma agonist at a dosage that do not exert glycemic control or induce overweight. A kit for use in treating or inhibiting an ischemic condition affecting the skeletal muscle comprising a quantity of an agent having a property to inhibit an activity or a protein expression of myostatin or growth differentiation factor 8 (GDF-8) and/or a quantity of a thiazolidenedione or other PPAR gamma agonist and instructions for administration of a dosage of that quantity according to a long term continuous regimen.,LOS ANGELES BIOMED RES INST,GONZALEZ-CADAVID NESTOR F;;WHITE RODNEY A,LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (2015-06-10),https://lens.org/152-468-793-984-324,Patent Application,yes,3,25,2,2,0,A61K31/425;;A61K31/7105;;A61K31/713;;A61K31/4439;;A61K35/545;;A61K31/4439;;A61K38/1709;;A61K38/39;;C07K16/22;;C12N15/1136;;A61K45/06;;C12N2320/31;;C12N2310/11;;C12N2310/141;;A61K31/7105;;A61K31/425;;A61K31/713,A61K31/4439;;A61K31/7105;;A61K35/545;;A61K38/17;;A61K38/39;;A61K45/06;;C07K16/22;;C12N15/113,,3,2,031-382-138-885-974;;091-742-457-508-052,15007007;;10.1161/01.cir.0000121427.53291.78;;18989575;;10.1111/j.1745-7270.2008.00473.x,"Higashi et al. Circulation 2004 109:1215-8;;Asai et al. (PLoS One 8:e806, pages 1-16, 2007);;Liu et al. Acta Biochim Biphys Sin 2008:40, 943-948",DISCONTINUED
38,ES,Y,ES 1235314 Y,135-904-296-879-461,2019-12-17,2019,ES 201931386 U,2019-08-19,ES 201931386 U,2019-08-19,MAQUINA DE LIMPIEZA DE LAMINAS PLASTICAS,,CARTONPLAST IBERICA SLU,GONZALEZ BENITO NESTOR;;CARRASCO TURRERO JOSE MARIA,,https://lens.org/135-904-296-879-461,Limited Patent,no,0,0,2,2,0,,B08B3/02;;G01N23/00,,0,0,,,,ACTIVE
39,ES,Y,ES 1288685 Y,199-712-997-635-246,2022-06-22,2022,ES 202132566 U,2021-12-30,ES 202132566 U,2021-12-30,DISPOSITIVO DE INSPECCION PARA MAQUINA DE LIMPIEZA DE SEPARADORES PLASTICOS,,CARTONPLAST IBERICA SLU,CARRASCO TURRERO JOSE MARIA;;GONZALEZ BENITO NESTOR,,https://lens.org/199-712-997-635-246,Limited Patent,no,0,0,2,2,0,,G01N23/00;;B08B3/02,,0,0,,,,ACTIVE
40,PT,U,PT 12119 U,076-893-474-911-075,2022-08-01,2022,PT 1211922 U,2022-02-01,PT 1211922 U,2022-02-01,DISPOSITIVO DE INSPECÇÃO PARA MÁQUINA DE LIMPEZA DE SEPARARADORES PLÁSTICOS,"DISPOSITIVO DE INSPECÇÃO (1) PARA MÁQUINA DE LIMPEZA (2) DE SEPARADORES PLÁSTICOS (3),DO TIPO DE SEPARADORES (3) UTILIZÁVEIS PARA SEPARAÇÃO DE NÍVEIS EM CAMADAS DERECIPIENTES NA DISTRIBUIÇÃO DE PRODUTOS, QUE COMPREENDE UM PRIMEIRO ELEMENTO DE INSPECÇÃO DE SUPERFÍCIE (4) COMPREENDENDO, PELO MENOS, UM PERFILÔMETRO DE LASER (41,42), CUJO FEIXE DE DETECÇÃO (41A, 42A) É ORIENTADO EM DIRECÇÃO A UMA ZONA DE DETECÇÃO(5) ATRAVÉS DA QUAL CORREM OS SEPARADORES (3), COMPREENDENDO, AINDA, UM SEGUNDO ELEMENTO DE INSPECÇÃO QUE COMPREENDE CÂMARAS DE GRAVAÇÃO DE IMAGEM (61, 62)DIRECCIONADAS PARA A ÁREA DE DETECÇÃO (5) E ASSOCIADAS A UM ELEMENTO INFORMÁTICO (7)PROVIDO COM UM BANCO DE DADOS (70) DE PADRÕES DE PONTOS E UM COMPARADOR (71) DOS REFERIDOS PADRÕES COM AS IMAGENS CAPTADAS PELAS CÂMARAS (61, 62) E QUE COMPREENDE,TAMBÉM, ELEMENTOS DE TRACÇÃO PARA OS SEPARADORES (3) ATRAVÉS DA ZONA DE DETECÇÃO",CARTONPLAST IBERICA S L U,JOSE MARIA CARRASCO TURRERO;;NESTOR GONZALEZ BENITO,,https://lens.org/076-893-474-911-075,Limited Patent,no,0,0,2,2,0,B08B7/0042,B08B3/00,,0,0,,,,ACTIVE
41,ES,U,ES 1235314 U,152-859-416-931-372,2019-09-26,2019,ES 201931386 U,2019-08-19,ES 201931386 U,2019-08-19,"PLASTIC SHEET CLEANING MACHINE (Machine-translation by Google Translate, not legally binding)","Plastic sheet cleaning machine (1), of the type comprising: - a single continuous sheet feeder (3), - a washing unit (4) with water sprinklers (5) or steam for impregnation, dragging and rinsing, scraping elements (6) for cleaning, and air blowers (7) for drying, - a first visual rejection selector (15) for broken or dirty sheets, and - an operating control unit (9); characterized in that it comprises an X-ray inspection element (10) arranged at the exit of the washing unit (4) for inspection of the sheets after washing. (Machine-translation by Google Translate, not legally binding)",CARTONPLAST IBERICA SLU,GONZALEZ BENITO NESTOR;;CARRASCO TURRERO JOSE MARIA,,https://lens.org/152-859-416-931-372,Patent Application,no,0,0,2,2,0,,B08B3/02;;G01N23/00,,0,0,,,,ACTIVE
42,PT,Y,PT 12119 Y,167-368-855-422-834,2022-12-13,2022,PT 1211922 U,2022-02-01,PT 1211922 U,2022-02-01,DISPOSITIVO DE INSPECÇÃO PARA MÁQUINA DE LIMPEZA DE SEPARARADORES PLÁSTICOS,"DISPOSITIVO DE INSPECÇÃO (1) PARA MÁQUINA DE LIMPEZA (2) DE SEPARADORES PLÁSTICOS (3),DO TIPO DE SEPARADORES (3) UTILIZÁVEIS PARA SEPARAÇÃO DE NÍVEIS EM CAMADAS DERECIPIENTES NA DISTRIBUIÇÃO DE PRODUTOS, QUE COMPREENDE UM PRIMEIRO ELEMENTO DE INSPECÇÃO DE SUPERFÍCIE (4) COMPREENDENDO, PELO MENOS, UM PERFILÔMETRO DE LASER (41,42), CUJO FEIXE DE DETECÇÃO (41A, 42A) É ORIENTADO EM DIRECÇÃO A UMA ZONA DE DETECÇÃO(5) ATRAVÉS DA QUAL CORREM OS SEPARADORES (3), COMPREENDENDO, AINDA, UM SEGUNDO ELEMENTO DE INSPECÇÃO QUE COMPREENDE CÂMARAS DE GRAVAÇÃO DE IMAGEM (61, 62)DIRECCIONADAS PARA A ÁREA DE DETECÇÃO (5) E ASSOCIADAS A UM ELEMENTO INFORMÁTICO (7)PROVIDO COM UM BANCO DE DADOS (70) DE PADRÕES DE PONTOS E UM COMPARADOR (71) DOS REFERIDOS PADRÕES COM AS IMAGENS CAPTADAS PELAS CÂMARAS (61, 62) E QUE COMPREENDE,TAMBÉM, ELEMENTOS DE TRACÇÃO PARA OS SEPARADORES (3) ATRAVÉS DA ZONA DE DETECÇÃO",CARTONPLAST IBERICA S L U,JOSE MARIA CARRASCO TURRERO;;NESTOR GONZALEZ BENITO,,https://lens.org/167-368-855-422-834,Limited Patent,no,0,0,2,2,0,B08B7/0042,B08B3/00,,0,0,,,,ACTIVE
43,WO,A1,WO 2014/093531 A1,197-585-491-580-733,2014-06-19,2014,US 2013/0074467 W,2013-12-11,US 201261735953 P,2012-12-11,MODULATION OF MYOFIBER REPAIR BY ANTI-MYOSTATIN IN STRATEGIES WITH STEM CELLS,Treating or inhibiting an ischemic condition affecting the skeletal muscle comprising administering an agent having a property to inhibit an activity or a protein expression of myostatin or growth differentiation factor 8 (GDF-8) according to a regimen to treat or inhibit the ischemic condition. Treating or inhibiting an ischemic condition affecting the skeletal muscle including administering an effective amount of a thiazolidenedione or other PPAR gamma agonist at a dosage that do not exert glycemic control or induce overweight. A kit for use in treating or inhibiting an ischemic condition affecting the skeletal muscle comprising a quantity of an agent having a property to inhibit an activity or a protein expression of myostatin or growth differentiation factor 8 (GDF-8) and/or a quantity of a thiazolidenedione or other PPAR gamma agonist and instructions for administration of a dosage of that quantity according to a long term continuous regimen.,LOS ANGELES BIOMED RES INST,GONZALEZ-CADAVID NESTOR F;;WHITE RODNEY A,,https://lens.org/197-585-491-580-733,Patent Application,yes,2,6,2,2,0,A61K31/425;;A61K31/7105;;A61K31/713;;A61K31/4439;;A61K35/545;;A61K31/4439;;A61K38/1709;;A61K38/39;;C07K16/22;;C12N15/1136;;A61K45/06;;C12N2320/31;;C12N2310/11;;C12N2310/141;;A61K31/7105;;A61K31/425;;A61K31/713,A01N43/78;;A61K31/425;;A61K39/395;;A61K48/00;;C07D277/00;;C07K2/00;;C07K16/18;;C12N5/071,,0,0,,,,PENDING
44,ES,U,ES 1288685 U,013-868-927-654-64X,2022-04-01,2022,ES 202132566 U,2021-12-30,ES 202132566 U,2021-12-30,"Inspection device for cleaning machine of plastic separators (Machine-translation by Google Translate, not legally binding)","Inspection device (1) for cleaning machine (2) of plastic separators (3), of the type of separators (3) usable for level separation in packaging chambers in product distribution, characterized by: -Comepret a first surface inspection element (4) comprising, at least, a profileometer (41, 42) laser, whose detection beam (41a, 42a) is oriented towards a detection zone (5) whereby discourse separators (3), - also a second inspection element comprising camera recording cameras (61, 62) directed towards the detection zone (5), and associated with a computer element (7) provided with a database (70) of patterns of spots and a comparator (71) of said patterns with the images taken by the chambers (61, 62); -Compiring some traction elements of the separators (3) by the detection zone (5). (Machine-translation by Google Translate, not legally binding)",CARTONPLAST IBERICA SLU,CARRASCO TURRERO JOSE MARIA;;GONZALEZ BENITO NESTOR,,https://lens.org/013-868-927-654-64X,Patent Application,no,0,0,2,2,0,,G01N23/00;;B08B3/02,,0,0,,,,ACTIVE
45,ES,A1,ES 2159230 A1,179-774-726-338-192,2001-09-16,2001,ES 9900563 A,1999-03-18,ES 9900563 A,1999-03-18,"Method and system for providing location, tracking, assistance and bidirectional communication services for tourists.","Method and system for providing location, tracking, assistance and bidirectional communication services for tourists.A method and system for personalised information and guidance, depending on the location of the user, used for example, as a personal guide for tourists, which includes in a Portable User Interface a location device such as the GPS/dGPS satellite positioning system to locate the user by means of a portable receiver. By means of a bidirectional communication system such as a mobile telephone, the user is kept in contact with a service providing centre by sending data such as the position of the user, personal preferences of the user or access to emergency services; the said services can be managed by a human operator or even automatically. The components permit the user to exercise control over the information he receives, and also to access services outside the system, such as, for example, the telephone service. The system can provide services to individual users or groups or gatherings.",SOCAS GONZALEZ NESTOR JAVIER;;MENESES GUVARA CARLOS RAFAEL,SOCAS GONZALEZ NESTOR JAVIER;;MENESES GUVARA CARLOS RAFAEL,,https://lens.org/179-774-726-338-192,Patent Application,no,3,0,2,2,0,,G01C21/20,,0,0,,,,EXPIRED
46,ES,B1,ES 2159230 B1,116-915-831-490-568,2002-04-01,2002,ES 9900563 A,1999-03-18,ES 9900563 A,1999-03-18,"METODO Y SISTEMA PARA PRESTAR SERVICIOS DE LOCALIZACION, SEGUIMIENTO, ASISTENCIA Y COMUNICACION BIDIRECCIONAL A TURISTAS.","Un método y sistema para información y guía personalizado en función del punto de ubicación del usuario, utilizado por ejemplo para guía turística de personas, integra en una Interface portátil de usuario un dispositivo de ubicación tal como un sistema de posicionamiento por satélite GPS/dGPS para localizar al usuario, a través de un receptor portátil. Mediante un sistema de comunicación bidireccional como un teléfono móvil, se mantiene en contacto al usuario con un centro proveedor de servicios, transmitiendo datos como posición del usuario, preferencias personalizadas por el usuario o acceso a servicios de emergencia; dichos servicios pueden ser gestionados por un operario humano o bien servicios de tipo automatizado. Los componentes permiten al usuario ejercer control sobre la información que recibe, también acceder a servicios ajenos al sistema, como por ejemplo el servicio telefónico. El sistema puede prestar servicios a usuarios individuales o bien a grupos o colectivos.",SOCAS GONZALEZ NESTOR JAVIER;;MENESES GUEVARA CARLOS RAFAEL,SOCAS GONZALEZ NESTOR JAVIER;;MENESES GUEVARA CARLOS RAFAEL,,https://lens.org/116-915-831-490-568,Granted Patent,no,0,0,2,2,0,,G01C21/20,,0,0,,,,EXPIRED
47,MX,A,MX 2010001818 A,098-770-842-969-659,2011-08-31,2011,MX 2010001818 A,2010-02-16,MX 2010001818 A,2010-02-16,CONNECTION DEVICE FOR CORRUGATED PIPING.,"The present invention refers to a connection device which coupling is hermetic for a short and long term, the device being useful for performing the attachment of a drainage piping to a current piping of higher diameter, the coupling being performed in a mechanical and manual form within a hole previously performed in the current piping, even when the same is being operated. The invention consists of an arrangement of four thermoplastic pieces, three of said pieces are semi-rigid, two are tubular elements threaded therebetween, and the fourth piece being a curved washer with an outer diameter higher than the hole diameter and flexible in the curved direction, which allows the same to be more curved so as to be introduced into the hole, but which are turned into more rigid upon being assembled, thereby generating a suitable contact with the inner surface of the current piping, once the pieces are located therein they may not be removed; the pieces are coaxially assembled and perfectly aligned due to the complementary form of the adjacent surfaces by means of a thread, which provides the required force to fix the arrangement to the piping.",ADS MEXICANA S A DE C V,GONZALEZ MANUEL DE JESUS GONZALEZ;;RAMIREZ FELIPE LUGO;;CHAVIRA NESTOR ALEJANDRO MARTINEZ,,https://lens.org/098-770-842-969-659,Patent Application,no,0,0,1,1,0,,F16L15/00,,0,0,,,,DISCONTINUED
48,WO,A1,WO 2020/159475 A1,010-049-583-219-397,2020-08-06,2020,US 2019/0015539 W,2019-01-29,US 2019/0015539 W,2019-01-29,PRINTER CARRIAGE ARRANGEMENTS,"It is hereby disclosed a carriage arrangement, in particular, a carriage arrangement suitable for a printing system comprising: a carriage; a carriage beam; and a drive mechanism; wherein the carriage is to move along a longitudinal direction of the carriage beam upon action by the drive mechanism and wherein the carriage arrangement comprises a beam compensation mechanism to exert a variable compensating force on the carriage beam, the variable compensating force depending on a deformation amount of the carriage beam.",HEWLETT PACKARD DEVELOPMENT CO LP,GONZALEZ PERELLO DANIEL;;LUID PINOL NESTOR;;OLMOS MARIN ADRIA,,https://lens.org/010-049-583-219-397,Patent Application,yes,4,0,6,6,0,B41J19/00;;B41J25/308;;B41J19/005;;B41J23/26;;B41J25/34;;B41J25/308;;B41J19/00,B41J25/34,,1,0,,,See also references of EP 3877188A4,PENDING
49,EP,A1,EP 3877188 A1,071-553-014-107-374,2021-09-15,2021,EP 19912280 A,2019-01-29,US 2019/0015539 W,2019-01-29,PRINTER CARRIAGE ARRANGEMENTS,,HEWLETT PACKARD DEVELOPMENT CO,GONZALEZ PERELLO DANIEL;;LUID PINOL NESTOR;;OLMOS MARIN ADRIA,,https://lens.org/071-553-014-107-374,Patent Application,yes,0,0,6,6,0,B41J19/00;;B41J25/308;;B41J19/005;;B41J23/26;;B41J25/34;;B41J25/308;;B41J19/00,B41J25/34,,0,0,,,,DISCONTINUED
50,MX,A,MX 9602991 A,011-446-426-596-872,1998-01-31,1998,MX 9602991 A,1996-07-25,MX 9602991 A,1996-07-25,IMPROVEMENTS IN PURIFIER WITH CONTROLLED OZONE SUPPLY AND PROCESS FOR THE PRODUCTION THEREOF.,"The present invention refers to improvements in a purifier with controlled ozone supply and process for the production thereof. The purifier comprises one or a plurality of water filtering and ozonization units, the improvements being characterized in that they comprise a system including: a first 12 volts transformer to feed low voltage to an electronic board; a second transformer having an outlet for a variety of voltages for an automotive coil which supplies high voltage to the ozonization unit; a rectifying hub for voltage which is fed to a coil; a maximum flow regulator; a first filter mounting with minimum, to retain solids in suspension, comprising silica sand, granulated activated carbon to retain chemical products such as chlorine and other; the ozonization unit comprising the automotive coil and a power card to allow coils to oscillate, which is mounted over a heat sink; the second transformer energizes the coil according to a required function; the coil is coupled with an electronic oscillator to adjust the electric frequency, thereby predefining ozone concentrations; the ozonization unit comprises an air filter assembly, an ozone generator and an ozonized air injector for injecting air into a mixing chamber to homogenize water and ozone, which preferably comprises a Venturi, a diaphragm and a static mixture element; a water outlet and security valve; and an electronic system comprising an electric terminal multi-connector, wherein the connections are disposed and arranged; from said multi-connector transformer lines are derived, which increase the ozone generator voltage, as well as operation pointer lines, failure sensors and protection fuses.",GONZALEZ NESTOR J PEREZ;;SANCHEZ JOSE RAMON MIGUEL ARSU,GONZALEZ NESTOR J PEREZ;;SANCHEZ JOSE RAMON MIGUEL ARSU,,https://lens.org/011-446-426-596-872,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
51,ES,Y,ES 1249406 Y,080-127-696-539-717,2020-10-05,2020,ES 202031096 U,2020-06-01,ES 202031096 U,2020-06-01,MAQUINA PARA VACIADO DE CAMADAS DE ENVASES SOBRE PALES,,CARTONPLAST IBERICA S L U;;METALOMECANICA LAVOS MAGALHAES & NOGUEIRA L D A,CARRASCO TURRERO JOSE MARIA;;GONZALEZ BENITO NESTOR;;MAGALHÃES JOSE,,https://lens.org/080-127-696-539-717,Limited Patent,no,0,0,5,5,0,B65G47/40,B65G47/40,,0,0,,,,ACTIVE
52,CN,A,CN 113348090 A,067-391-177-239-538,2021-09-03,2021,CN 201980090788 A,2019-01-29,US 2019/0015539 W,2019-01-29,PRINTER CARRIAGE ARRANGEMENTS,"It is hereby disclosed a carriage arrangement, in particular, a carriage arrangement suitable for a printing system comprising: a carriage; a carriage beam; and a drive mechanism; wherein the carriage is to move along a longitudinal direction of the carriage beam upon action by the drive mechanism and wherein the carriage arrangement comprises a beam compensation mechanism to exert a variable compensating force on the carriage beam, the variable compensating force depending on a deformation amount of the carriage beam.",HEWLETT PACKARD DEVELOPMENT CO,GONZALEZ PERELLO DANIEL;;LUID PINOL NESTOR;;OLMOS MARIN ADRIA,,https://lens.org/067-391-177-239-538,Patent Application,no,17,0,6,6,0,B41J19/00;;B41J25/308;;B41J19/005;;B41J23/26;;B41J25/34;;B41J25/308;;B41J19/00,B41J25/34,,0,0,,,,DISCONTINUED
53,US,B2,US 11376877 B2,039-229-828-748-117,2022-07-05,2022,US 201917262262 A,2019-01-29,US 2019/0015539 W,2019-01-29,Printer carriage arrangements,"It is hereby disclosed a carriage arrangement, in particular, a carriage arrangement suitable for a printing system comprising: a carriage; a carriage beam; and a drive mechanism; wherein the carriage is to move along a longitudinal direction of the carriage beam upon action by the drive mechanism and wherein the carriage arrangement comprises a beam compensation mechanism to exert a variable compensating force on the carriage beam, the variable compensating force depending on a deformation amount of the carriage beam.",HEWLETT PACKARD DEVELOPMENT CO,GONZALEZ PERELLO DANIEL;;LUID PINOL NESTOR;;OLMOS MARIN ADRIA,HP PRINTING AND COMPUTING SOLUTIONS S.L.U (2019-01-21);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2021-01-27),https://lens.org/039-229-828-748-117,Granted Patent,yes,10,0,6,6,0,B41J19/00;;B41J25/308;;B41J19/005;;B41J23/26;;B41J25/34;;B41J25/308;;B41J19/00,B41J25/34;;B41J19/00;;B41J23/26;;B41J25/308,,0,0,,,,ACTIVE
54,ES,U,ES 1050028 U,066-359-783-775-721,2002-02-16,2002,ES 200102218 U,2001-09-05,ES 200102218 U,2001-09-05,"Improved touch screen. (Machine-translation by Google Translate, not legally binding)","Touchscreen perfected, that being especially suitable for application to a personal computer and being of the type incorporating an area touch drive in which the icons for the operating system used are set, the toolbar area work any software application or computer program, etc., characterized in that in the marginal areas thereof and any suitable arrangement incorporates representations of conventional keys on a computer keyboard, also similar to touch icons drive mentioned above, so that said keypad is integrated in the screen facilitating the actuation thereof by disabled persons such as who must use a unicorn attached to its head to act on different touch points on the screen. (Machine-translation by Google Translate, not legally binding)",UNIV PAIS VASCO,GARDEAZABAL MONTON LUIS;;GARAY VITORIA NESTOR;;ABASCAL GONZALEZ JULIO,,https://lens.org/066-359-783-775-721,Patent Application,no,0,0,2,2,0,,G06F3/02;;H04N5/64,,0,0,,,,EXPIRED
55,EP,A4,EP 3877188 A4,130-314-817-640-594,2022-06-29,2022,EP 19912280 A,2019-01-29,US 2019/0015539 W,2019-01-29,PRINTER CARRIAGE ARRANGEMENTS,,HEWLETT PACKARD DEVELOPMENT CO,GONZALEZ PERELLO DANIEL;;LUID PINOL NESTOR;;OLMOS MARIN ADRIA,,https://lens.org/130-314-817-640-594,Search Report,no,4,0,6,6,0,B41J19/00;;B41J25/308;;B41J19/005;;B41J23/26;;B41J25/34;;B41J25/308;;B41J19/00,B41J19/00;;B41J25/308,,1,0,,,See also references of WO 2020159475A1,DISCONTINUED
56,US,A1,US 2021/0347188 A1,145-243-457-865-114,2021-11-11,2021,US 201917262262 A,2019-01-29,US 2019/0015539 W,2019-01-29,PRINTER CARRIAGE ARRANGEMENTS,"It is hereby disclosed a carriage arrangement, in particular, a carriage arrangement suitable for a printing system comprising: a carriage; a carriage beam; and a drive mechanism; wherein the carriage is to move along a longitudinal direction of the carriage beam upon action by the drive mechanism and wherein the carriage arrangement comprises a beam compensation mechanism to exert a variable compensating force on the carriage beam, the variable compensating force depending on a deformation amount of the carriage beam.",HEWLETT PACKARD DEVELOPMENT CO,GONZALEZ PERELLO DANIEL;;LUID PINOL NESTOR;;OLMOS MARIN ADRIA,HP PRINTING AND COMPUTING SOLUTIONS S.L.U (2019-01-21);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2021-01-27),https://lens.org/145-243-457-865-114,Patent Application,yes,0,1,6,6,0,B41J19/00;;B41J25/308;;B41J19/005;;B41J23/26;;B41J25/34;;B41J25/308;;B41J19/00,B41J25/34;;B41J19/00;;B41J23/26,,0,0,,,,ACTIVE
57,PT,U,PT 11970 U,164-841-886-223-08X,2020-12-29,2020,PT 1197020 U,2020-06-29,ES 202031096 U,2020-06-01,MÁQUINA PARA ESVAZIAMENTO DE CAMADAS DE EMBALAGENS SOBRE PALETES,"O PRESENTE INVENTO REFERE-SE A UMA MÁQUINA PARA ESVAZIAMENTO DE CAMADAS DE EMBALAGENS SOBRE PALETES, DO TIPO DE CAMADAS (2) QUE COMPREENDEM VÁRIOS NÍVEIS (20), SEPARADOS POR DIVISÓRIAS LAMINARES (4) E FIXADAS POR UM ENVOLTÓRIO RETRÁCTIL (5), QUE COMPREENDE UMA PLATAFORMA BASCULANTE (6) E UM MOTOR (8) DE ACCIONAMENTO DO EIXO GIRATÓRIO, UM FUNDO (60)PARA APOIO DAS CAMADAS (2), UMA ABERTURA DE ENTRADA (61) PARA INTRODUÇÃO DAS CAMADAS (2), UMA ABERTURA DE SAÍDA (62) DISPOSTA NA ZONA INCLINADA EM BAIXO (66) DA PLATAFORMA (2) PARA QUEDA DAS EMBALAGENS (3), UNS SEPARADORES (4) DISPOSTOS NA ABERTURA DE SAÍDA A INTERVALOS SUPERIORES ÀS DIMENSÕES DAS EMBALAGENS (3), UM ENVOLTÓRIO RETRÁCTIL (5) DA PLATAFORMA (2) ABERTO NA PARTE FRONTAL À ABERTURA DE SAÍDA (62) DA PLATAFORMA (6).",CARTONPLAST IBERICA S L U;;METALOMECANICA LAVOS MAGALHAES & NOGUEIRA LDA,JOSE MARIA CARRASCO TURRERO;;NESTOR GONZALEZ BENITO;;JOSÉ MAGALHÃES,,https://lens.org/164-841-886-223-08X,Limited Patent,no,0,0,5,5,0,B65G47/40,B65G47/40,,0,0,,,,ACTIVE
58,ES,A1,ES 2212694 A1,099-500-399-884-728,2004-07-16,2004,ES 200102009 A,2001-09-05,ES 200102009 A,2001-09-05,"Universal emulator human interface device e.g. keyboard, for disabled users, has user interface connected with Universal Serial Bus module and personal computer through Universal Serial Bus, and interface module fixed with control unit","The device has a Universal Serial Bus (USB)module (1) provided with a logic device. A user interface is connected with the USBmodule and a personal computer (3) through a USBcable (4). An interface module (2) i.e. microcontroller, is fixed with a control unit. Multiple input and output units are connected with the user interface. The USBmodule and the interface module are connected with each other by an electrical wire. The logic device is connected with a hub device.",UNIV PAIS VASCO,GARDEZABAL MONTON LUIS;;GARAY VITORIA NESTOR;;ABASCAL GONZALEZ JULIO,,https://lens.org/099-500-399-884-728,Patent Application,no,1,3,2,2,0,A61F4/00,A61F4/00,,0,0,,,,EXPIRED
59,ES,B1,ES 2212694 B1,146-554-852-311-618,2005-10-01,2005,ES 200102009 A,2001-09-05,ES 200102009 A,2001-09-05,EMULADOR UNIVERSAL DE DISPOSITIVOS DE INTERFACES HUMANAS PARA USUARIOS DISCAPACITADOS.,"Emulador universal de dispositivos de interfaces humanas para usuarios discapacitados. La presente invención consiste en un dispositivo electrónico destinado a ser conectado al bus USB (Universal Serial Bus) de un ordenador personal con objeto de que al mismo se puedan conectar tras una adecuada configuración cualquier tipo de interfaces humanas como pueden ser un teclado, ratón, joystick controlador de juegos, pantalla táctil, etc. El emulador universal está especialmente destinado a facilitar el acceso de personas discapacitadas a equipos informáticos, cualquiera que sea el tipo de discapacidad de los mismos, y consiste en un dispositivo que se conecta al bus USB (Universal Serial Bus) de un ordenador personal convencional, y está capacitado para gestionar cualquier interfaz de usuario que se desee para lo cual el emulador es configurable.",UNIV PAIS VASCO,GARDEZABAL MONTON LUIS;;GARAY VITORIA NESTOR;;ABASCAL GONZALEZ JULIO,,https://lens.org/146-554-852-311-618,Granted Patent,no,0,1,2,2,0,A61F4/00,A61F4/00,,0,0,,,,EXPIRED
60,ES,Y,ES 1050028 Y,155-734-047-633-918,2002-06-16,2002,ES 200102218 U,2001-09-05,ES 200102218 U,2001-09-05,PANTALLA TACTIL PERFECCIONADA.,,UNIV PAIS VASCO,GARDEAZABAL MONTON LUIS;;GARAY VITORIA NESTOR;;ABASCAL GONZALEZ JULIO,,https://lens.org/155-734-047-633-918,Limited Patent,no,0,0,2,2,0,,G06F3/02;;H04N5/64,,0,0,,,,EXPIRED
61,PT,Y,PT 11970 Y,000-419-014-316-421,2021-06-01,2021,PT 1197020 U,2020-06-29,ES 202031096 U,2020-06-01,MÁQUINA PARA ESVAZIAMENTO DE CAMADAS DE EMBALAGENS SOBRE PALETES,"O PRESENTE INVENTO REFERE-SE A UMA MÁQUINA PARA ESVAZIAMENTO DE CAMADAS DE EMBALAGENS SOBRE PALETES, DO TIPO DE CAMADAS (2) QUE COMPREENDEM VÁRIOS NÍVEIS (20), SEPARADOS POR DIVISÓRIAS LAMINARES (4) E FIXADAS POR UM ENVOLTÓRIO RETRÁCTIL (5), QUE COMPREENDE UMA PLATAFORMA BASCULANTE (6) E UM MOTOR (8) DE ACCIONAMENTO DO EIXO GIRATÓRIO, UM FUNDO (60)PARA APOIO DAS CAMADAS (2), UMA ABERTURA DE ENTRADA (61) PARA INTRODUÇÃO DAS CAMADAS (2), UMA ABERTURA DE SAÍDA (62) DISPOSTA NA ZONA INCLINADA EM BAIXO (66) DA PLATAFORMA (2) PARA QUEDA DAS EMBALAGENS (3), UNS SEPARADORES (4) DISPOSTOS NA ABERTURA DE SAÍDA A INTERVALOS SUPERIORES ÀS DIMENSÕES DAS EMBALAGENS (3), UM ENVOLTÓRIO RETRÁCTIL (5) DA PLATAFORMA (2) ABERTO NA PARTE FRONTAL À ABERTURA DE SAÍDA (62) DA PLATAFORMA (6).",CARTONPLAST IBERICA S L U;;METALOMECANICA LAVOS MAGALHAES & NOGUEIRA LDA,JOSE MARIA CARRASCO TURRERO;;NESTOR GONZALEZ BENITO;;JOSÉ MAGALHÃES,,https://lens.org/000-419-014-316-421,Limited Patent,no,0,0,5,5,0,B65G47/40,B65G47/40,,0,0,,,,ACTIVE
62,ES,U9,ES 1249406 U9,077-291-485-411-402,2020-07-21,2020,ES 202031096 U,2020-06-01,ES 202031096 U,2020-06-01,MAQUINA PARA VACIADO DE CAMADAS DE ENVASES SOBRE PALES,,CARTONPLAST IBERICA S L U;;METALOMECANICA LAVOS MAGALHAES & NOGUEIRA L D A,CARRASCO TURRERO JOSE MARIA;;GONZALEZ BENITO NESTOR;;MAGALHÃES JOSE,,https://lens.org/077-291-485-411-402,Unknown,no,0,0,5,5,0,B65G47/40,B65G47/40,,0,0,,,,ACTIVE
63,ES,U,ES 1249406 U,155-423-486-196-328,2020-07-14,2020,ES 202031096 U,2020-06-01,ES 202031096 U,2020-06-01,"MACHINE FOR EMPTYING PACKAGING LINES ON PALES (Machine-translation by Google Translate, not legally binding)","Machine (1) for emptying layers (2) of containers (3) on pallets (103), of the type of layers (2) comprising several levels (20) separated by laminar separators (4) and fixed by a wrapper shrink (5); characterized in that it comprises a tilting platform (6) supported on rotating supports (7) aligned on a tilting axis (70), and a motor (8) for driving said rotation; said basket comprising (6): -a bottom (60) to support the litter (2), - an entrance opening (61) for introducing the litter (2), - an outlet opening (62) arranged in the downwardly tiltable area (68) of the basket (2) for dropping the containers (3), -a crossbars (63), arranged in the outlet opening (62) in contact with the separators (4) to retain them inside the basket (6) and at intervals greater than the dimensions of the containers (3), and where the shrink wrap (5) of the litter (2) is open in its part facing the outlet opening (62) of the basket (6). (Machine-translation by Google Translate, not legally binding)",CARTONPLAST IBERICA S L U;;METALOMECANICA LAVOS MAGALHAES & NOGUEIRA L D A,CARRASCO TURRERO JOSE MARIA;;GONZALEZ BENITO NESTOR;;MAGALHÃES JOSE,,https://lens.org/155-423-486-196-328,Patent Application,no,0,0,5,5,0,B65G47/40,B65G47/40,,0,0,,,,ACTIVE
64,CU,A1,CU 21642 A1,072-190-189-742-077,1987-10-12,1987,CU 36059 A,1984-04-27,CU 36059 A,1984-04-27,PROCEDURE FOR THE NATURAL CLYNOPTHILOLITE USE AS MOLECULAR SCREEN,,CENTRO INVEST QUIMICAS,LLABRE RAURELL GLORIA;;TRAVIESO TUMA NESTOR;;GONZALEZ MORALES JOSE ANDRES,,https://lens.org/072-190-189-742-077,Limited Patent,no,0,0,1,1,0,,C01B33/26,,0,0,,,,EXPIRED
65,US,A1,US 2016/0214906 A1,095-792-873-117-000,2016-07-28,2016,US 201414914198 A,2014-08-28,MX 2013010088 A;;EP 2014068249 W,2013-09-02,METHOD FOR PRODUCING CEMENT WITH AN INTEGRATED CURING AGENT INCLUDED THEREIN AND THE USE THEREOF IN CEMENT-BASED MATERIALS AND THE CEMENT PRODUCED,"A method to produce a cement with an integrated curing agent for concrete mixtures, mortars and other cement-based materials is disclosed. The method describes an integrated milling of all cement components (clinker, gypsum and other additives) and the curing agent, that will allow reducing the plastic shrinkage cracking on the casted elements that use this cement-based mix.",CEMEX RES GROUP AG;;CEMEX RES GROUP AG,RAMIREZ TOVIAS HOMERO;;SERRANO GONZALEZ KARLA;;QUINTERO MORA NESTOR ISAIAS,CEMEX RESEARCH GROUP AG (2016-02-01),https://lens.org/095-792-873-117-000,Patent Application,yes,7,1,6,6,0,C04B28/02;;C04B7/527;;C04B2103/52;;C04B2111/34;;Y02W30/91;;C04B2111/34;;C04B7/527;;C04B2103/52;;C04B28/02;;Y02W30/91;;C04B24/383;;C04B40/0028;;C04B2111/346,C04B40/00;;C04B24/38,,0,0,,,,DISCONTINUED
66,US,A1,US 2020/0397317 A1,076-935-707-773-527,2020-12-24,2020,US 201916975203 A,2019-03-20,US 201916975203 A;;US 201862647178 P;;US 2019/0023190 W,2018-03-23,VISUALIZATION OF 4D DYNAMIC PULSATILE FLOW,"Systems and methods for monitoring pulsatile flows are disclosed. One method includes obtaining a plurality of magnetic resonance imaging (MRI) scans of a biological structure, acquired consecutively in time, each of the MRI scans acquired using a modified True FISP sequence. The method also includes assembling the plurality of scans into a video file of the biological structure and identifying pulsatile features within the video file.",CEDARS SINAI MEDICAL CENTER,DANIELPOUR MOISE;;BINESH NADER;;PRESSMAN BARRY;;MAYA MARCEL;;GONZALEZ NESTOR,CEDARS-SINAI MEDICAL CENTER (2019-03-25),https://lens.org/076-935-707-773-527,Patent Application,yes,0,0,2,2,0,A61B5/026;;A61B5/055;;G01R33/56308;;G01R33/5614;;G01R33/56325;;G01R33/4822;;A61B5/0042;;A61B5/0042;;A61B5/02007;;A61B5/02014;;A61B5/02108;;A61B5/0263;;A61B5/0285;;A61B5/055;;A61B5/4088;;A61B5/4842;;G01R33/385;;G01R33/4822;;G01R33/5614;;G01R33/56325,A61B5/026;;A61B5/00;;A61B5/02;;A61B5/021;;A61B5/0285;;A61B5/055;;G01R33/385;;G01R33/48;;G01R33/561;;G01R33/563,,0,0,,,,DISCONTINUED
67,WO,A1,WO 2019/183234 A1,173-568-999-017-428,2019-09-26,2019,US 2019/0023190 W,2019-03-20,US 201862647178 P,2018-03-23,VISUALIZATION OF 4D DYNAMIC PULSATILE FLOW,"Systems and methods for monitoring pulsatile flows are disclosed. One method includes obtaining a plurality of magnetic resonance imaging (MRI) scans of a biological structure, acquired consecutively in time, each of the MRI scans acquired using a modified True FISP sequence. The method also includes assembling the plurality of scans into a video file of the biological structure and identifying pulsatile features within the video file.",CEDARS SINAI MEDICAL CENTER,DANIELPOUR MOISE;;BINESH NADER;;PRESSMAN BARRY;;MAYA MARCEL;;GONZALEZ NESTOR,,https://lens.org/173-568-999-017-428,Patent Application,yes,4,0,2,2,0,A61B5/026;;A61B5/055;;G01R33/56308;;G01R33/5614;;G01R33/56325;;G01R33/4822;;A61B5/0042;;A61B5/0042;;A61B5/02007;;A61B5/02014;;A61B5/02108;;A61B5/0263;;A61B5/0285;;A61B5/055;;A61B5/4088;;A61B5/4842;;G01R33/385;;G01R33/4822;;G01R33/5614;;G01R33/56325,A61B5/055;;A61B5/026;;A61B5/05;;G01R33/483;;G01R33/561;;G01R33/565,,1,1,108-753-609-475-114,12835970;;10.1007/s00330-003-1846-3,"SCHMITZ ET AL.: ""Three-dimensional true FISP for high-resolution imaging of the whole brain"", EUR RADIOL, vol. 13, no. 7, 26 February 2003 (2003-02-26), pages 1577 - 1582, XP055638027, Retrieved from the Internet <URL:https://vdocuments.site/documents/three-dimensional-true-fisp-for-high-resolution-imaging-of-the-whole-brain.html> [retrieved on 20190521]",PENDING
68,CU,A,CU 35512 A,026-821-844-485-127,1982-12-22,1982,CU 35512 A,1981-08-28,CU 35512 A,1981-08-28,TOLUENE'S DISPROPORTION IN CATALYZERS CONTAINING CLINOPTILOLITES OF NATURAL MORDENITES,,CENTRO INVEST QUIMICAS,GONZALEZ MORALES JOSE A;;TRAVIESO TUMA NESTOR;;ARTEAGA BUZON MARITZA,,https://lens.org/026-821-844-485-127,Unknown,no,0,0,1,1,0,,B01J21/12,,0,0,,,,DISCONTINUED
69,ES,A1,ES 2847908 A1,191-495-918-583-62X,2021-08-04,2021,ES 202130036 A,2021-01-21,ES 202130036 A,2021-01-21,"REPAIR PROCEDURE FOR PLASTIC SEPARATORS AND PLASTIC SEPARATOR OBTAINED BY SAID PROCEDURE (Machine-translation by Google Translate, not legally binding)","Procedure for repairing plastic spacers (1), of the type that comprise longitudinal internal cells (100), comprising the following stages: -identification and extraction of the damaged areas to be repaired (2), leaving certain gaps (4), -preparation of grafts (5) correspondingly with said holes (4), and -joint by heat welding (6) of the grafts (5) in the holes (4); -where the extraction of the damaged areas to be repaired is carried out by means of cuts (3) with a curved path, and -where in the graft preparation stage (5) grafts are machined with an outer edge (50) aligned with the edges (10) of the separator (1), and an inner edge (51) parallel to the curved path of the cut (3), a space for filling (7) with filler material (8) being defined between the cut (3) made in the separator (1) and the inner edge (51) of the graft (5). (Machine-translation by Google Translate, not legally binding)",CARTONPLAST IBERICA S L U;;PLASTIC REPAIR SYSTEM 2011 S L,URIBE PLAZA JOSE IGNACIO;;CARRASCO TURRERO JOSE MARIA;;GONZALEZ BENITO NESTOR,,https://lens.org/191-495-918-583-62X,Patent Application,no,2,0,8,8,0,B29C73/04;;B29C73/02;;B29C73/04;;B29C73/24,B29C73/04;;B29C73/24,,0,0,,,,ACTIVE
70,US,A1,US 2024/0066815 A1,138-860-181-095-410,2024-02-29,2024,US 202118261750 A,2021-12-01,ES 202130036 A;;ES 2021070866 W,2021-01-21,METHOD FOR REPAIRING PLASTIC DIVIDERS AND PLASTIC DIVIDER OBTAINED BY SAID METHOD,"Method for repairing plastic dividers ( 1 ), having longitudinal internal cavities ( 100 ), by following the steps of: identifying and extracting the damaged areas to be repaired ( 2 ), some gaps ( 4 ) being defined, preparing inserts ( 5 ) with a shape matching the gaps ( 4 ), and attaching by heat welds ( 8 ) the inserts ( 5 ) in the gaps ( 4 ); wherein the damaged areas to be repaired are extracted by cuts ( 3 ) with a curved path, and wherein in the step of preparing the inserts ( 5 ), the inserts are machined with an outer edge ( 50 ) aligned with the edges ( 10 ) of the divider ( 1 ), and an inner edge ( 51 ) parallel to the curved path of the cut ( 3 ), there being defined between the cut ( 3 ) made in the divider ( 1 ) and the inner edge ( 51 ) of the insert ( 5 ) a filling space ( 7 ) for filling with filler material ( 8 ).",CARTONPLAST IBERICA SLU;;PLASTIC REPAIR SYSTEM 2011 SL,URIBE PLAZA JOSE IGNACIO;;CARRASCO TURRERO JOSE MARIA;;GONZALEZ BENITO NESTOR,PLASTIC REPAIR SYSTEM 2011 SL (2023-07-07);;CARTONPLAST IBERICA SLU (2023-07-07),https://lens.org/138-860-181-095-410,Patent Application,yes,0,0,8,8,0,B29C73/04;;B29C73/02;;B29C73/04;;B29C73/24,B29C73/04;;B29C37/04;;B29C65/18,,0,0,,,,PENDING
71,PE,A1,PE 20231235 A1,010-205-533-720-388,2023-08-21,2023,PE 2023002093 A,2021-12-01,ES 202130036 A;;ES 2021070866 W,2021-01-21,PROCEDIMIENTO DE REPARACION DE SEPARADORES PLASTICOS Y SEPARADOR PLASTICO OBTENIDO POR DICHO PROCEDIMIENTO,"Procedimiento de reparacion de separadores (1) plasticos, del tipo que comprenden unos alveolos (100) internos longitudinales, que comprende las siguientes etapas: identificacion y extraccion de las zonas danadas a reparar (2), quedando determinados unos huecos (4), preparacion de unos injertos (5) de forma correspondiente con dichos huecos (4), y union mediante terrnosoldaduras (6) de los injertos (5) en los huecos (4); donde la extraccion de las zonas danadas a reparar se realiza mediante cortes (3) de trayectoria curva, y donde en la etapa de preparacion de los injertos (5) se mecanizan injertos con un borde exterior (50) alineado con los bordes (10) de! separador (1), y un borde interior (51) paralelo a la trayectoria curva del corte (3), quedando definido entre corte (3) practicado en el separador (1) y el borde interior (51) del injerto (5) un espacio para relleno (7) con material de aporte (8).",CARTONPLAST IBERICA SLU;;PLASTIC REPAIR SYSTEM 2011 SL,URIBE PLAZA JOSE IGNACIO;;CARRASCO TURRERO JOSE MARIA;;GONZALEZ BENITO NESTOR,,https://lens.org/010-205-533-720-388,Patent Application,no,0,0,8,8,0,B29C73/04;;B29C73/02;;B29C73/04;;B29C73/24,B29C73/04;;B29C73/24,,0,0,,,,PENDING
72,ES,B2,ES 2847908 B2,108-534-512-208-781,2022-03-31,2022,ES 202130036 A,2021-01-21,ES 202130036 A,2021-01-21,PROCEDIMIENTO DE REPARACION DE SEPARADORES PLASTICOS Y SEPARADOR PLASTICO OBTENIDO POR DICHO PROCEDIMIENTO,,CARTONPLAST IBERICA S L U;;PLASTIC REPAIR SYSTEM 2011 S L,URIBE PLAZA JOSE IGNACIO;;CARRASCO TURRERO JOSE MARIA;;GONZALEZ BENITO NESTOR,,https://lens.org/108-534-512-208-781,Granted Patent,no,0,0,8,8,0,B29C73/04;;B29C73/02;;B29C73/04;;B29C73/24,B29C73/04;;B29C73/24,,0,0,,,,ACTIVE
73,US,B1,US 8426374 B1,144-667-600-897-710,2013-04-23,2013,US 74415807 A,2007-05-03,US 74415807 A;;US 79806306 P,2006-05-04,Method for modifying myostatin expression,"A method comprising inhibiting myostatin expression or activity to increase muscle mass. Still further, methods for locally inhibiting myostatin expression or activity to reduce fibrosis are provided. The method comprises introducing a nucleotide sequence into a vector wherein the nucleotide sequence is expressed as a shRNA having a property to inhibit myostatin expression. The vector including the sequence may be delivered to a mammalian tissue. An electrical pulse may be applied across a point of delivery. A composition comprising a vector having a nucleotide sequence wherein the nucleotide sequence is expressed as a shRNA having a property to inhibit myostatin expression is further provided.",MAGEE THOMAS R;;GONZALEZ-CADAVID NESTOR F;;FERRINI MONICA G;;RAJFER JACOB;;LOS ANGELES BIOMED RES INST,MAGEE THOMAS R;;GONZALEZ-CADAVID NESTOR F;;FERRINI MONICA G;;RAJFER JACOB,LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (2007-05-02),https://lens.org/144-667-600-897-710,Granted Patent,yes,4,2,1,1,10,C12N15/1136;;C12N15/1136,A61K48/00,514/44;;536/24.5;;536/24.31;;536/24.1,52,51,025-183-383-900-577;;058-687-672-324-146;;134-638-451-537-686;;045-642-638-567-32X;;067-096-474-993-21X;;061-959-179-393-580;;003-111-845-590-294;;059-393-958-757-089;;104-967-147-127-315;;091-785-423-738-546;;027-683-183-742-58X;;069-289-681-048-425;;037-910-222-888-515;;068-231-838-256-583;;012-192-715-564-112;;088-408-896-066-426;;027-734-203-258-363;;069-047-059-494-669;;101-944-608-428-209;;069-658-664-429-198;;009-687-629-787-965;;037-278-245-253-137;;080-846-402-649-584;;120-499-076-314-695;;037-317-342-496-842;;011-280-480-451-351;;019-339-164-844-879;;018-587-760-394-524;;108-585-233-526-138;;054-415-018-794-341;;025-507-666-035-147;;074-861-474-677-187;;026-954-798-748-414;;060-496-085-426-447;;038-824-269-672-768;;035-856-336-611-47X;;159-288-562-669-833;;031-950-131-777-252;;021-226-172-296-105;;046-820-957-391-494;;051-030-158-828-615;;045-765-398-836-809;;045-097-269-639-55X;;077-009-665-810-417;;029-513-414-380-450;;072-784-687-857-705;;018-099-554-374-677;;040-185-677-411-018;;108-795-152-070-728;;002-879-409-291-011;;095-673-122-755-106,10.1016/j.jbiotec.2005.04.023;;16005092;;10.1002/dvdy.10454;;15042708;;15878958;;10.1210/en.2005-0362;;12459784;;10.1038/nature01154;;15791004;;10.1096/fj.04-2796com;;10.1126/science.1068999;;11910072;;10.1002/jgm.352;;12692866;;10.1038/35078107;;11373684;;10.1089/104454903322624984;;14683588;;10.1006/niox.2001.0421;;12009846;;16025524;;10.1002/mus.20399;;15592423;;10.1038/sj.gt.3302405;;10.1097/01.mco.0000134365.99523.7f;;15192449;;10.1073/pnas.95.25.14938;;pmc24554;;9843994;;10.1002/gene.10188;;12717734;;10.1002/jgm.650;;15515140;;10.1152/ajpcell.00579.2003;;15355854;;pmc1306793;;10.1073/pnas.0505996102;;16330774;;15473835;;10.1146/annurev.cellbio.20.012103.135836;;11846609;;10.1006/meth.2001.1262;;10.1016/j.ymthe.2004.09.013;;pmc2581717;;15668136;;10.1002/jgm.946;;16810717;;12222534;;16079293;;10.1242/jcs.02482;;15161333;;10.2165/00063030-200418030-00002;;9139826;;09139826;;10.1038/387083a0;;10.1073/pnas.94.23.12457;;pmc24998;;9356471;;10200250;;10.1073/pnas.96.8.4262;;pmc16320;;10.1016/s0006-291x(02)00209-7;;12054591;;10.1016/j.nmd.2004.10.018;;15694133;;8740508;;10.1016/0009-9120(96)00003-6;;12824080;;10.1152/ajpendo.00107.2003;;10.1006/mthe.2001.0465;;11592834;;10.1006/mthe.2002.0526;;11829520;;15215484;;10.1056/nejmoa040933;;10.1093/nar/gni065;;15831785;;pmc1079974;;10.1016/j.tips.2003.11.006;;14723975;;11253666;;10.1038/35038533;;10090572;;10.1007/s004180050341;;10.1073/pnas.0506306102;;pmc1196357;;16141338;;10.1152/ajpendo.2001.280.2.e221;;11158924;;14638460;;10976104;;10.1074/jbc.m004356200;;15907921;;10.1016/j.coph.2005.01.011;;10.1002/jgm.745;;15756716;;10.1002/ana.10385;;12447939;;15295618;;10.1038/sj.gt.3302337;;10.1016/s0006-291x(02)02953-4;;12559968;;pmc2705429;;10.1186/1297-9686-34-2-221;;12081809;;10.1051/gse:2002005;;14671324;;pmc307655;;10.1073/pnas.2534946100;;10.1016/j.yjmcc.2005.06.005;;16125197,"Acosta, J., et al., ""Myostatin gene silenced by RNAi show a zebrafish giant phenotype,"" J Biotechnol, Oct. 10, 2005, vol. 119(4), pp. 324-331.;;Amali, A.A., et al., ""Up-regulation of muscle-specific transcription factors during embryonic somitogenesis of zebrafish (Danio rerio) by knock-down of myostatin-1,"" Dev Dyn, Apr. 2004, vol. 229(4), pp. 847-856.;;Artaza, J.N., et al., ""Myostatin Inhibits Myogenesis and Promotes Adipogenesis in C3H 10T(1/2) Mesenchymal Multipotent Cells,"" Endocrinology, Aug. 2005, vol. 146(8), pp. 3547-3557.;;Bogdanovich, S., et al., ""Functional improvement of dystrophic muscle by myostatin blockade,"" Nature, Nov. 28, 2002, vol. 420(6914), pp. 418-421.;;Bogdanovich, S., et al., ""Myostatin propeptide-mediated amelioration of dystrophic pathophysiology,"" FASEB J, Apr. 2005, vol. 19, pp. 543-549.;;Brummelkamp, T.R., et al., ""A System for Stable Expression of Short Interfering RNAs in Mammalian Cells,"" Science, Apr. 19, 2002, vol. 296, pp. 550-553.;;Cappelletti, M., et al., ""Gene electro-transfer improves transduction by modifying the fate of intramuscular DNA,"" J Gene Med, Apr. 2003, vol. 5(4), pp. 324-332.;;Elbashir, S.M., et al., ""Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells,"" Nature, May 24, 2001, vol. 411(6836), pp. 494-498.;;Faurie, C., et al., ""Cell and animal imaging of electrically mediated gene transfer,"" DNA Cell Biol, Dec. 2003, vol. 22(12), pp. 777-783.;;Ferrini, M.G., et al., ""Antifibrotic role of inducible nitric oxide synthase,"" Nitric Oxide, May 2002, vol. 6(3), pp. 283-294, Abstract.;;Frimel, T.N., et al., ""A model of muscle atrophy using cast immobilization in mice,"" Muscle Nerve, Nov. 2005, vol. 32(5), pp. 672-674.;;Golzio, M., et al., ""Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery,"" Gene Therapy, Feb. 2005, vol. 12(3), pp. 246-251.;;Gonzalez-Cadavid, N.F., et al., ""Role of myostatin in metabolism,"" Current Opinion in Clinical Nutrition & Metabolic Care, Jul. 2004, vol. 7(4), pp. 451-457.;;Gonzalez-Cadavid, N.F., et al., ""Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting,"" Proc Natl Acad Sci USA, Dec. 1998, vol. 95, pp. 14938-14943.;;Grobet, L., et al., ""Modulating Skeletal Muscle Mass by Postnatal, Muscle-Specific Inactivation of the Myostatin Gene,"" Genesis, 2003, vol. 35, pp. 227-238.;;Gronevik, E., ""Gene expression and immune response kinetics using electroporation-mediated DNA delivery to muscle,"" J Gene Med, Feb. 2005, vol. 7(2), pp. 218-227.;;Jackman, R.W., et al., ""The molecular basis of skeletal muscle atrophy,"" Am J Physiol Cell Physiol, 2004, vol. 287, pp. C834-C843.;;Lee, S.J., et al., ""Regulation of muscle growth by multiple ligands signaling through activin type II receptors,"" Proc Natl Acad Sci USA, Dec. 13, 2005, vol. 102(50), pp. 18117-18122.;;Lee, S.J., ""Regulation of Muscle Mass by Myostatin,"" Annu Rev Cell Dev Biol, 2004, vol. 20, pp. 61-86.;;Livak, K.J., et al., ""Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-DeltaDeltaCT Method,"" Methods, 2001, vol. 25, pp. 402-408.;;Liu, M., et al., ""Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury,"" Mol Ther, Feb. 2005, vol. 11(2), pp. 245-256.;;Magee, T.R., et al., ""Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass,"" J Gene Med, 2006, vol. 8, pp. 1171-1181.;;Magee, T.R., et al., ""Gene Therapy of Erectile Dysfunction in the Rat with Penile Neuronal Nitric Oxide Synthase,"" Biology of Reproduction, Jul. 2002, vol. 67(1), pp. 20-28 (Corrected and republished in Biology of Reproduction, Sep. 2002, vol. 67(3), pp. 1033-1041).;;McCroskery, S., et al., ""Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice,"" J Cell Sci, 2005, vol. 118(15), pp. 3531-3541.;;McMahon, J.M., et al., ""Electroporation for Gene Transfer to Skeletal Muscles: Current Status,"" BioDrugs, 2004, vol. 18(3), pp. 155-165.;;McPherron, A.C., et al., ""Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member,"" Nature, May 1, 1997, vol. 387(6628), pp. 83-90.;;McPherron, A.C., et al., ""Double muscling in cattle due to mutations in the myostatin gene,"" Proc Natl Acad Sci USA, Nov. 1997, vol. 94, pp. 12457-12461.;;Mir, L.M., et al., ""High-efficiency gene transfer into skeletal muscle mediated by electric pulses,"" Proc Natl Acad Sci USA, Apr. 1999, vol. 96, pp. 4262-4267.;;Nishi, M., et al., ""A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle,"" Biochem Biophys Res Commun, Apr. 26, 2002, vol. 293(1), pp. 247-251.;;Patel, K., et al., ""The function of myostatin and strategies of myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle,"" Neuromuscul Disord, Feb. 2005, vol. 15(2), pp. 117-126.;;Reddy, G.K., et al., ""A simplified method for the analysis of hydroxyproline in biological tissues,"" Clin Biochem, Jun. 1996, vol. 29(3), pp. 225-229.;;Reisz-Porszasz, S., et al., ""Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin,"" Am J Physiol Endocrinol Metab, 2003, vol. 285, pp. E876-E888.;;Satkauskas, S., et al., ""Slow Accumulation of Plasmid in Muscle Cells: Supporting Evidence for a Mechanism of DNA Uptake by Receptor-Mediated Endocytosis,"" Molecular Therapy, Oct. 2001, vol. 4(4), pp. 317-323.;;Satkauskas, S., et al., ""Mechanisms of in Vivo DNA Electrotransfer: Respective Contributions of Cell Electropermeabilization and DNA Electrophoresis,"" Molecular Therapy, Feb. 2002, vol. 5(2), pp. 133-140.;;Schuelke, M., et al., ""Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child,"" N Engl J Med, Jun. 24, 2004, vol. 350(26), pp. 2682-2688.;;Seibler, J., et al., ""Single copy shRNA configuration for ubiquitous gene knockdown in mice,"" Nucleic Acids Research, 2005, vol. 33(7), pp. e67 (10 pages).;;Sioud, M., ""Therapeutic siRNAs,"" Trends in Pharmacological Sciences, Jan. 2004, vol. 25(1), pp. 22-28.;;Somia, N., et al., ""Gene therapy: trials and tribulations,"" Nat Rev Genet, Nov. 2000, vol. 1(2), pp. 91-99.;;Staron, R.S., et al, ""Fiber type composition of four hindlimb muscles of adult Fisher 344 rats,"" Histochem Cell Biol, Feb. 1999, vol. 111(2), pp. 117-123.;;Stegmeier, F., et al., ""A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells,"" Proc Natl Acad Sci USA, Sep. 13, 2005, vol. 102(37), pp. 13212-13217.;;Taylor, W.E., et al., ""Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells,"" Am J Physiol Endocrinol Metab, 2001, vol. 280, pp. E221-E228.;;Taylor, W.E., et al., ""Alteration of gene expression profiles in skeletal muscle of rats exposed to microgravity during a spaceflight,"" Journal of Gravitational Physiology, Dec. 2002, vol. 9(2), pp. 61-70.;;Thomas, M., et al., ""Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation,"" J Biol Chem, Dec. 22, 2000, vol. 275(51), pp. 40235-40243.;;Tobin, J.F., et al., ""Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases,"" Curr Opin Pharmacol, Jun. 2005, vol. 5(3), pp. 328-332.;;Uchida, Y., et al., ""Effective repetitive dystrophin gene transfer into skeletal muscle of adult mdx mice using a helper-dependent adenovirus vector expressing the coxsackievirus and adenovirus receptor (CAR) and dystrophin,"" J Gene Med, Aug. 2005, vol. 7(8), pp. 1010-1022.;;Wagner, K.R., et al., ""Loss of myostatin attenuates severity of muscular dystrophy in mdx mice,"" Ann Neurol, Dec. 2002, vol. 52(6), pp. 832-836, Abstract.;;Wells, D.J., ""Gene therapy progress and prospects: electroporation and other physical methods,"" Gene Therapy, Sep. 2004, vol. 11(18), pp. 1363-1369.;;Whittemore, L.A., et al., ""Inhibition of myostatin in adult mice increases skeletal muscle mass and strength,"" Biochem Biophys Res Commun, Jan. 24, 2003, vol. 300(4), pp. 965-971.;;Wiener, P., et al., ""Muscle-related traits in cattle: The role of the myostatin gene in the South Devon breed,"" Genet Sel Evol, 2002, vol. 34, pp. 221-232.;;Wolfman, N.M., et al., ""Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases,"" Proc Natl Acad Sci USA, Dec. 23, 2003, vol. 100(26), pp. 15842-15846.;;Yin, C., et al., ""Silencing heat shock factor 1 by small interfering RNA abrogates heat shock-induced cardioprotection against ischemia-reperfusion injury in mice,"" J Mol Cell Cardiol, Oct. 2005, vol. 39(4), pp. 681-689.;;""pSilencer(TM) 2.1-U6 neo,"" http:www.ambion.com/techlib/misc/vectors/2.1-neo.html, Ambion Inc., 2006, 8 pages.",ACTIVE
74,WO,A1,WO 2016/046419 A1,136-085-835-627-299,2016-03-31,2016,EP 2015072292 W,2015-09-28,EP 14186723 A,2014-09-28,NEW IMMUNOSTIMULATORY COMPOUNDS,"The present invention relates to novel immunostimulatory molecules which are derived from the intestinal protozoan Entamoeba histolytica .The compounds have been found to be useful for enhancing and/or inducing an immune response in a subject in need thereof. Specifically, the compounds have been found to be useful for the treatment of cancer diseases, such as breast cancer, and parasitic diseases, such as leishmaniasis. The invention also provides pharmaceutical compositions comprising the novel compounds.",BERNHARD NOCHT INST FÜR TROPENMEDIZIN;;FORSCHUNGSZENTRUM BORSTEL,LOTTER HANNELORE;;BERNIN HANNAH;;TANNICH EGBERT;;GONZALEZ-ROLDAN NESTOR;;FUJIMOTO YUKARI;;FUKASE KOICHI,,https://lens.org/136-085-835-627-299,Patent Application,yes,5,1,8,8,0,A61K31/683;;A61K31/7034;;A61K35/15;;C07F9/6552;;C07F9/65586;;A61K39/39;;A61K2039/55511;;C07F9/117;;C07H15/207;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;Y02A50/30;;A61K39/4634;;A61K39/4644;;A61K39/4615;;A61K2239/49;;A61K39/4622;;C07F9/65586;;A61K35/15;;A61K31/7034;;C07F9/6552;;A61K31/683;;A61K2039/55511;;A61K39/39;;Y02A50/30;;C07F9/117;;A61K2039/5154;;A61K2039/54;;C07H15/207,A61K31/683;;A61K31/7034;;A61K35/15;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;C07F9/10;;C07H15/20,,2,2,003-016-667-355-594;;023-857-870-905-047,pmc2674934;;19436711;;10.1371/journal.ppat.1000434;;pmc1868730;;10.1186/1476-8518-5-7;;17477875,"HANNELORE LOTTER ET AL: ""Natural Killer T Cells Activated by a Lipopeptidophosphoglycan from Entamoeba histolytica Are Critically Important To Control Amebic Liver Abscess"", PLOS PATHOGENS, vol. 5, no. 5, 15 May 2009 (2009-05-15), pages e1000434, XP055178811, DOI: 10.1371/journal.ppat.1000434;;GHANEKAR SMITA A ET AL: ""Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors"", JOURNAL OF IMMUNE BASED THERAPIES AND VACCINES, BIOMED CENTRAL LTD., LONDON, GB, vol. 5, no. 1, 3 May 2007 (2007-05-03), pages 7, XP021024503, ISSN: 1476-8518, DOI: 10.1186/1476-8518-5-7",PENDING
75,US,A1,US 2017/0298083 A1,171-794-702-567-369,2017-10-19,2017,US 201515513002 A,2015-09-28,EP 14186723 A;;EP 2015072292 W,2014-09-28,NEW IMMUNOSTIMULATORY COMPOUNDS,"The present invention relates to novel immunostimulatory molecules which are derived from the intestinal protozoan Entamoeba histolytica. The compounds have been found to be useful for enhancing and/or inducing an immune response in a subject in need thereof. Specifically, the compounds have been found to be useful for the treatment of cancer diseases, such as breast cancer, and parasitic diseases, such as leishmaniasis. The invention also provides pharmaceutical compositions comprising the novel compounds.",BERNHARD-NOCHT-INSTITUT FÜR TROPENMEDIZIN;;FORSCHUNGSZENTRUM BORSTEL,LOTTER HANNELORE;;BERNIN HANNAH;;TANNICH EGBERT;;GONZALEZ-ROLDAN NESTOR;;FUJIMOTO YUKARI;;FUKASE KOICHI,BERNHARD-NOCHT-INSTITUT FÜR TROPENMEDIZIN (2017-03-07);;FORSCHUNGSZENTRUM BORSTEL (2017-03-13),https://lens.org/171-794-702-567-369,Patent Application,yes,0,0,8,8,0,A61K31/683;;A61K31/7034;;A61K35/15;;C07F9/6552;;C07F9/65586;;A61K39/39;;A61K2039/55511;;C07F9/117;;C07H15/207;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;Y02A50/30;;A61K39/4634;;A61K39/4644;;A61K39/4615;;A61K2239/49;;A61K39/4622;;C07F9/65586;;A61K35/15;;A61K31/7034;;C07F9/6552;;A61K31/683;;A61K2039/55511;;A61K39/39;;Y02A50/30;;C07F9/117;;A61K2039/5154;;A61K2039/54;;C07H15/207,C07F9/117;;A61K39/00;;C07H15/207,,0,0,,,,DISCONTINUED
76,BR,A2,BR 112017006177 A2,060-964-033-727-445,2017-12-19,2017,BR 112017006177 A,2015-09-28,EP 2015072292 W;;EP 14186723 A,2014-09-28,compostos imunoestimuladores,"a presente invenção refere-se a moléculas imunoestimuladoras que são derivadas do protozoário intestinal entamoeba histolytica. os compostos foram verificados serem úteis para aperfeiçoamento e/ou indução de uma resposta imune em um sujeito em sua necessidade. especificamente, os compostos foram verificados serem úteis para o tratamento de doenças de câncer, tal como câncer de mama, e doenças parasíticas, como leishmaniose. a invenção também provê composições farmacêuticas compreendendo os novos compostos.",BERNHARD NOCHT INST FUER TROPENMEDIZIN;;FORSCHUNGSZENTRUM BORSTEL,EGBERT TANNICH;;HANNAH BERNIN;;HANNELORE LOTTER;;KOICHI FUKASE;;NESTOR GONZALEZ-ROLDAN;;YUKARI FUJIMOTO,,https://lens.org/060-964-033-727-445,Patent Application,no,0,0,8,8,0,A61K31/683;;A61K31/7034;;A61K35/15;;C07F9/6552;;C07F9/65586;;A61K39/39;;A61K2039/55511;;C07F9/117;;C07H15/207;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;Y02A50/30;;A61K39/4634;;A61K39/4644;;A61K39/4615;;A61K2239/49;;A61K39/4622;;C07F9/65586;;A61K35/15;;A61K31/7034;;C07F9/6552;;A61K31/683;;A61K2039/55511;;A61K39/39;;Y02A50/30;;C07F9/117;;A61K2039/5154;;A61K2039/54;;C07H15/207,C07F9/10;;A61K31/683;;A61K31/7034;;A61K35/15;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;C07H15/20,,0,0,,,,DISCONTINUED
77,EP,A1,EP 3000471 A1,027-357-477-333-585,2016-03-30,2016,EP 14186723 A,2014-09-28,EP 14186723 A,2014-09-28,Novel immunostimulatory molecules,"The present invention relates to novel immunostimulatory molecules which are derived from the intestinal protozoan  Entamoeba histolytica.  The compounds have been found to be useful for enhancing and/or inducing an immune response in a subject in need thereof. Specifically, the compounds have been found to be useful for the treatment of cancer diseases, such as breast cancer, and parasitic diseases, such as leishmaniasis. The invention also provides pharmaceutical compositions comprising the novel compounds.
",BERNHARD NOCHT INST FÜR TROPENMEDIZIN;;FORSCHUNGSZENTRUM BORSTEL,BERNIN HANNAH;;LOTTER HANNELORE;;GONZALEZ-ROLDAN NESTOR;;TANNICH EGBERT;;FUJIMOTO YUKARI;;FUKASE KOICHI,,https://lens.org/027-357-477-333-585,Patent Application,yes,5,0,8,8,0,A61K31/683;;A61K31/7034;;A61K35/15;;C07F9/6552;;C07F9/65586;;A61K39/39;;A61K2039/55511;;C07F9/117;;C07H15/207;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;Y02A50/30;;A61K39/4634;;A61K39/4644;;A61K39/4615;;A61K2239/49;;A61K39/4622;;C07F9/65586;;A61K35/15;;A61K31/7034;;C07F9/6552;;A61K31/683;;A61K2039/55511;;A61K39/39;;Y02A50/30;;C07F9/117;;A61K2039/5154;;A61K2039/54;;C07H15/207,A61K31/683;;A61K31/7034;;A61K35/15;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;C07F9/10;;C07H15/20,,19,19,003-016-667-355-594;;023-857-870-905-047;;004-311-944-000-539;;004-311-944-000-539;;079-575-561-519-843;;008-302-426-494-760;;177-900-403-168-522;;119-013-352-138-360;;155-904-537-291-147;;000-139-967-959-075;;003-016-667-355-594;;014-076-870-045-202;;047-184-940-372-248;;012-889-618-000-577;;004-678-535-025-429;;061-851-870-799-302;;103-738-656-250-332;;042-250-394-244-986;;028-155-220-981-430,pmc2674934;;19436711;;10.1371/journal.ppat.1000434;;pmc1868730;;10.1186/1476-8518-5-7;;17477875;;10.1002/chem.201204222;;23371033;;10.1002/chem.201204222;;23371033;;10.1002/anie.200462513;;15693041;;10.1517/13543776.2013.828035;;23957267;;10.1016/j.exppara.2013.07.022;;23933281;;10.1016/j.inhe.2012.06.004;;24029394;;15756017;;10.1158/1078-0432.ccr-04-1453;;24428717;;10.1021/jm4010863;;pmc2674934;;19436711;;10.1371/journal.ppat.1000434;;pmc3570563;;10.1371/journal.pone.0055694;;23424637;;23972958;;10.1016/j.tmaid.2013.05.003;;10.1002/eji.200323707;;12616479;;pmc3771300;;10.4269/ajtmh.12-0736;;23857024;;10.1021/ol0493397;;15151436;;10.1007/s00262-007-0373-5;;17690880;;20730114;;pmc2920333;;10.1371/journal.pone.0012103;;10.1021/jo060702s;;16776522,"HANNELORE LOTTER ET AL: ""Natural Killer T Cells Activated by a Lipopeptidophosphoglycan from Entamoeba histolytica Are Critically Important To Control Amebic Liver Abscess"", PLOS PATHOGENS, vol. 5, no. 5, 15 May 2009 (2009-05-15), pages e1000434, XP055178811, DOI: 10.1371/journal.ppat.1000434;;GHANEKAR SMITA A ET AL: ""Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors"", JOURNAL OF IMMUNE BASED THERAPIES AND VACCINES, BIOMED CENTRAL LTD., LONDON, GB, vol. 5, no. 1, 3 May 2007 (2007-05-03), pages 7, XP021024503, ISSN: 1476-8518, DOI: 10.1186/1476-8518-5-7;;IWASAKI, T. ET AL., CHEM. EUR. J. 2013, vol. 19, 2013, pages 2956 - 2960;;IWASAKI, T. ET AL., CHEM. EUR. J., vol. 19, 2013, pages 2956 - 2960;;SABURI, H. ET AL., ANGEW. CHEM. INT. ED., vol. 44, 2005, pages 1730 - 1732;;ARIAS JL: ""Liposomes in drug delivery: a patent review (2007-present"", EXPERT OPIN THER PAT., vol. 23, no. 11, 2013, pages 1399 - 414;;BARROS NB ET AL.: ""Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: macrophage as target cell"", EXPERIMENTAL PARASITOLOGY, vol. 135, 2013, pages 337 - 343;;BLUM J ET AL.: ""Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis"", INTERNATIONAL HEALTH, vol. 4, 2012, pages 153 - 163;;ISHIKAWA A ET AL.: ""A phase I study of a-galactosylceramide (KRN-7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer"", CLINICAL CANCER RESEARCH, vol. 11, no. 5, 2005, pages 1919 - 7, XP055220329, DOI: doi:10.1158/1078-0432.CCR-04-1453;;LAURENT X ET AL.: ""Switching Invariant Natural Killer T (iNKT) Cell Response from Anti-cancerous to Anti-Inflammatory Effect: Molecular Bases"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 57, 2014, pages 5489 - 5508;;LOTTER H ET AL.: ""Natural killer T cells activated by a lipopeptidephosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess"", PLOS PATHOG, vol. 5, 2009, pages E1000434;;LOTTER H ET AL.: ""Testosterone increases susceptibility to amebic liver abscess in mice and mediates inhibition ofIFNgamma secretion in natural killer T cells"", PLOS ONE, vol. 8, 2013, pages E55694;;NEUMAYR AL ET AL.: ""Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-alpha antagonists"", TRAVEL MEDICINE AND INFECTIOUS DISEASE, vol. 11, 2013, pages 412 - 420;;SANDBERG JK ET AL.: ""Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24NKT cell compartment"", EUR J IMMUNOL, vol. 33, no. 3, 2003, pages 588 - 96;;SOSA N ET AL.: ""Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama"", THE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, vol. 89, 2013, pages 557 - 563;;TANAKA, S. ET AL., ORG. LETT., vol. 4, 2004, pages 1873 - 1875;;UCHIDA T ET AL.: ""Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer"", CANCER IMMUNOL. IMMMUNOTHER., vol. 57, 2008, pages 337 - 345, XP019586687;;WEGWITZ F ET AL.: ""Tumorigenic WAP-T mouse mammary carcinoma cells: a model for a self-reproducing homeostatic cancer cell system"", PLOS ONE, vol. 5, 2010, pages E12103;;XU, YJ ET AL., J. ORG. CHEM., vol. 71, 2006, pages 4919 - 4928",DISCONTINUED
78,NO,A1,NO 20121254 A1,132-598-751-303-789,2012-12-18,2012,NO 20121254 A,2012-10-26,NO 20100451 A;;NO 2011000108 W;;NO 20121254 A,2010-03-26,Forbindelse og sammensetning for kontroll av parasitter,"Det beskrives carvacrol og/eller tymol eller en sammensetning omfattende en eller begge av disse aktive forbindelser for anvendelse i behandling av lusangrep på fisk og en fremgangsmåte for å drepe, bekjempe eller regulere lus, fortrinnsvis innen fiskeoppdrettsindustrien, og likeledes et fôr for fisk.",EWOS INNOVATION AS,VECINO JOSE LUIS GONZALEZ;;EL-MOWAFI ADEL;;KIRSTEN JOSE MIGUEL TRONCOSO;;FORETIC NESTOR JAVIER GONZALEZ;;MARAMBIO JORGE EDUARDO PINO,,https://lens.org/132-598-751-303-789,Patent Application,no,0,0,9,9,0,A61K31/05;;A61K31/05;;A61K45/06;;A61K45/06;;A61P33/00;;A61P33/14,A61K31/05;;A61K33/00,,0,0,,,,PENDING
79,ZA,B,ZA 201702925 B,024-787-085-566-073,2018-11-28,2018,ZA 201702925 A,2017-04-26,EP 14186723 A;;EP 2015072292 W,2014-09-28,NEW IMMUNOSTIMULATORY COMPOUNDS,,FORSCHUNGSZENTRUM BORSTEL;;BERNHARD NOCHT INST FUER TROPENMEDIZIN,GONZALEZ-ROLDAN NESTOR;;TANNICH EGBERT;;BERNIN HANNAH;;LOTTER HANNELORE;;FUKASE KOICHI;;FUJIMOTO YUKARI,,https://lens.org/024-787-085-566-073,Granted Patent,no,0,0,8,8,0,A61K31/683;;A61K31/7034;;A61K35/15;;C07F9/6552;;C07F9/65586;;A61K39/39;;A61K2039/55511;;C07F9/117;;C07H15/207;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;Y02A50/30;;A61K39/4634;;A61K39/4644;;A61K39/4615;;A61K2239/49;;A61K39/4622;;C07F9/65586;;A61K35/15;;A61K31/7034;;C07F9/6552;;A61K31/683;;A61K2039/55511;;A61K39/39;;Y02A50/30;;C07F9/117;;A61K2039/5154;;A61K2039/54;;C07H15/207,,,0,0,,,,ACTIVE
80,NO,A1,NO 20121253 A1,184-534-247-309-712,2012-11-21,2012,NO 20121253 A,2012-10-26,NO 20100454 A;;NO 2011000106 W;;NO 20121253 A,2010-03-26,Forbindelse og sammensetning for kontroll av bakterier og virus,"Det beskrives en propyl-metyl-fenolforbindelse, spesielt Thymol og/eller Carvacrol eller sammensetninger omfattende en propyl-metyl-fenolforbindelse for anvendelse i behandling og/eller profylakse av salmonid rickettsial septikemi (SRS) og/eller syk dommer forårsaket av Piscirickettsia salmonis, og/eller for anvendelse i dreping, bekjemping eller regulering av Piscirickettsia salmonis, og for anvendelse i behandling og/eller profylakse av infektiøs lakseanemi (ISA) og/eller sykdommer forårsaket av infektiøs lakseanemivirus, og/eller for anvendelse i dreping, bekjemping eller regulering av infektiøs lakseanemivirus.",EWOS INNOVATION AS,VECINO JOSE LUIS GONZALEZ;;EL-MOWAFI ADEL;;KIRSTEN JOSE MIGUEL TRONCOSO;;FORETIC NESTOR JAVIER GONZALEZ;;MARAMBIO JORGE EDUARDO PINO,,https://lens.org/184-534-247-309-712,Patent Application,no,0,0,14,14,0,A61K31/05;;A61P31/00;;A61P31/04;;A61P31/12;;Y02A50/30;;A23K10/30;;A23K20/111;;A23K50/80;;A61K36/00;;A61K36/53;;A61K31/05;;A61P31/00;;A61P31/04,A61K31/05;;A61K45/06;;A61P31/00,,0,0,,,,ACTIVE
81,EP,A1,EP 3197461 A1,089-663-823-293-833,2017-08-02,2017,EP 15770891 A,2015-09-28,EP 14186723 A;;EP 2015072292 W,2014-09-28,NEW IMMUNOSTIMULATORY COMPOUNDS,,BERNHARD-NOCHT-INSTITUT FÜR TROPENMEDIZIN;;FORSCHUNGSZENTRUM BORSTEL LEIBNIZ-ZENTRUM FÜR MEDIZIN UND BIOWISSENSCHAFTEN,LOTTER HANNELORE;;BERNIN HANNAH;;TANNICH EGBERT;;GONZALEZ-ROLDAN NESTOR;;FUJIMOTO YUKARI;;FUKASE KOICHI,,https://lens.org/089-663-823-293-833,Patent Application,yes,0,0,8,8,0,A61K31/683;;A61K31/7034;;A61K35/15;;C07F9/6552;;C07F9/65586;;A61K39/39;;A61K2039/55511;;C07F9/117;;C07H15/207;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;Y02A50/30;;A61K39/4634;;A61K39/4644;;A61K39/4615;;A61K2239/49;;A61K39/4622;;C07F9/65586;;A61K35/15;;A61K31/7034;;C07F9/6552;;A61K31/683;;A61K2039/55511;;A61K39/39;;Y02A50/30;;C07F9/117;;A61K2039/5154;;A61K2039/54;;C07H15/207,A61K31/683;;A61K31/7034;;A61K35/15;;A61P31/00;;A61P33/00;;A61P33/02;;A61P35/00;;C07F9/10;;C07H15/20,,0,0,,,,PENDING
82,WO,A1,WO 2011/119047 A1,037-318-325-416-438,2011-09-29,2011,NO 2011000106 W,2011-03-28,NO 20100454 A,2010-03-26,CARVACROL/THYMOL COMPOSITION FOR THE TREATMENT OF SALMONID RICKETTSIAL SEPTICEMIA AND INFECTIOUS SALMON ANEMIA,"The present invention relates to a propyl-methyl-phenol compound, in particular thymol and/or carvacrol or composition comprising a propyl-methyl-phenol compound for use in the treatment and/or prophylaxis of Salmonid rickettsial septicemia (SRS) and/or diseases caused by Piscirickettsia salmonis, and/or for the use in killing, combating or controlling Piscirickettsia salmonis , and for use in the treatment and/or prophylaxis of Infectious salmon anemia (ISA) and/or diseases caused by Infectious salmon anemia virus, and/or for the use in killing, combating or controlling Infectious salmon anemia virus.",EWOS INNOVATION AS;;TRANCOSO KIRSTEN JOSE MIGUEL;;PINO MARMBIO JORGE EDUARDO;;GONZALEZ FORETIC NESTOR JAVER;;GONZALEZ VECINO JOSE LUIS;;EL-MOWAFI ADEL,TRANCOSO KIRSTEN JOSE MIGUEL;;PINO MARMBIO JORGE EDUARDO;;GONZALEZ FORETIC NESTOR JAVER;;GONZALEZ VECINO JOSE LUIS;;EL-MOWAFI ADEL,,https://lens.org/037-318-325-416-438,Patent Application,yes,2,6,14,14,0,A61K31/05;;A61P31/00;;A61P31/04;;A61P31/12;;Y02A50/30;;A23K10/30;;A23K20/111;;A23K50/80;;A61K36/00;;A61K36/53;;A61K31/05;;A61P31/00;;A61P31/04,A61K31/05;;A61K45/06;;A61P31/00;;A61P31/04;;A61P31/12,,4,0,,,"O JINTASATAPORN, C KAMEL: ""THE EFFECT OF THE FEEDING OF ENCAPSULATED THYMOL AND CARVACROL IN LOW-PROTEIN DIETS FOR HYBRID CATFISH ON PERFORMANCE UNDER NORMAL AND DISEASE CHALLENGE CONDITIONS"", 5 August 2009 (2009-08-05), XP002646013, Retrieved from the Internet <URL:http://en.engormix.com/MA-aquaculture/articles/the-effect-feeding-encapsulated-t1391/p0.htm> [retrieved on 20110629];;DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; HEIL T P ET AL: ""SENSORY PROPERTIES OF THIOPHENOLS AND ALKYLPHENOLS CAUSING FLAVOR TAINTING IN FISH FROM THE UPPER WISCONSIN RIVER USA"", XP002427057, retrieved from BIOSIS Database accession no. 198988125920;;FEMS MICROBIOLOGY LETTERS, vol. 197, no. 35, pages 19 - 22;;See also references of EP 2552431A1",PENDING
83,CL,A1,CL 2012002654 A1,001-261-129-615-340,2013-08-09,2013,CL 2012002654 A,2012-09-25,NO 20100454 A,2010-03-26,Compuesto de propilmetilfenol o una composicion que lo comprende para tratar septicemia rickettsial salmonidea (srs) y/o enfermedades causadas por la piscirickettsia salmonis.,,EWOS INNOVATIONS AS,TRONCOSO KIRSTEN JOSE MIGUEL;;GONZALEZ FORETIC NESTOR JAVIER;;GONZALEZ VECINO JOSE LUIS;;EL MOWAFI ADEL;;PINO MARAMBIO JORGE EDUARDO,,https://lens.org/001-261-129-615-340,Patent Application,no,0,0,14,14,0,A61K31/05;;A61P31/00;;A61P31/04;;A61P31/12;;Y02A50/30;;A23K10/30;;A23K20/111;;A23K50/80;;A61K36/00;;A61K36/53;;A61K31/05;;A61P31/00;;A61P31/04,A61K31/05;;A61K45/06;;A61P31/00,,0,0,,,,PENDING
84,CA,C,CA 2794480 C,173-478-269-204-839,2017-12-05,2017,CA 2794480 A,2011-03-28,NO 20100454 A;;NO 2011000106 W,2010-03-26,CARVACROL/THYMOL COMPOSITION FOR THE TREATMENT OF SALMONID RICKETTSIAL SEPTICEMIA AND INFECTIOUS SALMON ANEMIA,"The present invention relates to a propyl-methyl-phenol compound, in particular thymol and/or carvacrol or composition comprising a propyl-methyl-phenol compound for use in the treatment and/or prophylaxis of Salmonid rickettsial septicemia (SRS) and/or diseases caused by Piscirickettsia salmonis, and/or for the use in killing, combating or controlling Piscirickettsia salmonis, and for use in the treatment and/or prophylaxis of Infectious salmon anemia (ISA) and/or diseases caused by Infectious salmon anemia virus, and/or for the use in killing, combating or controlling Infectious salmon anemia virus.",EWOS INNOVATION AS,TRONCOSO KIRSTEN JOSE MIGUEL;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ FORETIC NESTOR JAVIER;;GONZALEZ VECINO JOSE LUIS;;EL-MOWAFI ADEL,,https://lens.org/173-478-269-204-839,Granted Patent,no,0,0,14,14,0,A61K31/05;;A61P31/00;;A61P31/04;;A61P31/12;;Y02A50/30;;A23K10/30;;A23K20/111;;A23K50/80;;A61K36/00;;A61K36/53;;A61K31/05;;A61P31/00;;A61P31/04,A61K31/05;;A61K45/06;;A61P31/00;;A61P31/04;;A61P31/12,,0,0,,,,ACTIVE
85,NO,A1,NO 20100454 A1,142-526-617-930-714,2011-09-27,2011,NO 20100454 A,2010-03-26,NO 20100454 A,2010-03-26,Forbindelse og sammensetning for kontroll av bakterier og virus,"Sammendrag Det beskrives en propyl-metyl-fenol-forbindelse eller sammensetning omfattende en propyl-metyl-fenol-forbindelse for anvendelse i behandling og/eller profylakse av salmonid rickettsial septikemi (SRS) og/eller sykdommer forårsaket av Piscirickettsia 5 salmonis, og/eller for anvendelse i dreping, bekjemping eller regulering av Pisciri-ckettsia salmonis, og for anvendelse i behandling og/eller profylakse av infeksiøs lakseanemi (ISA) og/eller sykdommer forårsaket av infektiøs lakseanemivirus, og/eller for anvendelse i dreping, bekjemping eller regulering av infektiøs lakse-anemivirus.",EWOS INNOVATION AS,EL-MOWAFI ADEL;;KIRSTEN JOSE MIGUEL TRONCOSO;;FORETIC NESTOR JAVIER GONZALEZ;;MARAMBIO JORGE EDUARDO PINO;;VECINO JOSE L GONZALEZ,,https://lens.org/142-526-617-930-714,Patent Application,no,0,0,14,14,0,A61K31/05;;A61P31/00;;A61P31/04;;A61P31/12;;Y02A50/30;;A23K10/30;;A23K20/111;;A23K50/80;;A61K36/00;;A61K36/53;;A61K31/05;;A61P31/00;;A61P31/04,A23K1/18;;A23K1/16;;A61K31/05;;A61K36/53;;A61P31/00;;A61P31/04;;A61P31/12,,0,0,,,,DISCONTINUED
86,EP,A1,EP 2552431 A1,118-036-938-822-130,2013-02-06,2013,EP 11717046 A,2011-03-28,NO 20100454 A;;NO 2011000106 W,2010-03-26,CARVACROL/THYMOL COMPOSITION FOR THE TREATMENT OF SALMONID RICKETTSIAL SEPTICEMIA AND INFECTIOUS SALMON ANEMIA,,EWOS INNOVATION AS,TRANCOSO KIRSTEN JOSE MIGUEL;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ FORETIC NESTOR JAVIER;;GONZALEZ VECINO JOSE LUIS;;EL-MOWAFI ADEL,,https://lens.org/118-036-938-822-130,Patent Application,yes,1,2,14,14,0,A61K31/05;;A61P31/00;;A61P31/04;;A61P31/12;;Y02A50/30;;A23K10/30;;A23K20/111;;A23K50/80;;A61K36/00;;A61K36/53;;A61K31/05;;A61P31/00;;A61P31/04,A61K31/05;;A61K45/06;;A61P31/00;;A61P31/04;;A61P31/12,,5,0,,,"CLAIRE YEW YOKE CHING D.V.M.: ""IMPROVING AQUACULTURE PRODUCTION THROUGH BETTER HEALTH AND DISEASE PREVENTION THE NATURAL WAY"", FEED TECHNOLOGY UPDATE (SOLUTIONS FOR THE GLOBAL FEED INDUSTRY, vol. 3, no. 1, 1 January 2008 (2008-01-01), HONOLULU, HAWAI, XP003034107;;DEA BARICEVIC AND THOMAS BARTOL: ""THE BIOLOGICAL/PHARMACOLOGICAL ACTIVITY OF THE ORIGANUM GENUS 2002"", OREGANO, THE GENERA ORIGANUM AND LIPPIA, 2002, TAYLOR AND FRANCIS, XP003034106;;M. YIAGNISIS ET AL.: ""EFFECT OF DIETARY OREGANO ESSENTIAL OIL SUPPLEMENTATION ON COMBINED INFECTIONS BY PATHOGENIC BACTERIA-PARASITES (SEA LICE AND COPEPODS) IN EUROPEAN SEA BASS DICENTRARCHUS LABRAX L."", 14TH. EAFP INT. CONF. (DISEASES OF FISH AND SHELLFISH), vol. O-123, 14 September 2009 (2009-09-14) - 19 September 2009 (2009-09-19), PRAGUE, pages 139, XP003034108;;PONGSAK RATTANACHAIKUNSOPON: ""ASSESSMENT OF SYNERGISTIC EFFICACY OF CARVACROL AND CYMENE AGAINST EDWARDSIELLA TARDA IN VITRO AND IN TILAPIA (OREOCHROMIS NILOTICUS)"", AFRICAN JOURNAL MICROBIOLOGY RESEARCH, vol. 4, no. 5, 4 March 2010 (2010-03-04), pages 420 - 425, XP003034109;;See also references of WO 2011119047A1",ACTIVE
87,CA,A1,CA 2794480 A1,160-472-753-116-452,2011-09-29,2011,CA 2794480 A,2011-03-28,NO 20100454 A;;NO 2011000106 W,2010-03-26,CARVACROL/THYMOL COMPOSITION FOR THE TREATMENT OF SALMONID RICKETTSIAL SEPTICEMIA AND INFECTIOUS SALMON ANEMIA,"The present invention relates to a propyl-methyl-phenol compound, in particular thymol and/or carvacrol or composition comprising a propyl-methyl-phenol compound for use in the treatment and/or prophylaxis of Salmonid rickettsial septicemia (SRS) and/or diseases caused by Piscirickettsia salmonis, and/or for the use in killing, combating or controlling Piscirickettsia salmonis, and for use in the treatment and/or prophylaxis of Infectious salmon anemia (ISA) and/or diseases caused by Infectious salmon anemia virus, and/or for the use in killing, combating or controlling Infectious salmon anemia virus.",EWOS INNOVATION AS,TRONCOSO KIRSTEN JOSE MIGUEL;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ FORETIC NESTOR JAVIER;;GONZALEZ VECINO JOSE LUIS;;EL-MOWAFI ADEL,,https://lens.org/160-472-753-116-452,Patent Application,no,0,0,14,14,0,A61K31/05;;A61P31/00;;A61P31/04;;A61P31/12;;Y02A50/30;;A23K10/30;;A23K20/111;;A23K50/80;;A61K36/00;;A61K36/53;;A61K31/05;;A61P31/00;;A61P31/04,A61K31/05;;A61K45/06;;A61P31/00;;A61P31/04;;A61P31/12,,0,0,,,,ACTIVE
88,CA,C,CA 2794481 C,197-995-599-571-160,2019-05-14,2019,CA 2794481 A,2011-03-28,NO 20100451 A;;NO 2011000108 W,2010-03-26,CARVACROL AND/OR THYMOL OR COMPOSITION THEREOF FOR PREVENTING OF INFECTION OR INFESTATION OF AN ECTOPARASITIC COPEPOD IN FISH,"The invention describes carvacrol and/ thymol or a composition comprising one or both of these active compounds for use in the treatment of sea lice infections in fish and a method of killing, combating or controlling sea lice, preferable in the fish farming industry as well as a feed for fish.",EWOS INNOVATION AS,TRONCOSO KIRSTEN JOSE MIGUEL;;GONZALEZ FORETIC NESTOR JAVIER;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ VECINO JOSE LUIS;;EL-MOWAFI ADEL,,https://lens.org/197-995-599-571-160,Granted Patent,no,0,0,9,9,0,A61K31/05;;A61K45/06;;A61P33/00;;A61P33/14;;A61K31/05;;A61K45/06,A61K31/05;;A61K33/00,,0,0,,,,ACTIVE
89,WO,A8,WO 2011/119047 A8,025-942-704-128-771,2013-05-23,2013,NO 2011000106 W,2011-03-28,NO 20100454 A,2010-03-26,CARVACROL/THYMOL COMPOSITION FOR THE TREATMENT OF SALMONID RICKETTSIAL SEPTICEMIA AND INFECTIOUS SALMON ANEMIA,"The present invention relates to a propyl-methyl-phenol compound, in particular thymol and/or carvacrol or composition comprising a propyl-methyl-phenol compound for use in the treatment and/or prophylaxis of Salmonid rickettsial septicemia (SRS) and/or diseases caused by Piscirickettsia salmonis, and/or for the use in killing, combating or controlling Piscirickettsia salmonis , and for use in the treatment and/or prophylaxis of Infectious salmon anemia (ISA) and/or diseases caused by Infectious salmon anemia virus, and/or for the use in killing, combating or controlling Infectious salmon anemia virus.",EWOS INNOVATION AS;;TRANCOSO KIRSTEN JOSE MIGUEL;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ FORETIC NESTOR JAVIER;;GONZALEZ VECINO JOSE LUIS;;EL-MOWAFI ADEL,TRANCOSO KIRSTEN JOSE MIGUEL;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ FORETIC NESTOR JAVIER;;GONZALEZ VECINO JOSE LUIS;;EL-MOWAFI ADEL,,https://lens.org/025-942-704-128-771,Amended Application,yes,0,0,14,14,0,A61K31/05;;A61P31/00;;A61P31/04;;A61P31/12;;Y02A50/30;;A23K10/30;;A23K20/111;;A23K50/80;;A61K36/00;;A61K36/53;;A61K31/05;;A61P31/00;;A61P31/04,A61K31/05;;A61K45/06;;A61P31/00;;A61P31/04;;A61P31/12,,0,0,,,,PENDING
90,CA,A1,CA 2794481 A1,037-713-485-170-270,2011-09-29,2011,CA 2794481 A,2011-03-28,NO 20100451 A;;NO 2011000108 W,2010-03-26,CARVACROL AND/OR THYMOL OR COMPOSITION THEREOF FOR PREVENTING OF INFECTION OR INFESTATION OF AN ECTOPARASITIC COPEPOD IN FISH,"The invention describes carvacrol and/ thymol or a composition comprising one or both of these active compounds for use in the treatment of sea lice infections in fish and a method of killing, combating or controlling sea lice, preferable in the fish farming industry as well as a feed for fish.",EWOS INNOVATION AS,TRONCOSO KIRSTEN JOSE MIGUEL;;GONZALEZ FORETIC NESTOR JAVIER;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ VECINO JOSE LOUIS;;EL-MOWAFI ADEL,,https://lens.org/037-713-485-170-270,Patent Application,no,0,0,9,9,0,A61K31/05;;A61K31/05;;A61K45/06;;A61K45/06;;A61P33/00;;A61P33/14,A61K31/05;;A61K33/00,,0,0,,,,ACTIVE
91,CL,A1,CL 2012002653 A1,051-932-336-801-849,2013-08-09,2013,CL 2012002653 A,2012-09-25,NO 20100451 A,2010-03-26,Composición de carvacrol y/o timol para la prevencion o infeccion o infestacion de copepodo ectoparasitoide en peces.,,EWOS INNOVATIONS AS,TRONCOSO KIRSTEN JOSE MIGUEL;;GONZALEZ FORETIC NESTOR JAVIER;;EL MOWAFI ADEL;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ VECINO JOSE LOUIS,,https://lens.org/051-932-336-801-849,Patent Application,no,0,0,9,9,0,A61K31/05;;A61K31/05;;A61K45/06;;A61K45/06;;A61P33/00;;A61P33/14,A61K31/05;;A61K33/00,,0,0,,,,PENDING
92,NO,A1,NO 20100451 A1,119-277-415-295-013,2011-09-27,2011,NO 20100451 A,2010-03-26,NO 20100451 A,2010-03-26,Forbindelse og sammensetning for kontroll av fiskeparasitter,,EWOS INNOVATION AS,EL-MOWAFI ADEL;;KIRSTEN JOSE MIGUEL TRONCOSO;;FORETIC NESTOR JAVIER GONZALEZ;;RUOHONEN KARI;;VECINO JOSE LUIS GONZALEZ;;MARAMBIO JORGE EDUARDO PINO;;VECINO JOSE L GONZALEZ,,https://lens.org/119-277-415-295-013,Patent Application,no,0,0,9,9,0,A61K31/05;;A61K31/05;;A61K45/06;;A61K45/06;;A61P33/00;;A61P33/14,A23K1/18;;A23K1/16;;A61K31/05;;A61K31/11;;A61K36/00;;A61K36/53;;A61P33/00;;A61P33/14,,0,0,,,,DISCONTINUED
93,WO,A1,WO 2022/157398 A1,008-478-217-516-66X,2022-07-28,2022,ES 2021070866 W,2021-12-01,ES 202130036 A,2021-01-21,METHOD FOR REPAIRING PLASTIC SEPARATORS AND PLASTIC SEPARATOR OBTAINED USING THE METHOD,"Disclosed is a method for repairing plastic separators (1) comprising longitudinal internal cavities (100), which comprises the following steps: identifying and removing the damaged areas (2) to be repaired, there being spaces (4) defined; preparing inserts (5) have a shape matching the spaces (4); and joining the inserts (5) in the gaps (4) by means of heat welds (8), wherein the damaged areas to be repaired are removed by means of cuts (3) having a curved path, and wherein, in the step of preparing the inserts (5), inserts are machined with an outer edge (50) aligned with the edges (10) of the separator (1) and with an inner edge (51) parallel to the curved path of the cut (3), a space (7) for filling with filler material (8) being defined between the cut (3) made in the separator (1) and the inner edge (51) of the insert (5).",CARTONPLAST IBERICA SLU 50%;;PLASTIC REPAIR SYSTEM 2011 SL 50%,URIBE PLAZA (50%) JOSE IGNACIO;;CARRASCO TURRERO (25%) JOSE MARIA;;GONZALEZ BENITO (25%) NESTOR,,https://lens.org/008-478-217-516-66X,Patent Application,yes,2,0,8,8,0,B29C73/04;;B29C73/02;;B29C73/04;;B29C73/24,B29C73/04;;B29C73/24,,0,0,,,,PENDING
94,CO,A2,CO 2023010512 A2,039-246-963-253-779,2023-08-28,2023,CO 2023010512 A,2023-08-10,ES 2021070866 W;;ES 202130036 A,2021-01-21,Procedimiento de reparacion de separadores plasticos y separador plastico obtenido por dicho procedimiento,"Procedimiento de reparación de separadores (1) plásticos, del tipo que comprenden unos alveolos (100) internos longitudinales, que comprende las siguientes etapas; -identificación y extracción de las zonas dañadas a reparar (2), quedando determinados unos huecos (4), -preparación de unos injertos (5) de forma correspondiente con dichos huecos (4), y -unión mediante termosoldaduras (8) de los injertos (5) en los huecos (4); -donde la extracción de las zonas dañadas a reparar se realiza mediante cortes (3) de trayectoria curva, y -donde en la etapa de preparación de los injertos (5) se mecanizan injertos con un borde exterior (50) alineado con los bordes (10) del separador (1), y un borde interior (51) paralelo a la trayectoria curva del corte (3), quedando definido entre el corte (3) practicado en el separador (1) y el borde interior (51) del injerto (5) un espacio para relleno (7) con material de aporte (8).",CARTONPLAST IBERICA SLU 50%;;PLASTIC REPAIR SYSTEM 2011 SL 50%,URIBE PLAZA (50%) JOSE IGNACIO;;CARRASCO TURRERO (25%) JOSE MARIA;;GONZALEZ BENITO (25%) NESTOR,,https://lens.org/039-246-963-253-779,Patent Application,no,0,0,8,8,0,B29C73/04;;B29C73/02;;B29C73/04;;B29C73/24,B29C73/04;;B29C73/24,,0,0,,,,PENDING
95,MX,A,MX 2012001219 A,104-592-858-012-938,2013-07-29,2013,MX 2012001219 A,2012-01-27,MX 2012001219 A,2012-01-27,MODULE FOR A LED LAMP.,"The present invention is a device or module with an LED lamp of compact dimensions for use in different lighting industries such as the automotive industry, the signaling industry or architectural industry. The module includes elements for simple and fast assembly, efficient production from a single plate and with structures for structural support and heat diffusion. Said device or module can be directly mounted in the application or on a supporting means made of insulating material. Said device or module additionally has two different types of connection which can be used independently or together, depending on the application.",CEMM MEX S A DE C V,GONZALEZ NESTOR TALAVERA;;MUNOZ ARTURO ANGEL BARRIOS;;RAMOS OSCAR RENE CAVAZOS;;SALAZAR LUIS REBOLLEDO,,https://lens.org/104-592-858-012-938,Patent Application,no,0,0,13,13,0,H01R33/09;;F21S43/195;;F21S43/14;;F21S45/47;;H05B33/06;;F21V29/70;;F21S43/14;;F21S45/47;;F21S43/195;;H01R33/09;;H05B33/06;;F21Y2115/10;;F21V29/70;;H01R33/09;;F21S43/195;;F21S43/14;;F21S45/47;;H05B33/06,H01J5/50,,0,0,,,,ACTIVE
96,CN,A,CN 104115347 A,077-819-567-509-035,2014-10-22,2014,CN 201280067573 A,2012-02-16,MX 2012000017 W;;MX 2012001219 A,2012-01-27,Module for an led lamp,"The present invention is a device or module with an LED lamp of compact dimensions for use in different lighting industries such as the automotive industry, the signalling industry or architectural industry. The module includes elements for simple and fast assembly, efficient production from a single plate and with structures for structural support and heat diffusion. Said device or module can be directly mounted in the application or on a supporting means made of insulating material. Said device or module additionally has two different types of connection which can be used independently or together, depending on the application.",CEMM MEX S A DE C V,TALAVERA GONZALEZ NESTOR;;BARRIOS MUNOZ ARTURO ANGEL;;CAVAZOS RAMOS OSCAR RENE;;REBOLLEDO SALAZAR LUIS,,https://lens.org/077-819-567-509-035,Patent Application,no,3,1,13,13,0,H01R33/09;;F21S43/195;;F21S43/14;;F21S45/47;;H05B33/06;;F21V29/70;;F21S43/14;;F21S45/47;;F21S43/195;;H01R33/09;;H05B33/06;;F21Y2115/10;;F21V29/70;;H01R33/09;;F21S43/195;;F21S43/14;;F21S45/47;;H05B33/06,H01R33/00;;F21S13/14,,0,0,,,,INACTIVE
97,WO,A1,WO 2013/112037 A1,170-979-446-817-561,2013-08-01,2013,MX 2012000017 W,2012-02-16,MX 2012001219 A,2012-01-27,MODULE FOR AN LED LAMP,"The present invention is a device or module with an LED lamp of compact dimensions for use in different lighting industries such as the automotive industry, the signalling industry or architectural industry. The module includes elements for simple and fast assembly, efficient production from a single plate and with structures for structural support and heat diffusion. Said device or module can be directly mounted in the application or on a supporting means made of insulating material. Said device or module additionally has two different types of connection which can be used independently or together, depending on the application.",CEMM MEX S A DE C V;;TALAVERA GONZALEZ NESTOR;;BARRIOS MUNOZ ARTURO ANGEL;;CAVAZOS RAMOS OSCAR RENE;;REBOLLEDO SALAZAR LUIS,TALAVERA GONZALEZ NESTOR;;BARRIOS MUNOZ ARTURO ANGEL;;CAVAZOS RAMOS OSCAR RENE;;REBOLLEDO SALAZAR LUIS,,https://lens.org/170-979-446-817-561,Patent Application,yes,7,0,13,13,0,H01R33/09;;F21S43/195;;F21S43/14;;F21S45/47;;H05B33/06;;F21V29/70;;F21S43/14;;F21S45/47;;F21S43/195;;H01R33/09;;H05B33/06;;F21Y2115/10;;F21V29/70;;H01R33/09;;F21S43/195;;F21S43/14;;F21S45/47;;H05B33/06,H01R33/00;;F21S13/14,,1,0,,,See also references of EP 2808957A4,PENDING
98,KR,A,KR 20140126344 A,045-777-018-211-398,2014-10-30,2014,KR 20147024080 A,2012-02-16,MX 2012001219 A;;MX 2012000017 W,2012-01-27,MODULE FOR AN LED LAMP,,CEMM MEX S A DE C V,TALAVERA GONZALEZ NESTOR;;BARRIOS MUNOZ ARTURO ANGEL;;CAVAZOS RAMOS OSCAR RENE;;REBOLLEDO SALAZAR LUIS,,https://lens.org/045-777-018-211-398,Patent Application,no,0,0,13,13,0,H01R33/09;;F21S43/195;;F21S43/14;;F21S45/47;;H05B33/06;;F21V29/70;;F21S43/14;;F21S45/47;;F21S43/195;;H01R33/09;;H05B33/06;;F21Y2115/10;;F21V29/70;;H01R33/09;;F21S43/195;;F21S43/14;;F21S45/47;;H05B33/06,F21S2/00;;H01R33/00,,0,0,,,,DISCONTINUED
99,CA,A1,CA 3205659 A1,144-974-307-932-417,2022-07-28,2022,CA 3205659 A,2021-12-01,ES 202130036 A;;ES 2021070866 W,2021-01-21,METHOD FOR REPAIRING PLASTIC DIVIDERS AND PLASTIC DIVIDER OBTAINED BY SAID METHOD,"Disclosed is a method for repairing plastic separators (1) comprising longitudinal internal cavities (100), which comprises the following steps: identifying and removing the damaged areas (2) to be repaired, there being spaces (4) defined; preparing inserts (5) have a shape matching the spaces (4); and joining the inserts (5) in the gaps (4) by means of heat welds (8), wherein the damaged areas to be repaired are removed by means of cuts (3) having a curved path, and wherein, in the step of preparing the inserts (5), inserts are machined with an outer edge (50) aligned with the edges (10) of the separator (1) and with an inner edge (51) parallel to the curved path of the cut (3), a space (7) for filling with filler material (8) being defined between the cut (3) made in the separator (1) and the inner edge (51) of the insert (5).",CARTONPLAST IBERICA SLU 50%;;PLASTIC REPAIR SYSTEM 2011 SL 50%,URIBE PLAZA (50%) JOSE IGNACIO;;CARRASCO TURRERO (25%) JOSE MARIA;;GONZALEZ BENITO (25%) NESTOR,,https://lens.org/144-974-307-932-417,Patent Application,no,0,0,8,8,0,B29C73/04;;B29C73/02;;B29C73/04;;B29C73/24,B29C73/04;;B29C73/24,,0,0,,,,PENDING
100,NO,A1,NO 20100446 A1,024-405-080-901-50X,2011-09-27,2011,NO 20100446 A,2010-03-26,NO 20100446 A,2010-03-26,Fôrsammensetning,Sammendrag Det beskrives et fôr for et dyr hvor nevnte fôr omfatter et alkadienal. Nevnte alkadienal eller et fôr omfattende nevnte forbindelse kan anvendes i behandling og profylakse av en parasittinfeksjon og/eller -angrep i et dyr.,EWOS INNOVATION AS,EL-MOWAFI ADEL;;KIRSTEN JOSE MIGUEL TRONCOSO;;FORETIC NESTOR JAVIER GONZALEZ;;MARAMBIO JORGE EDUARDO PINO;;RUOHONEN KARI;;VECINO JOSE LUIS GONZALEZ,,https://lens.org/024-405-080-901-50X,Patent Application,no,0,0,2,2,0,A23K50/80;;A23K20/105,A23K1/16;;A01N35/02;;A23K1/18;;A61K31/11,,0,0,,,,DISCONTINUED
101,US,A1,US 2017/0332714 A1,157-999-146-322-230,2017-11-23,2017,US 201715589138 A,2017-05-08,US 201715589138 A;;US 201662337480 P,2016-05-17,GRIP SURFACES,"Provided among other things is a method of forming a composite glove with a grip texture, comprising: (a) providing a coagulant-coated support layer that is a fabric layer or a polymeric layer; (b) dip applying to the support layer a foamed polymer dispersion comprising about 0.5% to about 2.0% by weight hygroscopic agent; (c) allowing a portion of the applied foamed polymer dispersion to coagulate based the coagulant diffusing from the support layer to form a partially coagulated foam layer; (d) washing the partially coagulated foam layer to remove uncoagulated polymer to form a coagulated foam layer; and (e) vulcanizing the coagulated foam layer to form a vulcanized open foam layer laminated to the support.",ANSELL LTD,GUTIÉRREZ JANETH RUBI HERRERA;;ESPINOZA NESTOR DAVID BALLEZA;;GONZALEZ MIGUEL ANGEL SANCHEZ;;MERCADO AGUSTIN PORTILLO,ANSELL LIMITED (2017-05-09),https://lens.org/157-999-146-322-230,Patent Application,yes,0,6,3,3,0,D06N2209/106;;D06N2211/103;;D06N3/0059;;D06N3/007;;D06N3/0086;;B29K2105/0064;;B29K2105/0005;;B29K2105/0058;;B29C67/20;;A41D19/01547;;B29C35/02;;B29C41/14;;B29C67/06;;B29K2105/04;;B29L2031/4864;;D06N2205/04;;D06N2205/24;;D06N2211/103;;B29K2105/0064;;B29C67/20;;D06N3/007;;D06N2209/106;;D06N3/0086;;D06N3/0059;;B29K2105/0058;;B29K2105/0005;;A41D19/01547;;B29C35/02;;B29C41/14;;B29C67/06;;B29K2105/04;;B29L2031/4864;;D06N3/0043;;D06N2205/04;;D06N2205/24,A41D19/015;;B29C35/02;;B29C41/14;;B29C67/06;;B29K105/04;;B29L31/48;;D06N3/00,,0,0,,,,DISCONTINUED
102,WO,A2,WO 2017/197429 A2,044-131-208-900-486,2017-11-23,2017,AU 2017/000101 W,2017-05-08,US 201662337480 P,2016-05-17,GRIP SURFACES,"Provided among other things is a method of forming a composite glove with a grip texture, comprising: (a) providing a coagulant-coated support layer that is a fabric layer or a polymeric layer; (b) dip applying to the support layer a foamed polymer dispersion comprising about 0.5 % to about 2.0 % by weight hygroscopic agent; (c) allowing a portion of the applied foamed polymer dispersion to coagulate based the coagulant diffusing from the support layer to form a partially coagulated foam layer; (d) washing the partially coagulated foam layer to remove uncoagulated polymer to form a coagulated foam layer; and (e) vulcanizing the coagulated foam layer to form a vulcanized open foam layer laminated to the support.",ANSELL LTD,GUTIERREZ JANETH RUBI HERRERA;;ESPINOZA NESTOR DAVID BALLEZA;;GONZALEZ MIGUEL ANGEL SANCHEZ;;MERCADO AGUSTIN PORTILLO,,https://lens.org/044-131-208-900-486,Patent Application,yes,0,1,3,3,0,D06N2209/106;;D06N2211/103;;D06N3/0059;;D06N3/007;;D06N3/0086;;B29K2105/0064;;B29K2105/0005;;B29K2105/0058;;B29C67/20;;A41D19/01547;;B29C35/02;;B29C41/14;;B29C67/06;;B29K2105/04;;B29L2031/4864;;D06N2205/04;;D06N2205/24;;D06N2211/103;;B29K2105/0064;;B29C67/20;;D06N3/007;;D06N2209/106;;D06N3/0086;;D06N3/0059;;B29K2105/0058;;B29K2105/0005;;A41D19/01547;;B29C35/02;;B29C41/14;;B29C67/06;;B29K2105/04;;B29L2031/4864;;D06N3/0043;;D06N2205/04;;D06N2205/24,B32B37/24;;B32B5/18;;B32B5/24;;B32B27/06;;B32B38/00;;B32B38/16,,0,0,,,,PENDING
103,US,A1,US 2023/0052591 A1,049-349-788-904-929,2023-02-16,2023,US 202217881672 A,2022-08-05,US 202217881672 A;;US 202163232236 P,2021-08-12,PROJECTION ADJUSTMENT ASSEMBLY FOR FIBER OPTIC EQUIPMENT,"A fiber optic apparatus is provided including a support bracket configured to be mounted to an equipment rack, the bracket having a movable projection extending therefrom and a chassis configured to support fiber optic communication equipment, the chassis including a plurality of detents or apertures configured to receive the movable projection, wherein the engagement of the movable projection into one of the detents or apertures defines the projection of the chassis from the rack.",CORNING RES & DEV CORP,BENAVIDES PADRON SANTOS RAMIRO;;BERRONES ROBERTO VALDERRABANO;;COVARRUBIAS JUAN MIGUEL GONZALEZ;;SANCHEZ ARRIAGA NESTOR EDUARDO,,https://lens.org/049-349-788-904-929,Patent Application,yes,0,0,1,1,0,G02B6/44528;;G02B6/44526;;G02B6/4452;;G02B6/3616;;G02B6/3825,G02B6/44;;G02B6/36;;G02B6/38,,0,0,,,,PENDING
104,WO,A3,WO 2017/197429 A3,147-585-166-768-632,2018-07-26,2018,AU 2017/000101 W,2017-05-08,US 201662337480 P,2016-05-17,GRIP SURFACES,"Provided among other things is a method of forming a composite glove with a grip texture, comprising: (a) providing a coagulant-coated support layer that is a fabric layer or a polymeric layer; (b) dip applying to the support layer a foamed polymer dispersion comprising about 0.5 % to about 2.0 % by weight hygroscopic agent; (c) allowing a portion of the applied foamed polymer dispersion to coagulate based the coagulant diffusing from the support layer to form a partially coagulated foam layer; (d) washing the partially coagulated foam layer to remove uncoagulated polymer to form a coagulated foam layer; and (e) vulcanizing the coagulated foam layer to form a vulcanized open foam layer laminated to the support.",ANSELL LTD,GUTIERREZ JANETH RUBI HERRERA;;ESPINOZA NESTOR DAVID BALLEZA;;GONZALEZ MIGUEL ANGEL SANCHEZ;;MERCADO AGUSTIN PORTILLO,,https://lens.org/147-585-166-768-632,Search Report,yes,5,0,3,3,0,D06N2209/106;;D06N2211/103;;D06N3/0059;;D06N3/007;;D06N3/0086;;B29K2105/0064;;B29K2105/0005;;B29K2105/0058;;B29C67/20;;A41D19/01547;;B29C35/02;;B29C41/14;;B29C67/06;;B29K2105/04;;B29L2031/4864;;D06N2205/04;;D06N2205/24;;D06N2211/103;;B29K2105/0064;;B29C67/20;;D06N3/007;;D06N2209/106;;D06N3/0086;;D06N3/0059;;B29K2105/0058;;B29K2105/0005;;A41D19/01547;;B29C35/02;;B29C41/14;;B29C67/06;;B29K2105/04;;B29L2031/4864;;D06N3/0043;;D06N2205/04;;D06N2205/24,B32B37/24;;B32B5/18;;B32B5/24;;B32B27/06;;B32B38/00;;B32B38/16,,0,0,,,,PENDING
105,WO,A1,WO 2011/119048 A1,175-346-645-176-332,2011-09-29,2011,NO 2011000107 W,2011-03-28,NO 20100446 A,2010-03-26,FEED COMPOSITION FOR PREVENTING INFECTION OR INFESTATION OF A PARASITE IN FISH,The invention describes a fish feed wherein said feed comprises an alkadienal. The alkadienal or a feed comprising said compound can be used in the treatment and prophylaxis of a parasite infection and/or infestation in an animal.,EWOS INNOVATION AS;;TRONCOSO KIRSTEN JOSE MIGUEL;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ FORETIC NESTOR JAVIER;;GONZALEZ VECINO DR JOSE LUIS;;EL-MOWAFI ADEL;;RUOHONEN KARI,TRONCOSO KIRSTEN JOSE MIGUEL;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ FORETIC NESTOR JAVIER;;GONZALEZ VECINO DR JOSE LUIS;;EL-MOWAFI ADEL;;RUOHONEN KARI,,https://lens.org/175-346-645-176-332,Patent Application,yes,2,3,2,2,0,A23K50/80;;A23K20/105,A23K1/18,,7,4,029-524-265-615-757;;057-864-569-746-55X;;098-303-464-272-340;;008-267-792-958-448,10.1242/jeb.00580;;12939379;;10.1242/jeb.015859;;18424676;;10.1111/j.1365-2761.1993.tb00844.x;;10.1016/j.aquaculture.2007.05.025,"N.N.: ""Summary of data for chemical selection. 2,4-Decadienal."", 6 November 2004 (2004-11-06), XP002642747, Retrieved from the Internet <URL:http://ntp.niehs.nih.gov/ntp/htdocs/Chem_Background/ExecSumm/Decadienal.html> [retrieved on 20110615];;G. ROMANO: ""A marine diatom-derived aldehyde induces apoptosis in copepod and sea urchin embryos"", JOURNAL OF EXPERIMENTAL BIOLOGY, vol. 206, no. 19, 1 October 2003 (2003-10-01), pages 3487 - 3494, XP055000857, ISSN: 0022-0949, DOI: 10.1242/jeb.00580;;I. BUTTINO ET AL: ""Aldehyde-encapsulating liposomes impair marine grazer survivorship"", JOURNAL OF EXPERIMENTAL BIOLOGY, vol. 211, no. 9, 1 May 2008 (2008-05-01), pages 1426 - 1433, XP055000858, ISSN: 0022-0949, DOI: 10.1242/jeb.015859;;ROTH M ET AL: ""Current practices in the chemotherapeutic control of sea lice infestations in aquaculture: A review"", JOURNAL OF FISH DISEASES, OXFORD, GB, vol. 16, no. 1, 1 January 1993 (1993-01-01), pages 1 - 26, XP009146063, ISSN: 0140-7775, DOI: DOI:10.1111/J.1365-2761.1993.TB00844.X;;MONTGOMERY, D.: ""Design and Analysis of Experiments"", 1997, JOHN WILEY & SONS, pages: 684;;MYERS, R., D. MONTGOMERY: ""Response Surface Methodology"", 1995, JOHN WILEY & SONS, pages: 700;;PINO-MARAMBIO, J.E., MORDUE (LUNTZ), A.J., BIRKETT, M.A., CARVAJAL, J., ASENCIO, G., MELLADO, A., QUIROZ, A.E.: ""Caligus rogercresseyi"", vol. 271, 2000, article ""Behavioural Studies of Host, Non-Host and Mate Location by the Sea Louse"", pages: 70 - 76",PENDING
106,CN,A,CN 104520725 A,130-011-192-409-254,2015-04-15,2015,CN 201380004720 A,2013-03-13,ES 2013000068 W,2013-03-13,Device for generating disturbances in an electrical grid,"The invention relates to a device for generating network disturbances at a generator. The device comprises an inductive voltage divider (34) including a control unit (2), a bench of 6 inductors (28 to 33) connected to one another via a matrix of 18 isolators (5 to 22) and 5 coupled switches (23 to 27). The following can be coupled to the divider (34): a set of transformers (40, 43); a bank of capacitors and resistors (75); and an overvoltage module (OVRT, 79). The device can be used to perform tests for generator (3) power values of between 0 kW and 8,000 kW. The overvoltage test is performed by passing short-circuit current through coils (77) coupled to coils (78), generating 403 different configurations and producing 2,821 different overvoltages using combinations of the inductors (28 to 33), isolators (5 to 16) and (17 to 22) and switches (24 to 27).",WYNNERTECH BEIJING CO LTD,DAVID UGENA GONZALEZ;;JOSE MANUEL TENA CEREZO;;NESTOR DANIEL CASTAGNOLA;;HIGINIO LOGROSAN DIAZ;;CESAR HERMOSO GARCIA,,https://lens.org/130-011-192-409-254,Patent Application,no,7,0,2,2,0,G01R1/20;;G01R31/34;;H02J3/26;;Y02E40/50,G01R31/34;;F03D11/00;;H02J3/38;;H02P9/02,,0,0,,,,DISCONTINUED
107,CA,A1,CA 3114264 A1,195-602-388-368-186,2020-04-02,2020,CA 3114264 A,2019-09-25,CU 20180117 A;;CU 2019050008 W,2018-09-27,SOLID COMPOSITION FOR AGRICULTURAL AND VETERINARY USE,"A solid composition for agricultural or veterinary use, comprising a mixture of a bacterial concentrate of strain C-924 and a culture medium or a commercially available organic amendment, an antifoam substance and sucrose, and having less than 12% of residual moisture. The components of the formulation ensure adequate wettability of the finished solid product and extended storage stability at temperatures of 2 to 8°C. The invention discloses the use of the solid composition to control of plant and animal pathogens, and to stimulate seed germination and plant growth.",CT INGENIERIA GENETICA BIOTECNOLOGIA,GONZALEZ FERNANDEZ NEMECIO;;MORAN VALDIVIA ROLANDO;;PEREZ HEREDIA CARLOS;;PANEQUE DIAZ YUNIER;;WONG PADILLA IDANIA;;SANCHEZ ORTIZ ILEANA;;MORA GONZALEZ NESTOR;;FRANCO RODRIGUEZ RAMON;;SOMONTES SANCHEZ DANALAY;;MENA CAMPOS JESUS;;GONZALEZ BLANCO SONIA,,https://lens.org/195-602-388-368-186,Patent Application,no,0,0,13,13,0,A01N63/20;;A01N63/20;;A01P3/00;;A01P5/00,A01N63/20;;A01P3/00;;A01P5/00;;A01P21/00,,0,0,,,,PENDING
108,CN,A,CN 113710092 A,175-296-429-401-731,2021-11-26,2021,CN 201980077374 A,2019-09-25,CU 20180117 A;;CU 2019050008 W,2018-09-27,SOLID COMPOSITION FOR AGRICULTURAL AND VETERINARY USE,"The invention relates to a solid composition for agricultural or veterinary use, comprising a mixture of a bacterial concentrate of strain C-924 and a culture medium or a commercially available organic amendment, an antifoam substance and sucrose, and having less than 12% of residual moisture. The components of the formulation ensure adequate wettability of the finished solid product and extended storage stability at temperatures of 2 to 8 DEG C. The invention discloses the use of the solid composition to control of plant and animal pathogens, and to stimulate seed germination and plant growth.",CT INGENIERIA GENETICA BIOTECNOLOGIA,GONZALEZ FERNANDEZ NEMECIO;;MORAN VALDIVIA ROLANDO;;PEREZ HEREDIA CARLOS;;PANEQUE DIAZ YUNIER;;WONG PADILLA IDANIA;;SANCHEZ ORTIZ ILEANA;;MORA GONZALEZ NESTOR;;FRANCO RODRIGUEZ RAMON;;SOMONTES SANCHEZ DANALAY;;MENA CAMPOS JESUS;;GONZALEZ BLANCO SONIA,,https://lens.org/175-296-429-401-731,Patent Application,no,9,0,13,13,0,A01N63/20;;A01N63/20;;A01P3/00;;A01P5/00,A01N63/20;;A01P3/00;;A01P5/00;;A01P21/00,,2,0,,,"JESUS MENA: ""HeberNem-S MATERIAL SAFETY DATA SHEET"", 《百度学术》;;JESUS MENA: ""Instruction for HeberNem Use"", 《百度学术》",DISCONTINUED
109,GB,B,GB 2492713 B,082-699-286-904-490,2016-10-26,2016,GB 201219238 A,2011-03-28,NO 20100451 A;;NO 2011000108 W,2010-03-26,Carvacrol and carvacrol compositions for treatment and/or prophylaxis of sea lice infection in salmonids,,EWOS INNOVATION AS,JOSE MIGUEL TRONCOSO KIRSTEN;;NESTOR JAVIER GONZALES FORETIC;;JORGE EDUARDO PINO MARAMBIO;;JOSE LOUIS GONZALEZ VECINO;;ADEL EL-MOWAFI,,https://lens.org/082-699-286-904-490,Granted Patent,no,3,0,9,9,0,A61K31/05;;A61K31/05;;A61K45/06;;A61K45/06;;A61P33/00;;A61P33/14,A61K31/05;;A61K33/00,,5,1,074-362-455-703-005,10.1080/13880200390501839,"PHARMACEUTICAL BIOLOGY, Vol. 41, 2003, TAMPIERI M P ET AL: ""Effect of selected essential oils and pure compounds on Saprolegnia parasitica"", Pages 584-591;;Retrieved from the Internet, O Jintasataporn, C Kamel : ""THE EFFECT OF FEEDING OF ENCAPUSLATED THYMOL AND CARVACROL IN LOW-PROTEIN DIETS FOR HYBRID CATFISH ON PERFORMANCE UNDER NORMAL AND DISEASE CHALLENEG CONDITIONS"", 2009, URL: http://en.engormix.com/MA-aquaculture/articles/the-effect-feeding-enca;;14th EAFP International Conference, Prague, September 2009, Yiagnisis et al, Diseases of Fish and Shellfish: 'Effect of dietary oregano essential oil...' p. 139 article O-123;;African Journal of Microbiology Research, vol. 4 issue 5, 2010, Rattanachaikunsopon et al, 'Assessment of synergistic efficacy of carvacrol and cymene...' pp. 420-425. Available online at http://www.academicjournals.org/journal/AJMR/article-full-text-pdf/EB58D5C11964 [Accessed 18 August 2016];;Feed Technology Update, vol. 3 issue 1, 2008, Yew, 'Improving aquaculture production...' pp. 3-9 Available online at http://www.aquafeed.com/newsletter_pdfs/nl_000314.pdf [Accessed 18 August 2016]",ACTIVE
110,GB,A,GB 2492713 A,094-788-358-699-490,2013-01-09,2013,GB 201219238 A,2011-03-28,NO 20100451 A;;NO 2011000108 W,2010-03-26,Carvacrol and/or thymol or composition thereof for preventing of infection infestation of an ectoparasitic copepod in fish,"The invention describes carvacrol and/ thymol or a composition comprising one or both of these active compounds for use in the treatment of sea lice infections in fish and a method of killing, combating or controlling sea lice, preferable in the fish farming industry as well as a feed for fish.",EWOS INNOVATION AS,KIRSTEN JOSE MIGUEL TRONCOSO;;FORETIC NESTOR JAVIER GONZALES;;MARAMBIO JORGE EDUARDO PINO;;VECINO JOSE LOUIS GONZALEZ;;EL-MOWAFI ADEL,,https://lens.org/094-788-358-699-490,Patent Application,no,2,0,9,9,0,A61K31/05;;A61K31/05;;A61K45/06;;A61K45/06;;A61P33/00;;A61P33/14,A61K31/05;;A61K33/00,,2,1,074-362-455-703-005,10.1080/13880200390501839,"PHARMACEUTICAL BIOLOGY, Vol. 41, 2003, TAMPIERI M P ET AL: ""Effect of selected essential oils and pure compounds on Saprolegnia parasitica"", Pages 584-591;;Retrieved from the Internet, O Jintasataporn, C Kamel : ""THE EFFECT OF FEEDING OF ENCAPUSLATED THYMOL AND CARVACROL IN LOW-PROTEIN DIETS FOR HYBRID CATFISH ON PERFORMANCE UNDER NORMAL AND DISEASE CHALLENEG CONDITIONS"", 2009, URL: http://en.engormix.com/MA-aquaculture/articles/the-effect-feeding-enca",ACTIVE
111,WO,A1,WO 2011/119049 A1,002-511-071-486-421,2011-09-29,2011,NO 2011000108 W,2011-03-28,NO 20100451 A,2010-03-26,CARVACROL AND/OR THYMOL OR COMPOSITION THEREOF FOR PREVENTING OF INFECTION INFESTATION OF AN ECTOPARASITIC COPEPOD IN FISH,"The invention describes carvacrol and/ thymol or a composition comprising one or both of these active compounds for use in the treatment of sea lice infections in fish and a method of killing, combating or controlling sea lice, preferable in the fish farming industry as well as a feed for fish.",EWOS INNOVATION AS;;TRONCOSO KIRSTEN JOSE MIGUEL;;GONZALES FORETIC NESTOR JAVIER;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ VECINO JOSE LOUIS;;EL-MOWAFI ADEL,TRONCOSO KIRSTEN JOSE MIGUEL;;GONZALES FORETIC NESTOR JAVIER;;PINO MARAMBIO JORGE EDUARDO;;GONZALEZ VECINO JOSE LOUIS;;EL-MOWAFI ADEL,,https://lens.org/002-511-071-486-421,Patent Application,yes,2,3,9,9,0,A61K31/05;;A61K31/05;;A61K45/06;;A61K45/06;;A61P33/00;;A61P33/14,A61K31/05;;A61K33/00,,3,1,074-362-455-703-005,10.1080/13880200390501839,"TAMPIERI M P ET AL: ""Effect of selected essential oils and pure compounds on Saprolegnia parasitica"", PHARMACEUTICAL BIOLOGY, vol. 41, no. 8, 1 December 2003 (2003-12-01), SWETS AND ZEITLINGER, LISSE, NL, pages 584 - 591, XP009089606, ISSN: 1388-0209;;O JINTASATAPORN, C KAMEL: ""THE EFFECT OF THE FEEDING OF ENCAPSULATED THYMOL AND CARVACROL IN LOW-PROTEIN DIETS FOR HYBRID CATFISH ON PERFORMANCE UNDER NORMAL AND DISEASE CHALLENGE CONDITIONS"", 5 August 2009 (2009-08-05), XP002646013, Retrieved from the Internet <URL:http://en.engormix.com/MA-aquaculture/articles/the-effect-feeding-encapsulated-t1391/p0.htm> [retrieved on 20110629];;""R Development Core Team"", 2008, R FOUNDATION FOR STATISTICAL COMPUTING, article ""R: A Language and Environment for Statistical Computing""",PENDING
112,CL,A1,CL 2015000848 A1,076-983-960-576-582,2015-08-28,2015,CL 2015000848 A,2015-04-02,NO 20100454 A,2010-03-26,"Uso de un compuesto de propilmetilfenol, o una composición que lo comprende, para producir una composición farmacéutica y/o nutracéutica para el tratamiento y/o profilaxis de la anemia infecciosa del salmón (isa) (divisional sol. n° 2654-12).",,EWOS INNOVATION AS,GONZALEZ FORETIC NESTOR JAVIER;;PINO MARAMBIO JORGE EDUARDO;;TRONCOSO KIRSTEN JOSÉ MIGUEL;;GONZÁLEZ VECINO JOSÉ LUIS;;EL-MOWAFI ADEL,,https://lens.org/076-983-960-576-582,Patent Application,no,0,0,14,14,0,A61K31/05;;A61P31/00;;A61P31/04;;A61P31/12;;Y02A50/30;;A23K10/30;;A23K20/111;;A23K50/80;;A61K36/00;;A61K36/53;;A61K31/05;;A61P31/00;;A61P31/04,A61K31/05;;A61P31/00;;A61P31/12,,0,0,,,,PENDING
113,CU,A1,CU 22116 A1,122-492-308-498-034,1997-01-06,1997,CU 10289 A,1989-05-16,CU 10289 A,1989-05-16,MÉTODO DE PURIFICACIÓN DE GASES DE DESECHO CON RECUPERACIÓN DE AMONIACO,"La invención está relacionada con el campo de la protección del medio ambiente y en particular con la purificación de afluentes gaseosos . Su objetivo es lograr la purificación de corrientes gaseosas contaminadas con amoníaco mediante el empleo de tamices moleculares baratos de alta eficiencia de remoción que permiten recuperar amoníaco. Se explica un método de purificación de gases de desechos industriales que contienen concentraciones de amoníaco tan altas como 50 000 ppm empleando tamices moleculares obtenidos a partir de zeolitas naturales cálcicas por procedimientos de intercambio iónico alcanzando niveles de remoción mayores del 99% del amoníaco El método ofrece variantes de regeneración del absorbente que permiten recuperar el amoníaco y opcionalmente variantes no recuperativas con o sin regeneración. Es aplicable en sistemas de purificación industrial en procesos de fabricación de fertilizantes y otros procesos e instalaciones industriales donde el amoníaco aparece como contaminante , así como para adsorbedores a escala pequena en filtros de protección individual.empleando tamices moleculares obtenidos a partir de zeolitas naturales cálcicas por procedimientos de intercambio iónico alcanzando niveles de remoción mayores del 99% del amoníaco",CT DE INVESTIGACIONES QUIMICAS,RODRIGUEZ GUZMAN EDUARDO;;NIEBLA TRUJILLO JOSE ANTONIO;;DIAZ DIAZ MIGUEL ANGEL;;LLABRE RAURELL GLORIA;;GONZALEZ MORALES JOSE ANDRES;;TRAVIESO TUMA NESTOR,,https://lens.org/122-492-308-498-034,Limited Patent,no,0,0,1,1,0,,B01D53/04;;B01J29/06,,0,0,,,,EXPIRED
114,CA,A1,CA 2518906 A1,158-088-040-565-284,2004-06-10,2004,CA 2518906 A,2003-11-27,CU 20020292 A;;CU 0300016 W,2002-11-27,"METHOD OF OBTAINING COCHLEAR STRUCTURES, VACCINE COMPOSITIONS, ADJUVANTS AND INTERMEDIATES THEREOF","The invention relates to the field of immunology and, more specifically, to the branch relating to adjuvants and vaccines. The invention relates to a method of obtaining cochlear structures from the outer membrane vesicles (bullae) of micro-organisms, in order to use same as adjuvants or vaccines. The invention also relates to the method of obtaining said cochlear structur es.",INST FINLAY CT DE INVESTIGACIO,GIL MARTINEZ DANAY;;MORA GONZALEZ NESTOR;;RODRIGUEZ RAMIREZ TAMARA;;DEL CAMPO ALONSO JUDITH MONICA;;BARBERA MORALES RAMON FAUSTINO;;ZAYAS VIGNIER CARIDAD;;LASTRE GONZALEZ MIRIAM DE SAN;;CAMPA HUERGO CONCEPCION;;SIERRA GONZALEZ VICTORIANO GUS;;TABOADA SUAREZ CARLOS;;PEREZ MARTIN OLIVER GERMAN;;BRACHO GRANDO GUSTAVO RAFAEL,,https://lens.org/158-088-040-565-284,Patent Application,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/00;;A61K9/127;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,DISCONTINUED
115,BR,A,BR 0316687 A,052-924-664-274-650,2005-10-18,2005,BR 0316687 A,2003-11-27,CU 20020292 A;;CU 0300016 W,2002-11-27,Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos,"""COMPOSIçãO E ADJUVANTE VACINAL E MéTODO PARA A OBTENçãO DE ESTRUTURAS COCLEARES A PARTIR DE VESìCULAS DE MEMBRANA EXTERNA DE ORGANISMOS VIVOS"". A presente invenção refere-se ao campo da imunologia, particularmente ao ramo referente aos adjuvantes e às vacinas. O objetivo técnico perseguido é o de obter estruturas cocleares a partir de vesículas de membrana externa (ampolas) de microorganismos, com o fim de empregá-las como adjuvantes ou como vacinas propriamente ditas. A invenção também se refere ao método de obtenção das estruturas cocleares.",INST FINLAY CT DE INVESTIGACIO,GRANADO GUSTAVO RAFAEL BRACHO;;HUERGO CONCEPCION CAMPA;;GONZALEZ NESTOR MORA;;MORALES RAMON FAUSTINO BARBERA;;ALONSO JUDIT MONICA DEL CAMPO;;RAMIREZ TAMARA RODRIGUEZ;;VIGNIER CARIDAD ZAYAS;;MARTINEZ DANAY GIL;;SUAREZ CARLOS TABOADA;;MARTIN OLIVER GERMAN PEREZ;;GONZALEZ MIRIAM DE SAN JUAN BO;;GONZALEZ VICTORIANO GUSTAVO SI,,https://lens.org/052-924-664-274-650,Patent Application,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/00;;A61K9/127;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,DISCONTINUED
116,HK,A1,HK 1088827 A1,078-896-095-532-960,2006-11-17,2006,HK 06109275 A,2006-08-22,CU 0300016 W;;CU 20020292 A,2002-11-27,"METHOD OF OBTAINING COCHLEAR STRUCTURES, VACCINE COMPOSITIONS, ADJUVANTS AND INTERMEDIATES THEREOF",,INST FINLAY CT DE INVESTIGACION PRODUCCION DE VACUNAS Y SUEROS,PEREZMARTIN OLIVER GERMAN;;GRANDO GUSTAVO RAFAEL BRACHO;;GONZALEZ MIRIAM DE SAN JUAN BOSCO LASTRE;;GONZALEZ VICTORIANO GUSTAVO SIERRA;;HUERGO CONCEPCION CAMPA;;GONZALEZ NESTOR MORA;;MORALES RAMON FAUSTINO BARBERA;;ALONSO JUDITH MONICA DEL CAMPO;;RAMIREZ TAMARA RODRIGUEZ;;VIGNIER CARIDAD ZAYAS;;MARTINEZ DANAY GIL;;SUAREZ CARLOS TABOADA,,https://lens.org/078-896-095-532-960,Patent Application,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K/;;A61K9/00;;A61K9/127;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,DISCONTINUED
117,ZA,B,ZA 200504729 B,183-764-474-949-16X,2006-09-27,2006,ZA 200504729 A,2005-06-09,CU 20020292 A,2002-11-27,"Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof",,INST FINLAY CT DE INVESTIGACIO,MARTIN OLIVER GERMAN PEREZ;;GONZALEZ MIRIAM DE SAN JUAN BO;;HUERGO CONCEPCION CAMPA;;MORALES RAMON FAUSTINO BARBERA;;RAMIREZ TAMARA RODRIGUEZ;;MARTINEZ DANAY GIL;;GRANDO GUSTAVO RAFAEL BRACHO;;GONZALEZ VICTORIANO GUSTAVO SI;;GONZALEZ NESTOR MORA;;ALONSO JUDITH MONICA DEL CAMPO;;VIGNIER CARIDAD ZAYAS;;SUAREZ CARLOS TABOADA,,https://lens.org/183-764-474-949-16X,Granted Patent,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K/;;A61K9/00;;A61K9/127;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,ACTIVE
118,AU,A1,AU 2003/281911 A1,102-643-414-693-669,2004-06-18,2004,AU 2003/281911 A,2003-11-27,CU 20020292 A;;CU 0300016 W,2002-11-27,"METHOD OF OBTAINING COCHLEAR STRUCTURES, VACCINE COMPOSITIONS, ADJUVANTS AND INTERMEDIATES THEREOF",,INSTITUTO FINLAY CENTRO DE INVESTIG PRODUCCION DE VACUNAS Y SUEROS,MARTIN OLIVER GERMAN PEREZ;;GRANDO GUSTAVO RAFAEL BRACHO;;GONZALEZ MIRIAM DE SAN JUAN BO;;GONZALEZ VICTORIANO GUSTAVO SI;;HUERGO CONCEPCION CAMPA;;GONZALEZ NESTOR MORA;;MORALES RAMON FAUSTINO BARBERA;;ALONSO JUDITH MONICA DEL CAMPO;;RAMIREZ TAMARA RODRIGUEZ;;VIGNIER CARIDAD ZAYAS;;MARTINEZ DANAY GIL;;SUAREZ CARLOS TABOADA,,https://lens.org/102-643-414-693-669,Patent Application,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/00;;A61K9/127;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,DISCONTINUED
119,CN,B,CN 1744883 B,183-148-534-663-528,2011-06-08,2011,CN 200380109258 A,2003-11-27,CU 0300016 W;;CU 20020292 A,2002-11-27,"Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof","The present invention has applications in the field of immunology, specifically in the sphere of adjuvants and vaccines. The invention aims at obtaining cochlear structures from vesicles found in the outer membranes of microorganisms, in order to employ them in the preparation of adjuvants and vaccines. The invention also discloses a method for obtaining cochlear structures.",INST FINLAY CT DE INVESTIGACIO,DANAY GIL MARTINEZ;;CARIDAD ZAYAS VIGNIER;;RAFAEL BRACHO GRANDO GUSTAVO;;TAMARA RODRIGUEZ RAMIREZ;;CONCEPCION CAMPA HUERGO;;NESTOR MORA GONZALEZ;;SAN LASTRE GONZALEZ MIRIAM DE;;GUS SIERRA GONZALEZ VICTORIANO;;FAUSTINO BARBERA MORALES RAMON;;MONICA DEL CAMPO ALONSO JUDITH;;GERMAN PEREZ MARTIN OLIVER;;CARLOS TABOADA SUAREZ,,https://lens.org/183-148-534-663-528,Granted Patent,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K39/00;;A61K9/00;;A61K9/127;;A61K39/39;;A61K47/46,,0,0,,,,EXPIRED
120,WO,A1,WO 2004/047805 A1,192-268-251-754-844,2004-06-10,2004,CU 0300016 W,2003-11-27,CU 20020292 A,2002-11-27,"METHOD OF OBTAINING COCHLEAR STRUCTURES, VACCINE COMPOSITIONS, ADJUVANTS AND INTERMEDIATES THEREOF","The invention relates to the field of immunology and, more specifically, to the branch relating to adjuvants and vaccines. The invention relates to a method of obtaining cochlear structures from the outer membrane vesicles (bullae) of micro-organisms, in order to use same as adjuvants or vaccines. The invention also relates to the method of obtaining said cochlear structures.",INST FINLAY CT DE INVESTIGACIO;;PEREZ MARTIN OLIVER GERMAN;;BRACHO GRANDO GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN;;SIERRA GONZALEZ VICTORIANO GUS;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODRIGUEZ RAMIREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,PEREZ MARTIN OLIVER GERMAN;;BRACHO GRANDO GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN;;SIERRA GONZALEZ VICTORIANO GUS;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODRIGUEZ RAMIREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,,https://lens.org/192-268-251-754-844,Patent Application,yes,9,4,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/00;;A61K9/127;;A61K39/00;;A61K39/39;;A61K47/46,,8,8,003-955-252-796-238;;121-778-600-692-050;;051-538-293-264-362;;020-833-791-988-686;;072-347-551-650-806;;083-182-685-449-733;;019-540-474-603-266;;001-827-166-909-049,10.1128/iai.69.7.4502-4508.2001;;11401992;;pmc98525;;pmc175328;;10.1128/iai.65.6.2371-2377.1997;;9169776;;10.1016/s0264-410x(99)00219-4;;10501249;;9916056;;10.1128/iai.67.2.539-545.1999;;pmc96352;;10.1016/0005-2736(75)90299-0;;805602;;10.1016/0003-2697(77)90043-4;;603028;;10.1016/s0021-9258(18)70226-3;;13641241;;1500182;;pmc257383;;10.1128/iai.60.9.3725-3730.1992,"PEREZ, O, ET AL: ""Immune 2 response induction and new effector mechanisms possibly involved in protection confered by the cuban anti-meningococcal BC vaccine."", INFECTION AND IMMUNITY. JULIO 2001, vol. 69, no. 7, 2001, pages 4502 - 4508, XP002991926;;AFRIN, F. & ALI, N.: ""Adjuvancity and protective immunity elicted by Leishmania donovani antigens encapsulated in positively charged liposomes"", INFECTION AND IMMUNITY. JUNIO 1997, vol. 65, no. 6, 1997, pages 2371 - 2377, XP002991927;;ESTEVEZ, F., CARR, A., SOLORZANO, L. ET AL: ""Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes(VSSP)"", VACCINE 2000, vol. 18, 2000, pages 190 - 197, XP002195653;;BENITEZ JA ET AL., INFECT AND IMMUN, vol. 67, no. 2, 1999, pages 539 - 545;;D. PAPAHADJOPOLOUS ET AL., BIOCHEM. BIOPHYS. ACTA, vol. 394, 1975, pages 483;;PETERSON, ANALYT. BIOCHEM., vol. 83, 1977, pages 346;;BARTLETT, J BIOL. CHEM, vol. 234, 1959, pages 466;;ROCKETT, KA ET AL., INFECT. IMMUN., vol. 60, 1992, pages 3725 - 3730",PENDING
121,AR,A1,AR 042237 A1,017-258-787-999-917,2005-06-15,2005,AR P030104387 A,2003-11-27,CU 20020292 A,2002-11-27,"OBTENCION DE ESTRUCTURAS COCLEARES, COMPOSICIONES VACUNALES, ADYUVANTES Y SUS INTERMEDIARIOS","Métodos de obtención de estructuras cocleares a partir de vesículas de membrana externa (ampollas) de microorganismos, con el fin de emplearlas como adyuvantes o como vacunas en si. Las vesículas de membrana externa se obtienen a partir de bacterias, protozoarios o células animales, opcionalmente la composición vacunal incluye proteínas naturales o recombinantes, péptidos, sacáridos, ácidos nucleicos, conjugados o alergenos.",INST FINLAY CT DE INVESTIGACIO,PEREZ MARTIN OLIVER GERMAN;;BRANCHO GRANDOS GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN JUAN BOSCO;;ZAYAS VIGNIER CARIDAD;;SIERRA GONZALEZ VICTORIANO GUSTAVO;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODRIGUEZ RAMIREZ TAMARA;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,,https://lens.org/017-258-787-999-917,Patent Application,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/00;;A61K9/127;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,PENDING
122,EP,A3,EP 2347764 A3,012-193-463-649-295,2011-10-26,2011,EP 10185705 A,2003-11-27,EP 03773445 A;;CU 20020292 A,2002-11-27,"Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof","The present invention has applications in the field of immunology, specifically in the sphere of adjuvants and vaccines. The invention aims at obtaining cochlear structures from vesicles found in the outer membranes of microorganisms, in order to employ them in the preparation of adjuvants and vaccines. The invention also discloses a method for obtaining cochlear structures.",INST FINLAY CT DE INVESTIGACION PRODUCCION DE VACUNAS Y SUEROS,PEREZ MARTIN OLIVER GERMAN;;BRACHO GRANDO GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN JUAN BOSCO;;SIERRA GONZALEZ VICTORIANO GUSTAVO;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODRIGUEZ RAMIREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,,https://lens.org/012-193-463-649-295,Search Report,yes,2,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K39/095;;A61K9/00;;A61K9/127;;A61K39/00;;A61K39/008;;A61K39/02;;A61K39/39;;A61K47/46,,3,3,003-955-252-796-238;;051-538-293-264-362;;121-778-600-692-050,10.1128/iai.69.7.4502-4508.2001;;11401992;;pmc98525;;10.1016/s0264-410x(99)00219-4;;10501249;;pmc175328;;10.1128/iai.65.6.2371-2377.1997;;9169776,"PEREZ OLIVER ET AL: ""Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine"", INFECTION AND IMMUNITY, vol. 69, no. 7, July 2001 (2001-07-01), pages 4502 - 4508, XP002991926, ISSN: 0019-9567;;ESTEVEZ FRANCISCO ET AL: ""Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP)"", VACCINE, vol. 18, no. 1-2, August 1999 (1999-08-01), pages 190 - 197, XP004178829, ISSN: 0264-410X;;AFRIN FARHAT ET AL: ""Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes"", INFECTION AND IMMUNITY, vol. 65, no. 6, 1997, pages 2371 - 2377, XP002991927, ISSN: 0019-9567",DISCONTINUED
123,ES,T3,ES 2376227 T3,170-636-262-984-002,2012-03-12,2012,ES 03773445 T,2003-11-27,CU 20020292 A;;CU 0300016 W,2002-11-27,"PROCEDIMIENTO DE OBTENCION DE ESTRUCTURAS COCLEARES, COMPOSICIONES DE VACUNA, ADYUVANTES Y SUS INTERMEDIOS.","La presente invención se relaciona con el campo de la Inmunología, específicamente con la rama de los adyuvantes y las vacunas. El objetivo técnico que se persigue es obtener estructuras cocleares a partir de vesículas de membrana externa (ampollas) de microorganismos, con el fin de emplearlas como adyuvantes o como vacunas en sí. La invención también se relaciona con el método de obtención de las estructuras cocleares.",INST FINLAY CT DE INVESTIGACION PRODUCCION DE VACUNAS Y SUEROS,PEREZ MARTIN OLIVER GERMAN;;BRACHO GRANDO GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN JUAN BOSCO;;SIERRA GONZALEZ VICTORIANO GUSTAVO;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODRIGUEZ RAMIREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,,https://lens.org/170-636-262-984-002,Granted Patent,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/127;;A61K9/00;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,EXPIRED
124,EP,B1,EP 1602360 B1,113-386-059-285-963,2011-10-26,2011,EP 03773445 A,2003-11-27,CU 0300016 W;;CU 20020292 A,2002-11-27,"METHOD OF OBTAINING COCHLEAR STRUCTURES, VACCINE COMPOSITIONS, ADJUVANTS AND INTERMEDIATES THEREOF",,INST FINLAY CT DE INVESTIGACION PRODUCCION DE VACUNAS Y SUEROS,PEREZ MARTIN OLIVER GERMAN;;BRACHO GRANDO GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN JUAN BOSCO;;SIERRA GONZALEZ VICTORIANO GUSTAVO;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODRIGUEZ RAMIREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,"INSTITUTO FINLAY, CENTRO DE INVESTIGACION-PRODUCCI (2011-05-04)",https://lens.org/113-386-059-285-963,Granted Patent,yes,1,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/127;;A61K9/00;;A61K39/00;;A61K39/39;;A61K47/46,,3,1,154-917-387-196-182,10.1038/mi.2009.124;;19890268;;pmc3428627,"EC LAVELLE ET AL.: ""The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis"", NATURE (ADVANCE ONLINE PUBLICATION), 4 November 2009 (2009-11-04), pages 1 - 12, Retrieved from the Internet <URL:www.nature.com/mi> DOI: 10.1038/mi.2009.124;;""Pathogen-associated molecular pattern"", 14 January 2010 (2010-01-14), Retrieved from the Internet <URL:http://en.wikipedia.org/wiki/Pathogen-associated_molecular_pattern>;;""Patrón molecular asociado a patógenos"", 10 November 2009 (2009-11-10), Retrieved from the Internet <URL:http://es.wikipedia.org/wiki/patrón_molecular_asociado_a_patógenos>",EXPIRED
125,EP,A2,EP 2347764 A2,106-863-113-215-217,2011-07-27,2011,EP 10185705 A,2003-11-27,EP 03773445 A;;CU 20020292 A,2002-11-27,"Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof","The present invention has applications in the field of immunology, specifically in the sphere of adjuvants and vaccines. The invention aims at obtaining cochlear structures from vesicles found in the outer membranes of microorganisms, in order to employ them in the preparation of adjuvants and vaccines. The invention also discloses a method for obtaining cochlear structures.",INST FINLAY CT DE INVESTIGACION PRODUCCION DE VACUNAS Y SUEROS,PEREZ MARTIN OLIVER GERMAN;;BRACHO GRANDO GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN JUAN BOSCO;;SIERRA GONZALEZ VICTORIANO GUSTAVO;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODRIGUEZ RAMIREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,,https://lens.org/106-863-113-215-217,Patent Application,yes,15,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K39/095;;A61K9/00;;A61K9/127;;A61K39/00;;A61K39/008;;A61K39/02;;A61K39/39;;A61K47/46,,15,12,020-833-791-988-686;;072-347-551-650-806;;074-957-097-598-374;;083-182-685-449-733;;019-540-474-603-266;;001-827-166-909-049;;014-824-205-346-321;;039-491-957-423-398;;035-021-381-004-446;;000-995-871-874-554;;022-349-510-456-05X;;045-943-884-843-827,9916056;;10.1128/iai.67.2.539-545.1999;;pmc96352;;10.1016/0005-2736(75)90299-0;;805602;;10.1172/jci109383;;pmc372024;;109466;;10.1016/0003-2697(77)90043-4;;603028;;10.1016/s0021-9258(18)70226-3;;13641241;;1500182;;pmc257383;;10.1128/iai.60.9.3725-3730.1992;;10.1016/j.vaccine.2011.06.077;;21736914;;20197500;;10.1128/mmbr.00031-09;;pmc2832350;;pmc180163;;10.1128/aac.27.5.841;;4015074;;10.1111/j.1432-1033.1976.tb10699.x;;823014;;10.1046/j.1432-1327.1998.2550690.x;;9738909;;12414662,"BENITEZ JA ET AL., INFECT AND IMMUN, vol. 67, no. 2, 1999, pages 539 - 545;;D. PAPAHADJOPOLOUS ET AL., BIOCHEM. BIOPHYS. ACTA, vol. 394, 1975, pages 483;;ZOLLINGER ET AL., J. CLIN. INVEST., vol. 63, 1979, pages 836 - 848;;FREDERIKSON ET AL., NIPH ANNALS, vol. 14, 1991, pages 67 - 80;;SAUDERS ET AL., INFECT. IMMUN., vol. 67, 1999, pages 113 - 119;;DRABICK ET AL., VACCINE, vol. 18, 2000, pages 160 - 172;;PETERSON, ANALYT. BIOCHEM., vol. 83, 1977, pages 346;;BARTLETT, J BIOL. CHEM, vol. 234, 1959, pages 466;;ROCKETT, KA ET AL., INFECT. IMMUN., vol. 60, 1992, pages 3725 - 3730;;RODRIGUEZ LISSETE ET AL: ""Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice"", VACCINE, vol. 29, no. 37, August 2011 (2011-08-01), pages 6236 - 6241, ISSN: 0264-410X(print);;ELLIS TERRI N ET AL: ""Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles"", MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, vol. 74, no. 1, March 2010 (2010-03-01), pages 81 - 94,CP2, ISSN: 1092-2172(print);;RUHR E ET AL: ""MODE OF ACTION OF THE PEPTIDE ANTIBIOTIC NISIN AND INFLUENCE ON THE MEMBRANE POTENTIAL OF WHOLE CELLS AND ON CYTOPLASMIC AND ARTIFICIAL MEMBRANE VESICLES"", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 27, no. 5, 1985, pages 841 - 845, ISSN: 0066-4804;;BISSCHOP A ET AL: ""RECONSTITUTION OF NADH OXIDASE ACTIVITY WITH MENADIONE IN MEMBRANE VESICLES FROM THE MENAQUINONE DEFICIENT BACILLUS-SUBTILIS AROD RELATION BETWEEN ELECTRON TRANSFER AND ACTIVE TRANSPORT"", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 67, no. 2, 1976, pages 357 - 365, ISSN: 0014-2956;;VAN WELY KAREL H M ET AL: ""Translocation of the precursor of alpha-amylase into Bacillus subtilis membrane vesicles"", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 255, no. 3, 1 August 1998 (1998-08-01), pages 690 - 697, ISSN: 0014-2956;;KIM CHAN WOO ET AL: ""Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin"", CANCER RESEARCH, vol. 62, no. 21, 1 November 2002 (2002-11-01), pages 6312 - 6317, ISSN: 0008-5472",DISCONTINUED
126,EP,A1,EP 1602360 A1,002-275-193-965-752,2005-12-07,2005,EP 03773445 A,2003-11-27,CU 0300016 W;;CU 20020292 A,2002-11-27,"METHOD OF OBTAINING COCHLEAR STRUCTURES, VACCINE COMPOSITIONS, ADJUVANTS AND INTERMEDIATES THEREOF","The present invention has applications in the field of immunology, specifically in the sphere of adjuvants and vaccines. The invention aims at obtaining cochlear structures from vesicles found in the outer membranes of microorganisms, in order to employ them in the preparation of adjuvants and vaccines. The invention also discloses a method for obtaining cochlear structures.",INST FINLAY CT DE INVESTIGACIO,PEREZ MARTIN OLIVER GERMAN;;BRACHO GRANDO GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN JUAN BOSCO;;SIERRA GONZALEZ VICTORIANO GUSTAVO;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODRIGUEZ RAMIREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,"INSTITUTO FINLAY, CENTRO DE INVESTIGACION-PRODUCCI (2011-05-04)",https://lens.org/002-275-193-965-752,Patent Application,yes,0,4,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/00;;A61K9/127;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,EXPIRED
127,AR,A2,AR 089022 A2,063-638-010-757-241,2014-07-23,2014,AR P120104477 A,2012-11-29,CU 2922002 A,2002-11-27,COMPOSICIONES Y ADYUVANTES VACUNALES,"Reivindicación 1: Composición vacunal caracterizada porque comprende vesículas obtenidas de la membrana externa de organismos vivos, excipientes adecuados, donde preferiblemente dichas vesículas de membrana externa están compuestas por proteínas, lípidos y estructuras moleculares asociadas a patógenos y en donde dichas vesículas son obtenidas de la membrana externa de una bacteria Gram positiva, un protozoario o una célula animal.",INST FINLAY CT DE INVESTIGACION PRODUCCION DE VACUNAS Y SUEROS,OLIVER GERMAN PEREZ MARTIN;;GUSTAVO RAFAEL BRANCHO GRANDOS;;MIRIAM DE SAN JUAN BOSCO LASTRE GONZALEZ;;VICTORIANO GUSTAVO SIERRA GONZALEZ;;CONCEPCION CAMPA HUERGO;;NESTOR MORA GONZALEZ;;RAMON FAUSTINO BARBERA MORALES;;JUDITH MONICA DEL CAMPO ALONSO;;TAMARA RODRIGUEZ RAMIREZ;;CARIDAD ZAYAS VIGNIER;;DANAY GIL MARTINEZ;;CARLOS TABOADA SUAREZ,,https://lens.org/063-638-010-757-241,Amended Application,no,0,0,1,1,0,,A61K39/39;;A61K9/127;;A61K47/46;;A61P31/00,,0,0,,,,PENDING
128,AT,T1,AT E530166 T1,192-894-046-953-199,2011-11-15,2011,AT 03773445 T,2003-11-27,CU 20020292 A;;CU 0300016 W,2002-11-27,"VERFAHREN ZUM ERHALT VON KOCHLEÄR-STRUKTUREN, IMPFZUSAMMENSETZUNGEN, HILFSMITTEL UND ZWISCHENPRODUKTE DAVON",,INST FINLAY CT DE INVESTIGACION PRODUCCION DE VACUNAS Y SUEROS,PEREZ MARTIN OLIVER GERMAN;;BRACHO GRANDO GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN JUAN BOSCO;;SIERRA GONZALEZ VICTORIANO GUSTAVO;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODROEGUEZ RAMOEREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTOENEZ DANAY;;TABOADA SUAREZ CARLOS,,https://lens.org/192-894-046-953-199,Granted Patent,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/00;;A61K9/127;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,EXPIRED
129,CN,A,CN 109563403 A,005-870-207-076-637,2019-04-02,2019,CN 201780047617 A,2017-06-29,ES 201630886 A;;ES 2017070474 W,2016-06-30,LUMINESCENT UPCONVERSION MATERIALS AND METHOD FOR PREPARING SAME,"The present invention relates to nanoparticles of formula MLnF4:RE+3, where M is an alkaline metal, Ln is a lanthanide element or an analog thereof and RE+3 is an ion of rare earth elements or combinations thereof, characterized in that said nanoparticles comprise organic ligands bound to the surface thereof by means of covalent bonds. The invention also relates to a method for preparing the luminescent upconversion nanoparticles of the invention, to the use of the luminescent upconversion nanoparticles of the invention as fluorescent markers or photosensitizers and to a luminescent compositematerial comprising the luminescent upconversion nanoparticles of the invention.",INNCEINNMAT SL;;UNIV VALENCIA;;CONSEJO SUPERIOR INVESTIGACION,PEREZ PRIETO JULIA;;GONZALEZ BEJAR MARIA;;ESTEBANEZ BLOEM NESTOR LUIS;;FERNANDEZ LOZANO JOSE FRANCISCO;;ENRIQUEZ PEREZ ESTHER;;LOPEZ BUENDIA ANGEL MIGUEL;;URQUIOLA CASAS MARIA DEL MAR,,https://lens.org/005-870-207-076-637,Patent Application,no,3,0,6,6,0,B82Y30/00;;B82Y40/00;;C01F17/00;;C09K11/025;;C09K11/04;;C09K11/7773;;G01N33/52;;G01N33/58,C09K11/02;;C09K11/85,,0,0,,,,DISCONTINUED
130,DK,T3,DK 1602360 T3,074-050-552-604-970,2012-02-13,2012,DK 03773445 T,2003-11-27,CU 20020292 A;;CU 0300016 W,2002-11-27,"Fremgangsmåde til opnåelse af sneglestrukturer, vaccinesammensætninger, adjuvanser og mellemprodukter dertil",,INST FINLAY CT DE INVESTIGACION PRODUCCION DE VACUNAS Y SUEROS,BRACHO GRANDO GUSTAVO RAFAEL;;LASTRE GONZALEZ MIRIAM DE SAN JUAN BOSCO;;SIERRA GONZALEZ VICTORIANO GUSTAVO;;ZAYAS VIGNIER CARIDAD;;TABOADA SUAREZ CARLOS;;PEREZ MARTIN OLIVER GERMAN;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON FAUSTINO;;DEL CAMPO ALONSO JUDITH MONICA;;RODRI GUEZ RAMI REZ TAMARA;;GIL MARTI NEZ DANAY,,https://lens.org/074-050-552-604-970,Granted Patent,no,0,0,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K9/127;;A61K9/00;;A61K39/00;;A61K39/39;;A61K47/46,,0,0,,,,EXPIRED
131,US,A1,US 2008/0173320 A1,036-224-960-465-868,2008-07-24,2008,US 62500007 A,2007-01-19,US 62500007 A,2007-01-19,Filtered Smoking Articles,"A smoking article is provided including (a) a tobacco rod comprising a smokable filler material contained within a circumscribing outer wrapping material, wherein the smokable filler material comprises at least about 45% by weight flue-cured tobacco based on the total dry weight of the smokable filler material; (b) one or more inner wrapping strips positioned between the tobacco rod and the outer wrapping material and extending longitudinally along the tobacco rod and including a burley tobacco; and (c) a filter element connected to the tobacco rod, the filter element having an end proximal to the tobacco rod and an end distal from the tobacco rod, wherein the filter element includes at least one fibrous tow section of filter material, a general adsorbent, and an ion exchange resin.",REYNOLDS TOBACCO CO R,DUNLAP SHARON PITTS;;FOOR SCOTT WILLIAM;;CANTRELL DANIEL VERDIN;;MARSHALL JERRY WAYNE;;BEESON DWAYNE WILLIAM;;ADAMS SUSAN MARLENE;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;NESTOR TIMOTHY BRIAN,R. J. REYNOLDS TOBACCO COMPANY (2007-03-02),https://lens.org/036-224-960-465-868,Patent Application,yes,46,37,1,1,0,A24D1/00;;A24D1/02;;A24D3/061;;A24D3/10;;A24D3/12;;A24D3/163;;A24D3/12;;A24D1/02;;A24D3/061;;A24D1/00;;A24D3/163;;A24D3/10,A24D1/00;;A24D1/02,131/365,0,0,,,,DISCONTINUED
132,US,A1,US 2006/0134134 A1,172-419-176-505-855,2006-06-22,2006,US 53677805 A,2005-09-21,CU 20020292 A;;CU 0300016 W,2002-11-27,"Method of obatining cochlear structures, vaccine compositions, adjuvants and interme- diates thereof","The present invention has applications in the field of immunology, specifically in the sphere of adjuvants and vaccines. The invention aims at obtaining cochlear structures from vesicles found in the outer membranes of microorganisms, in order to employ them in the preparation of adjuvants and vaccines. The invention also discloses a method for obtaining cochlear structures.",PEREZ MARTIN OLIVER G;;BRACHO GRANADO GUSTAVO R;;LASTRE GONZALEZ MIRIAM D S;;SIERRA GOZALEZ VICTORIANO G;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON F;;DEL CAMPO ALONSO JUDITH M;;RODRIGUEZ RAMIREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,PEREZ MARTIN OLIVER G;;BRACHO GRANADO GUSTAVO R;;LASTRE GONZALEZ MIRIAM D S;;SIERRA GOZALEZ VICTORIANO G;;CAMPA HUERGO CONCEPCION;;MORA GONZALEZ NESTOR;;BARBERA MORALES RAMON F;;DEL CAMPO ALONSO JUDITH M;;RODRIGUEZ RAMIREZ TAMARA;;ZAYAS VIGNIER CARIDAD;;GIL MARTINEZ DANAY;;TABOADA SUAREZ CARLOS,,https://lens.org/172-419-176-505-855,Patent Application,yes,0,3,18,18,0,A61K9/0019;;A61K9/0043;;A61K9/006;;A61K39/008;;A61K39/0275;;A61K39/095;;A61K47/46;;A61K2039/55594;;A61P43/00;;Y02A50/30;;A61K9/0043;;A61K9/0019;;A61K39/008;;A61K9/006;;A61K39/0275;;A61K2039/55594;;A61K39/095;;A61K47/46;;Y02A50/30,A61K39/02;;A61K9/00;;A61K9/127;;A61K39/00;;A61K39/002;;A61K39/39;;A61K47/46,424/200.1;;424/277.1;;424/266.1,0,0,,,,DISCONTINUED
133,US,B2,US 9182155 B2,110-572-269-627-618,2015-11-10,2015,US 27720408 A,2008-11-24,US 27720408 A;;US 29668105 A;;US 63441904 P,2004-12-08,Environmentally adaptable transport device,"Disclosed is a device for the transport of temperature sensitive products including an insulated container, an insulated lid, a fastener to secure the lid to the container, an active heat exchanger, a thermal circuit to circulate heat exchange, a temperature sensor read by a temperature regulating circuit that maintains a temperature range, a power source, and a support frame that arranges the elements of the device with the overall center of mass at a location adapted for transport and storage of the device. Disclosed is also a method of transport for temperature sensitive products including securing the temperature sensitive product within an insulated container with a lid, removing heat from the container to maintain a temperature range, strapping the device onto the user's back and adjusting to the shape of the user, freeing both hands during transport of the device, and minimizing hindrances to user mobility caused by the device.",CRUMLIN ETHAN J;;BECKER GEOFF;;JIN SHAUNA;;WONG AMY LAI;;BALL NATHAN BARKER;;SANCHEZ GABRIEL NESTOR;;WALKER DANIEL GEORGE;;POSSINGER CHRISTOPHER PAUL;;ONI OLUMUYIWA;;SMITH EMILY;;MUKADDAM KABIR;;GONZALEZ MYRAIDA A VEGA,CRUMLIN ETHAN J;;BECKER GEOFF;;JIN SHAUNA;;WONG AMY LAI;;BALL NATHAN BARKER;;SANCHEZ GABRIEL NESTOR;;WALKER DANIEL GEORGE;;POSSINGER CHRISTOPHER PAUL;;ONI OLUMUYIWA;;SMITH EMILY;;MUKADDAM KABIR;;GONZALEZ MYRAIDA A VEGA,,https://lens.org/110-572-269-627-618,Granted Patent,yes,16,13,2,5,0,A45F3/047;;A45F3/10;;A45F2003/045;;F25D29/003;;F25D2331/8011;;F25D2700/123;;F25B9/14;;A45F3/10;;F25D29/003;;F25D2700/123;;A45F3/047;;F25D2331/8011;;A45F2003/045,F25B9/14,,0,0,,,,INACTIVE
134,WO,A1,WO 2011/028372 A1,172-475-322-878-702,2011-03-10,2011,US 2010/0044989 W,2010-08-10,US 54610709 A,2009-08-24,SEGMENTED SMOKING ARTICLE WITH INSULATION MAT,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source configured to be activated by combustion of a smokable material and an insulation layer of a non-glass material that is woven, knit, or both, and (ii) an aerosol-generating segment with aerosol-forming material disposed between, but physically separate from, each of the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the cigarette rod using tipping material.",REYNOLDS TOBACCO CO R;;SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ ALVARO PARRA;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ ALVARO PARRA;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,,https://lens.org/172-475-322-878-702,Patent Application,yes,113,45,13,13,0,A24D1/22;;A24D1/22,A24D1/22,,3,1,042-131-419-918-990,27035260;;10.1080/08958378.2000.11720735,"INHALATION TOXICOLOGY, vol. 12, no. 5, 2000, pages 1 - 58;;KONDO, MICROCAPSULE PROCESSING AND TECHNOLOGY, 1979;;IWAMOTO ET AL., AAPS PHARM. SCI. TECH., vol. 3, no. 3, 2002",PENDING
135,CN,B,CN 102481021 B,040-732-922-954-295,2014-12-10,2014,CN 201080038270 A,2010-08-10,US 2010/0044989 W;;US 54610709 A,2009-08-24,Segmented smoking article with insulation mat,,REYNOLDS TOBACCO CO R,SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ ALVARO PARRA;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,,https://lens.org/040-732-922-954-295,Granted Patent,no,0,0,13,13,0,A24D1/22;;A24D1/22,A24D1/22,,0,0,,,,ACTIVE
136,PL,T3,PL 2470033 T3,145-855-845-048-607,2019-02-28,2019,PL 10745077 T,2010-08-10,US 54610709 A;;EP 10745077 A;;US 2010/0044989 W,2009-08-24,SEGMENTED SMOKING ARTICLE WITH INSULATION MAT,,REYNOLDS TOBACCO CO R,SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ ALVARO PARRA;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,,https://lens.org/145-855-845-048-607,Patent Application,no,0,0,13,13,0,A24D1/22;;A24D1/22,A24D1/22,,0,0,,,,PENDING
137,US,A1,US 2011/0041861 A1,177-336-386-210-199,2011-02-24,2011,US 54610709 A,2009-08-24,US 54610709 A,2009-08-24,SEGMENTED SMOKING ARTICLE WITH INSULATION MAT,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source configured to be activated by combustion of a smokable material and an insulation layer of a non-glass material that is woven, knit, or both, and (ii) an aerosol-generating segment with aerosol-forming material disposed between, but physically separate from, each of the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the cigarette rod using tipping material.",SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ-PARRA ALVARO;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ-PARRA ALVARO;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,R.J. REYNOLDS TOBACCO COMPANY (2009-09-01),https://lens.org/177-336-386-210-199,Patent Application,yes,98,137,13,13,0,A24D1/22;;A24D1/22,A24D1/02;;A24D1/22,131/365,0,0,,,,ACTIVE
138,EP,B1,EP 2470033 B1,014-066-665-266-218,2018-09-19,2018,EP 10745077 A,2010-08-10,US 54610709 A;;US 2010/0044989 W,2009-08-24,SEGMENTED SMOKING ARTICLE WITH INSULATION MAT,,REYNOLDS TOBACCO CO R,SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ ALVARO PARRA;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,,https://lens.org/014-066-665-266-218,Granted Patent,yes,6,0,13,13,0,A24D1/22;;A24D1/22,A24D1/22,,0,0,,,,ACTIVE
139,EP,A1,EP 2470033 A1,125-892-147-772-857,2012-07-04,2012,EP 10745077 A,2010-08-10,US 54610709 A;;US 2010/0044989 W,2009-08-24,SEGMENTED SMOKING ARTICLE WITH INSULATION MAT,,REYNOLDS TOBACCO CO R,SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ ALVARO PARRA;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,,https://lens.org/125-892-147-772-857,Patent Application,yes,0,0,13,13,0,A24D1/22;;A24D1/22,A24D1/22,,0,0,,,,ACTIVE
140,US,A1,US 2013/0233329 A1,104-350-275-828-634,2013-09-12,2013,US 201313870684 A,2013-04-25,US 201313870684 A;;US 54610709 A,2009-08-24,SEGMENTED SMOKING ARTICLE WITH FOAMED INSULATION MATERIAL,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source configured to be activated by combustion of a smokable material and an insulation layer of a non-glass material that is woven, knit, or both, and (ii) an aerosol-generating segment with aerosol-forming material disposed between, but physically separate from, each of the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the cigarette rod using tipping material.",SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ-PARRA ALVARO;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ-PARRA ALVARO;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,R.J. REYNOLDS TOBACCO COMPANY (2009-09-01),https://lens.org/104-350-275-828-634,Patent Application,yes,0,28,13,13,0,A24D1/22;;A24D1/22,A24D1/22,131/329,0,0,,,,ACTIVE
141,US,A1,US 2009/0139248 A1,137-340-805-574-044,2009-06-04,2009,US 27720408 A,2008-11-24,US 27720408 A;;US 29668105 A;;US 63441904 P,2004-12-08,ENVIRONMENTALLY ADAPTABLE TRANSPORT DEVICE,"Disclosed is a device for the transport of temperature sensitive products including an insulated container, an insulated lid, a fastener to secure the lid to the container, an active heat exchanger, a thermal circuit to circulate heat exchange, a temperature sensor read by a temperature regulating circuit that maintains a temperature range, a power source, and a support frame that arranges the elements of the device with the overall center of mass at a location adapted for transport and storage of the device. Disclosed is also a method of transport for temperature sensitive products including securing the temperature sensitive product within an insulated container with a lid, removing heat from the container to maintain a temperature range, strapping the device onto the user's back and adjusting to the shape of the user, freeing both hands during transport of the device, and minimizing hindrances to user mobility caused by the device.",CRUMLIN ETHAN J;;BECKER GEOFF;;JIN SHAUNA;;WONG AMY LAI;;BALL NATHAN BARKER;;SANCHEZ GABRIEL NESTOR;;WALKER DANIEL GEORGE;;POSSINGER CHRISTOPHER PAUL;;ONI OLUMUYIWA;;SMITH EMILY;;MUKADDAM KABIR JAMES;;GONZALEZ MYRAIDA A VEGA,CRUMLIN ETHAN J;;BECKER GEOFF;;JIN SHAUNA;;WONG AMY LAI;;BALL NATHAN BARKER;;SANCHEZ GABRIEL NESTOR;;WALKER DANIEL GEORGE;;POSSINGER CHRISTOPHER PAUL;;ONI OLUMUYIWA;;SMITH EMILY;;MUKADDAM KABIR JAMES;;GONZALEZ MYRAIDA A VEGA,,https://lens.org/137-340-805-574-044,Patent Application,yes,16,31,2,5,0,A45F3/047;;A45F3/10;;A45F2003/045;;F25D29/003;;F25D2331/8011;;F25D2700/123;;F25B9/14;;A45F3/10;;F25D29/003;;F25D2700/123;;A45F3/047;;F25D2331/8011;;A45F2003/045,B65D81/38;;F25D25/00;;F25D3/00;;G01K13/00,62/62;;62/371;;62/457.1;;62/129;;220/592.27,0,0,,,,INACTIVE
142,TR,T4,TR 201815206 T4,046-655-456-195-595,2018-11-21,2018,TR 201815206 T,2010-08-10,US 54610709 A,2009-08-24,İzolasyon altlığına sahip bölümlere ayrılmış tütün içme ürünü.,"Bir sigara, yakma ve ağız uçlarını içerir. Bu, yakma ucunda düzenlenmiş içilebilir bir bölümü içerebilir. Sigara, ayrıca bir ağız ucu bölümünü; yakma ve ağız uçları arasında düzenlenen, (i) içilebilir bölüme bitişik düzenlenen bir ısı üretme bölümünü ve (ii) ısı üretme bölümü ve ağız ucu arasında düzenlenen, ancak bunların her birinden fiziksel olarak ayrı olan aerosol oluşturucu maddeye sahip bir aerosol üretme bölümünü içeren bir aerosol üretme sistemini ve aerosol üretme bölümünün en azından bir kısmı, ısı üretme bölümü ve içilebilir bölümün en azından bir kısmı çevresinde bir üst sargı sağlayan bir parça halinde dış sargı malzemesini içerir.",REYNOLDS TOBACCO CO R,ANDRIES DON SEBASTIAN;;BILLY TYRONE CONNER;;CHANDRA K BANERJEE;;STEVEN L ALDERMAN;;PAUL E BRAXTON;;CAROLYN R CARPENTER;;ALVARO PARRA GONZALEZ;;BRADLEY J INGEBRETHSEN;;KRISTEN L MURRAY;;TIMOTHY B NESTOR;;EVON LLEWELLYN CROOKS,,https://lens.org/046-655-456-195-595,Granted Patent,no,0,0,13,13,0,A24D1/22;;A24D1/22,A24D1/22,,0,0,,,,ACTIVE
143,US,B2,US 9486013 B2,053-780-192-234-98X,2016-11-08,2016,US 201313870684 A,2013-04-25,US 201313870684 A;;US 54610709 A,2009-08-24,Segmented smoking article with foamed insulation material,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source configured to be activated by combustion of a smokable material and an insulation layer of a non-glass material that is woven, knit, or both, and (ii) an aerosol-generating segment with aerosol-forming material disposed between, but physically separate from, each of the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the cigarette rod using tipping material.",SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ-PARRA ALVARO;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN;;REYNOLDS TOBACCO CO R,SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ-PARRA ALVARO;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,R.J. REYNOLDS TOBACCO COMPANY (2009-09-01),https://lens.org/053-780-192-234-98X,Granted Patent,yes,99,8,13,13,0,A24D1/22;;A24D1/22,A24D1/22,,10,0,,,"US 5,119,837, 06/1992, Banerjee et al. (withdrawn);;International Search Report for International Application No. PCT/US2010/044989, dated Jan. 21, 2011, 2 pages.;;Written Opinion of the International Searching Authority for International Application No. PCT/US2010/044989, dated Jan. 21, 2011, 6 pages.;;International Search Report for International Application No. PCT/US2011/034040, dated Oct. 19, 2011, 3 pages.;;U.S. Appl. No. 11/377,630.;;U.S. Appl. No. 12/688,598.;;U.S. Appl. No. 12/775,130.;;U.S. Appl. No. 12/775,278.;;U.S. Appl. No. 12/859,494.;;U.S. Appl. No. 13/236,962.",ACTIVE
144,WO,A3,WO 2006/062942 A3,102-080-353-053-185,2007-04-19,2007,US 2005/0044060 W,2005-12-07,US 63441904 P,2004-12-08,ENVIRONMENTALLY ADAPTABLE TRANSPORT DEVICE,"A temperature regulating device capable for environmentally adaptable transport of transporting temperature sensitive products is provided including an insulated casing having an interior portion and a temperature regulating device for maintaining the interior portion at a temperature range lower than ambient temperature exterior to the interior portion, wherein the temperature regulating device maintains the lower temperature without external power sources. The temperature device is personally portable and includes a backpack attachment for transporting by a single individual.",ONEWORLD MEDICAL DEVICES;;CRUMLIN ETHAN J;;SMITH EMILY;;BECKER GEOFF;;JIN SHAUNA;;WONG AMY LAI;;BALL NATHAN BARKER;;SANCHEZ GABRIEL NESTOR;;WALKER DANIEL GEORGE;;POSSINGER CHRISTOPHER PAUL;;ONI MUYIWA;;MUKADDAM KABIR JAMES;;GONZALEZ MYRAIDA A VEGA,CRUMLIN ETHAN J;;SMITH EMILY;;BECKER GEOFF;;JIN SHAUNA;;WONG AMY LAI;;BALL NATHAN BARKER;;SANCHEZ GABRIEL NESTOR;;WALKER DANIEL GEORGE;;POSSINGER CHRISTOPHER PAUL;;ONI MUYIWA;;MUKADDAM KABIR JAMES;;GONZALEZ MYRAIDA A VEGA,,https://lens.org/102-080-353-053-185,Search Report,yes,3,0,3,5,0,A45F3/10;;A45F2003/045;;A45F3/10;;A45F2003/045,F25D3/08,,0,0,,,,PENDING
145,CN,A,CN 102481021 A,180-602-864-200-364,2012-05-30,2012,CN 201080038270 A,2010-08-10,US 2010/0044989 W;;US 54610709 A,2009-08-24,Segmented smoking article with insulation mat,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source configured to be activated by combustion of a smokable material and an insulation layer of a non-glass material that is woven, knit, or both, and (ii) an aerosol-generating segment with aerosol-forming material disposed between, but physically separate from, each of the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the cigarette rod using tipping material.",REYNOLDS TOBACCO CO R,DON SEBASTIAN ANDRIES;;TYRONE CONNER BILLY;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;PARRA GONZALEZ ALVARO;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;LLEWELLYN CROOKS EVON,,https://lens.org/180-602-864-200-364,Patent Application,no,6,34,13,13,0,A24D1/22;;A24D1/22,A24D1/22,,0,0,,,,ACTIVE
146,US,B2,US 8464726 B2,145-121-632-723-696,2013-06-18,2013,US 54610709 A,2009-08-24,US 54610709 A,2009-08-24,Segmented smoking article with insulation mat,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source configured to be activated by combustion of a smokable material and an insulation layer of a non-glass material that is woven, knit, or both, and (ii) an aerosol-generating segment with aerosol-forming material disposed between, but physically separate from, each of the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the cigarette rod using tipping material.",SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ-PARRA ALVARO;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN;;REYNOLDS TOBACCO CO R,SEBASTIAN ANDRIES DON;;CONNER BILLY TYRONE;;BANERJEE CHANDRA K;;ALDERMAN STEVEN L;;BRAXTON PAUL E;;CARPENTER CAROLYN R;;GONZALEZ-PARRA ALVARO;;INGEBRETHSEN BRADLEY J;;MURRAY KRISTEN L;;NESTOR TIMOTHY B;;CROOKS EVON LLEWELLYN,R.J. REYNOLDS TOBACCO COMPANY (2009-09-01),https://lens.org/145-121-632-723-696,Granted Patent,yes,103,97,13,13,0,A24D1/22;;A24D1/22,A24D1/22,131/271,10,0,,,"US 5,119,837, 06/1992, Banerjee et al. (withdrawn);;International Search Report for International Application No. PCT/US2011/034040, dated Oct. 19, 2011, 3 pages.;;U.S. Appl. No. 11/377,630.;;U.S. Appl. No. 12/688,598.;;U.S. Appl. No. 12/775,130.;;U.S. Appl. No. 12/775,278.;;U.S. Appl. No. 12/859,494.;;U.S. Appl. No. 13/236,962.;;International Search Report for International Application No. PCT/US2010/044989, dated Jan. 21, 2011, 2 pages.;;Written Opinion of the International Searching Authority for International Application No. PCT/US2010/044989, dated Jan. 21, 2011, 6 pages.",ACTIVE
147,CN,A,CN 103929989 A,000-736-300-334-822,2014-07-16,2014,CN 201280055319 A,2012-08-22,US 2012/0051850 W;;US 201113236962 A,2011-09-20,Segmented smoking article with substrate cavity,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source and an insulation layer and (ii) an aerosol-generating segment including a substrate, which may include tobacco pellets and aerosol-forming material disposed in a substrate cavity between the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment and includes a foil strip laminated thereon; those segments being connected together by the overwrap to provide a cigarette rod; ; that is connected to the mouth-end segment using tipping material.",REYNOLDS TOBACCO CO R,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;ZHANG YIPING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,,https://lens.org/000-736-300-334-822,Patent Application,no,4,24,13,42,0,A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22,A24C5/00;;A24D1/22;;B32B29/00,,0,0,,,,ACTIVE
148,EP,B1,EP 2757912 B1,073-679-030-738-738,2022-08-10,2022,EP 12753893 A,2012-08-22,US 201113236962 A;;US 2012/0051850 W,2011-09-20,SEGMENTED SMOKING ARTICLE WITH SUBSTRATE CAVITY,,REYNOLDS TOBACCO CO R,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,,https://lens.org/073-679-030-738-738,Granted Patent,yes,7,0,13,42,0,A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22,A24C5/00;;A24D1/22;;B32B29/00,,0,0,,,,ACTIVE
149,EP,A2,EP 2757912 A2,189-424-709-470-709,2014-07-30,2014,EP 12753893 A,2012-08-22,US 201113236962 A;;US 2012/0051850 W,2011-09-20,SEGMENTED SMOKING ARTICLE WITH SUBSTRATE CAVITY,,REYNOLDS TOBACCO CO R,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,,https://lens.org/189-424-709-470-709,Patent Application,yes,0,1,13,42,0,A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22,A24C5/00;;A24D1/22;;B32B29/00,,0,0,,,,ACTIVE
150,IN,A,IN 2160CHN2014 A,091-954-395-700-106,2015-05-29,2015,IN 2160CHN2014 A,2014-03-20,US 201113236962 A;;US 2012/0051850 W,2011-09-20,SEGMENTED SMOKING ARTICLE WITH SUBSTRATE CAVITY,A cigarette includes lighting (714) and mouth ends (718). It may include a smokable segment disposed at the lighting end. It also includes a mouth end segment; an aerosol generation system disposed between the lighting and mouth ends which includes (i) a heat generation segment (735) adjacent the smokable segment including a heat source and an insulation layer and (ii) an aerosol generating segment including a substrate (763) which may include tobacco pellets and aerosol forming material disposed in a substrate cavity (756) between the heat generation segment and the mouth end; a piece of outer wrapping material (764) that provides an overwrap around at least a portion of the aerosol generating segment the heat generation segment and at least a portion of the smokable segment and includes a foil strip (784) laminated thereon; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the mouth end segment using tipping material (778).,REYNOLDS TOBACCO CO R,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI PING;;BARNES VERNON BRENT;;GONZALEZ PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,,https://lens.org/091-954-395-700-106,Patent Application,no,0,0,13,42,0,A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22,A24C5/00;;A24D1/22;;B32B29/00,,0,0,,,,PENDING
151,CU,A1,CU 22875 A1,016-191-896-420-134,2003-12-20,2003,CU 1998048 A,1998-04-14,CU 1998048 A,1998-04-14,PROCESO DE PURIFICACIÓN DE POLIPÉPTIDOS MULTIEPITÓPICOS (MEPS),"Desarrollo de un proceso para la obtención de Polipéptidos Multiepitópicos para la eliminación de los contaminantes derivados de la cepa hospedera, Escherichia coli K12, y otras fuentes. Esencialmente consiste en un lavado diferencial del precipitado celular insoluble con un detergente (Tritón X-100) y un agente desnaturalizante (Urea). La extracción se efectúa a molaridades relativamente elevadas de este mismo agente. El proceso cromatográfico consta de tres pasos. El fraccionamiento, donde se utiliza una matriz utilizando una matriz de filtración en gel. Los polipéptidos Multiepitópicos purificados y renaturalizados apropiadamente pueden ser utilizados en el diágnostico y como preparado vacunal al formularse con el adyuvante oleoso Montanide ISA 720. Los polipéptidos Multiepitópicos purificados y los anticuerpos generados contra ellos pueden tener utilidad en el diagnóstico, la terapéutica o la prevención del SIDA.",CT INGENIERIA GENETICA BIOTECH,SOTO BORROTO ALEJANDRO LIONEL;;DUARTE CANO CARLOS ANTONIO;;EXPOSITO RAYA NESTOR SANTOS;;MARTINEZ NUNEZ ANAZURIA;;PEREZ DE LA IGLESIA MARIELA;;PENA RIVERO MAXLENIN;;RODRIGUEZ MUNOZ ARIANE;;GONZALEZ ROCHE DIAMILE;;BRITO LEON JOSE ENRIQUE;;QUINTANA VAZQUEZ DIOGENES;;PAEZ MEIRELES ROLANDO,,https://lens.org/016-191-896-420-134,Limited Patent,no,0,0,1,1,0,,A61K39/21;;A61K39/395;;C12N5/20;;C12N15/49;;C12P21/08;;G01N33/569,,0,0,,,,EXPIRED
152,EP,A1,EP 4115756 A1,087-230-746-339-01X,2023-01-11,2023,EP 22189116 A,2012-08-22,US 201113236962 A;;EP 12753893 A;;US 2012/0051850 W,2011-09-20,SEGMENTED SMOKING ARTICLE WITH SUBSTRATE CAVITY,"An aerosol-generation system for a smoking article comprises a heat generation segment including an insulation layer of flame-retardant material and an aerosol-generating segment including a tobacco substrate and incorporating aerosol-forming material, the tobacco substrate being disposed within a substrate cavity, in which the tobacco substrate is dimensioned to fit within the substrate cavity. The system also comprises a wrapping material circumscribing at least a portion of the heat generation segment and the aerosol-generating segment. The wrapping material comprises a foil strip circumferentially encompassing and extending lengthwise along at least a lengthwise portion of the substrate cavity and overlapping at least a lengthwise portion of the heat generation segment. The wrapping material also comprises a paper material, and the foil strip is laminated to a surface of the paper material, registered for alignment with the substrate cavity at a predetermined location.
",REYNOLDS TOBACCO CO R,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,,https://lens.org/087-230-746-339-01X,Patent Application,yes,73,0,13,42,0,A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22,A24C5/00;;A24D1/22;;B32B29/00,,3,1,042-131-419-918-990,27035260;;10.1080/08958378.2000.11720735,"""Tobacco Production, Chemistry and Technology"", 1999;;""Chemical and Biological Studies on New Cigarette Prototypes that Heat Instead of Burn Tobacco"", 1988, R. J. REYNOLDS TOBACCO COMPANY MONOGRAPH;;INHALATION TOXICOLOGY, vol. 12, no. 5, 2000, pages 1 - 58",PENDING
153,PL,T3,PL 2757912 T3,136-474-973-464-247,2023-01-09,2023,PL 12753893 T,2012-08-22,US 201113236962 A;;US 2012/0051850 W,2011-09-20,SEGMENTED SMOKING ARTICLE WITH SUBSTRATE CAVITY,,REYNOLDS TOBACCO CO R,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,,https://lens.org/136-474-973-464-247,Patent Application,no,0,0,13,42,0,A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22,A24C5/00;;A24D1/22;;B32B29/00,,0,0,,,,PENDING
154,US,A1,US 2012/0067360 A1,150-044-881-589-218,2012-03-22,2012,US 201113236962 A,2011-09-20,US 201113236962 A;;US 77513010 A;;US 77527810 A;;US 85949410 A,2010-05-06,SEGMENTED SMOKING ARTICLE WITH SUBSTRATE CAVITY,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source and an insulation layer and (ii) an aerosol-generating segment including a substrate, which may include tobacco pellets and aerosol-forming material disposed in a substrate cavity between the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment and includes a foil strip laminated thereon; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the mouth-end segment using tipping material.",CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,R. J. REYNOLDS TOBACCO COMPANY (2011-10-17),https://lens.org/150-044-881-589-218,Patent Application,yes,4,101,4,42,0,A24B15/165;;A24C5/00;;A24D1/08;;A24D1/22;;A24B15/165;;A24D1/22;;A24C5/00;;A24D1/08,A24D1/02;;A24C5/00;;A24D1/22,131/280;;131/194;;131/361,0,0,,,,ACTIVE
155,WO,A3,WO 2013/043299 A3,122-285-439-128-728,2013-08-01,2013,US 2012/0051850 W,2012-08-22,US 201113236962 A,2011-09-20,SEGMENTED SMOKING ARTICLE WITH SUBSTRATE CAVITY,"A cigarette includes lighting (714) and mouth ends (718). It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment (735) adjacent the smokable segment, including a heat source and an insulation layer and (ii) an aerosol-generating segment including a substrate (763), which may include tobacco pellets and aerosol-forming material disposed in a substrate cavity (756) between the heat generation segment and the mouth end; a piece of outer wrapping material (764) that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment and includes a foil strip (784) laminated thereon; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the mouth-end segment using tipping material (778).",REYNOLDS TOBACCO CO R;;CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,,https://lens.org/122-285-439-128-728,Search Report,yes,7,0,13,42,0,A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22,A24C5/00;;A24D1/22;;B32B29/00,,0,0,,,,PENDING
156,US,B2,US 9149072 B2,024-541-959-768-283,2015-10-06,2015,US 201113236962 A,2011-09-20,US 201113236962 A;;US 77513010 A;;US 77527810 A;;US 85949410 A,2010-05-06,Segmented smoking article with substrate cavity,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source and an insulation layer and (ii) an aerosol-generating segment including a substrate, which may include tobacco pellets and aerosol-forming material disposed in a substrate cavity between the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment and includes a foil strip laminated thereon; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the mouth-end segment using tipping material.",CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE;;REYNOLDS TOBACCO CO R,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,R. J. REYNOLDS TOBACCO COMPANY (2011-10-17),https://lens.org/024-541-959-768-283,Granted Patent,yes,103,38,4,42,0,A24B15/165;;A24C5/00;;A24D1/08;;A24D1/22;;A24B15/165;;A24D1/22;;A24C5/00;;A24D1/08,A24C5/00;;A24D1/22,,10,0,,,"US 5,119,837, 06/1992, Banerjee et al. (withdrawn);;International Search Report and Written Opinion for Int'l Application No. PCT/US2012/051850, date of mailing Jun. 11, 2013.;;U.S. Appl. No. 11/377,630.;;U.S. Appl. No. 12/688,598.;;U.S. Appl. No. 12/775,130.;;U.S. Appl. No. 12/775,278.;;U.S. Appl. No. 12/859,494.;;International Search Report for International Application No. PCT/US2010/044989, dated Jan. 21, 2011, 3 pages.;;Written Opinion of the International Searching Authority for International Application No. PCT/US2010/044989, dated Jan. 21, 2011, 6 pages.;;International Search Report for International Application No. PCT/US2011/034040, dated Oct. 19, 2011, 3 pages.",ACTIVE
157,US,A1,US 2015/0359259 A1,050-539-485-138-262,2015-12-17,2015,US 201514835441 A,2015-08-25,US 201514835441 A;;US 201113236962 A;;US 77513010 A;;US 77527810 A;;US 85949410 A,2010-05-06,SEGMENTED SMOKING ARTICLE WITH SUBSTRATE CAVITY,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source and an insulation layer and (ii) an aerosol-generating segment including a substrate, which may include tobacco pellets and aerosol-forming material disposed in a substrate cavity between the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment and includes a foil strip laminated thereon; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the mouth-end segment using tipping material.",REYNOLDS TOBACCO CO R,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA K;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN R;;NESTOR TIMOTHY B;;WHITE JACKIE L,R.J. REYNOLDS TOBACCO COMPANY (2011-10-17),https://lens.org/050-539-485-138-262,Patent Application,yes,0,9,4,42,0,A24B15/165;;A24C5/00;;A24D1/08;;A24D1/22;;A24B15/165;;A24D1/22;;A24C5/00;;A24D1/08,A24D1/08;;A24C5/00;;A24D1/22,,0,0,,,,ACTIVE
158,WO,A2,WO 2013/043299 A2,028-011-822-606-600,2013-03-28,2013,US 2012/0051850 W,2012-08-22,US 201113236962 A,2011-09-20,SEGMENTED SMOKING ARTICLE WITH SUBSTRATE CAVITY,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source and an insulation layer and (ii) an aerosol-generating segment including a substrate, which may include tobacco pellets and aerosol-forming material disposed in a substrate cavity between the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment and includes a foil strip laminated thereon; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the mouth-end segment using tipping material.",REYNOLDS TOBACCO CO R;;CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA KUMAR;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN RIERSON;;NESTOR TIMOTHY BRIAN;;WHITE JACKIE LEE,,https://lens.org/028-011-822-606-600,Patent Application,yes,69,16,13,42,0,A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22;;A24C5/00;;A24D1/22,A24C5/00;;A24D1/22,,3,1,042-131-419-918-990,27035260;;10.1080/08958378.2000.11720735,"DAVIS ET AL.: ""Tobacco Production, Chemistry and Technology"", 1999;;""Chemical and Biological Studies on New Cigarette Prototypes that Heat Instead of Burn Tobacco"", 1988, R. J. REYNOLDS TOBACCO COMPANY;;INHALATION TOXICOLOGY, vol. 12, no. 5, 2000, pages 1 - 58",PENDING
159,US,B2,US 9439453 B2,061-782-165-499-121,2016-09-13,2016,US 201514835441 A,2015-08-25,US 201514835441 A;;US 201113236962 A;;US 77513010 A;;US 77527810 A;;US 85949410 A,2010-05-06,Segmented smoking article with substrate cavity,"A cigarette includes lighting and mouth ends. It may include a smokable segment disposed at the lighting end. It also includes a mouth-end segment; an aerosol-generation system disposed between the lighting and mouth ends, which includes (i) a heat-generation segment adjacent the smokable segment, including a heat source and an insulation layer and (ii) an aerosol-generating segment including a substrate, which may include tobacco pellets and aerosol-forming material disposed in a substrate cavity between the heat generation segment and the mouth end; a piece of outer wrapping material that provides an overwrap around at least a portion of the aerosol-generating segment, the heat-generation segment, and at least a portion of the smokable segment and includes a foil strip laminated thereon; those segments being connected together by the overwrap to provide a cigarette rod; that is connected to the mouth-end segment using tipping material.",REYNOLDS TOBACCO CO R,CONNER BILLY TYRONE;;SEBASTIAN ANDRIES DON;;CROOKS EVON LLEWELLYN;;THOMAS TIMOTHY FREDERICK;;STONE JAMES RICHARD;;BANERJEE CHANDRA K;;CHANG YI-PING;;BARNES VERNON BRENT;;GONZALEZ-PARRA ALVARO;;MCCLANAHAN DAVID NEIL;;CARPENTER CAROLYN R;;NESTOR TIMOTHY B;;WHITE JACKIE L,R.J. REYNOLDS TOBACCO COMPANY (2011-10-17),https://lens.org/061-782-165-499-121,Granted Patent,yes,102,17,4,42,0,A24B15/165;;A24C5/00;;A24D1/08;;A24D1/22;;A24B15/165;;A24D1/22;;A24C5/00;;A24D1/08,A24C5/00;;A24D1/08;;A24D1/22,,10,0,,,"US 5,119,837, 06/1992, Banerjee et al. (withdrawn).;;U.S. Appl. No. 11/377,630.;;U.S. Appl. No. 12/688,598.;;U.S. Appl. No. 12/775,130.;;U.S. Appl. No. 12/775,278.;;U.S. Appl. No. 12/859,494.;;International Search Report for International Application No. PCT/US2010/044989, dated Jan. 21, 2011, 3 pages.;;Written Opinion of the International Searching Authority for International Application No. PCT/US2010/044989, dated Jan. 21, 2011, 6 pages.;;International Search Report for International Application No. PCT/US2011/034040, dated Oct. 19, 2011, 3 pages.;;International Search Report and Written Opinion for Int'l Application No. PCT/US2012/051850, date of mailing Jun. 11, 2013.",ACTIVE
160,EP,A4,EP 1909073 A4,064-012-806-905-678,2013-03-06,2013,EP 06743456 A,2006-04-24,ES 2006000201 W;;ES 200500991 A,2005-04-25,UNIVERSAL RECONFIGURABLE SYSTEM AND METHOD FOR THE REMOTE READING OF COUNTERS OR EQUIPMENT COMPRISING VISUAL INDICATORS,,SERVICIOS INFORMATICOS KIFER S L;;UNIV DEL PAIS VASCO UPV EHU;;UNIV AUTONOMA DE BARCELONA UAB;;CSIC CONSEJO SUP INVEST CIENTIFICAS,AYUSO RUBIO NESTOR;;PICO MACHO JESUS;;BENITEZ GALARZA NAGORE;;CARRABINA BORDOLL JORDI;;PONS MONTSERRAT ENRIC;;MARTINEZ HUERTA BORJA;;CASTELLS RUFAS DAVID;;MONTON MACIAN MARIUS;;TERES TERES LLUIS;;MERINO PANADES JOSE LUIS;;GONZALEZ BAZO ENRIQUE;;GUERENDIAIN OLIVER ALFONSO;;ALVAREZ BALBAS GONZALO;;AMUCHASTEGUI URIARTE CARLOS,"CSIC-CONSEJO SUP. INVEST. CIENTIFICAS (2012-08-15);;UNIVERSIDAD AUTONOMA DE BARCELONA-UAB (2012-08-15);;UNIVERSIDAD DEL PAIS VASCO (UPV-EHU) (2012-08-15);;SERVICIOS INFORMATICOS KIFER, S.L. (2012-08-15)",https://lens.org/064-012-806-905-678,Search Report,no,2,0,7,7,0,G01D4/008;;H04Q9/00;;G01D4/004;;G01D5/39;;H04Q2209/10;;H04Q2209/40;;H04Q2209/60;;Y02B90/20;;Y04S20/30;;G01D4/002;;G05B19/4185;;G01D4/004;;G01D4/008;;H04Q9/00;;G01D5/39;;H04Q2209/10;;H04Q2209/40;;H04Q2209/60;;Y02B90/20;;Y04S20/30,G01D4/00;;G01D5/39;;G05B19/042;;G08C17/02;;H04Q9/00,,0,0,,,,DISCONTINUED
161,WO,A9,WO 2006/114462 A9,089-436-216-936-331,2007-02-01,2007,ES 2006000201 W,2006-04-24,ES 200500991 A,2005-04-25,UNIVERSAL RECONFIGURABLE SYSTEM AND METHOD FOR THE REMOTE READING OF COUNTERS OR EQUIPMENT COMPRISING VISUAL INDICATORS,"The invention relates to a system (1) for the remote reading of counters (5) or equipment comprising visual data indicators (6), which is characterised in that it is based on the use of reconfigurable logic devices (9) and in that it can be remotely reconfigured, thereby converting said system (1) into a universal system which is suitable for any type of counter (5) and which can be adapted to variations in the installation or operation conditions of the counter (5) or the system (1) itself. The invention also relates to reconfiguration methods, image capture methods, etc., which are characterised in that they comprise the parallel implementation of tasks with the use of queues, thereby reducing the capacity or quantity of data storage memories needed.",SERVICIOS INFORMATICOS KIFER S;;UNIV DEL PAIS VASCO UPV EHU;;SERVICIOS DE TXINGUDI S A;;UNIV AUTONOMA DE BARCELONA UAB;;CSIC CONSEJO SUP INVEST CIENTI;;AYUSO RUBIO NESTOR;;PICO MACHO JESUS;;BENITEZ GALARZA NAGORE;;CARRABINA BORDOLL JORDI;;PONS MONTSERRAT ENRIC;;MARTINEZ HUERTA BORJA;;CASTELLS RUFAS DAVID;;MONTON MACIAN MARIUS;;TERES TERES LLUIS;;MERINO PANADES JOSE LUIS;;GONZALEZ BAZO ENRIQUE;;GUERENDIAIN OLIVER ALFONSO;;ALVAREZ BALBAS GONZALO;;AMUCHASTEGUI URIARTE CARLOS,AYUSO RUBIO NESTOR;;PICO MACHO JESUS;;BENITEZ GALARZA NAGORE;;CARRABINA BORDOLL JORDI;;PONS MONTSERRAT ENRIC;;MARTINEZ HUERTA BORJA;;CASTELLS RUFAS DAVID;;MONTON MACIAN MARIUS;;TERES TERES LLUIS;;MERINO PANADES JOSE LUIS;;GONZALEZ BAZO ENRIQUE;;GUERENDIAIN OLIVER ALFONSO;;ALVAREZ BALBAS GONZALO;;AMUCHASTEGUI URIARTE CARLOS,,https://lens.org/089-436-216-936-331,Patent Application,no,0,0,7,7,0,G01D4/008;;H04Q9/00;;G01D4/004;;G01D5/39;;H04Q2209/10;;H04Q2209/40;;H04Q2209/60;;Y02B90/20;;Y04S20/30;;G01D4/002;;G05B19/4185;;G01D4/004;;G01D4/008;;H04Q9/00;;G01D5/39;;H04Q2209/10;;H04Q2209/40;;H04Q2209/60;;Y02B90/20;;Y04S20/30,G01D4/00;;G05B19/042;;G08C17/02,,0,0,,,,PENDING
162,WO,A1,WO 2006/114462 A1,106-936-296-151-651,2006-11-02,2006,ES 2006000201 W,2006-04-24,ES 200500991 A,2005-04-25,UNIVERSAL RECONFIGURABLE SYSTEM AND METHOD FOR THE REMOTE READING OF COUNTERS OR EQUIPMENT COMPRISING VISUAL INDICATORS,"The invention relates to a system (1) for the remote reading of counters (5) or equipment comprising visual data indicators (6), which is characterised in that it is based on the use of reconfigurable logic devices (9) and in that it can be remotely reconfigured, thereby converting said system (1) into a universal system which is suitable for any type of counter (5) and which can be adapted to variations in the installation or operation conditions of the counter (5) or the system (1) itself. The invention also relates to reconfiguration methods, image capture methods, etc., which are characterised in that they comprise the parallel implementation of tasks with the use of queues, thereby reducing the capacity or quantity of data storage memories needed.",SERVICIOS INFORMATICOS KIFER S;;UNIV DEL PAIS VASCO UPV EHU;;SERVICIOS DE TXINGUDI S A;;UNIV AUTONOMA DE BARCELONA UAB;;CSIC CONSEJO SUP INVEST CIENTI;;AYUSO RUBIO NESTOR;;PICO MACHO JESUS;;BENITEZ GALARZA NAGORE;;CARRABINA BORDOLL JORDI;;PONS MONTSERRAT ENRIC;;MARTINEZ HUERTA BORJA;;CASTELLS RUFAS DAVID;;MONTON MACIAN MARIUS;;TERES TERES LLUIS;;MERINO PANADES JOSE LUIS;;GONZALEZ BAZO ENRIQUE;;GUERENDIAIN OLIVER ALFONSO;;ALVAREZ BALBAS GONZALO;;AMUCHASTEGUI URIARTE CARLOS,AYUSO RUBIO NESTOR;;PICO MACHO JESUS;;BENITEZ GALARZA NAGORE;;CARRABINA BORDOLL JORDI;;PONS MONTSERRAT ENRIC;;MARTINEZ HUERTA BORJA;;CASTELLS RUFAS DAVID;;MONTON MACIAN MARIUS;;TERES TERES LLUIS;;MERINO PANADES JOSE LUIS;;GONZALEZ BAZO ENRIQUE;;GUERENDIAIN OLIVER ALFONSO;;ALVAREZ BALBAS GONZALO;;AMUCHASTEGUI URIARTE CARLOS,,https://lens.org/106-936-296-151-651,Patent Application,yes,4,2,7,7,0,G01D4/008;;H04Q9/00;;G01D4/004;;G01D5/39;;H04Q2209/10;;H04Q2209/40;;H04Q2209/60;;Y02B90/20;;Y04S20/30;;G01D4/002;;G05B19/4185;;G01D4/004;;G01D4/008;;H04Q9/00;;G01D5/39;;H04Q2209/10;;H04Q2209/40;;H04Q2209/60;;Y02B90/20;;Y04S20/30,G01D4/00;;G05B19/042;;G08C17/02,,0,0,,,,PENDING
163,EP,A1,EP 1909073 A1,198-568-762-737-360,2008-04-09,2008,EP 06743456 A,2006-04-24,ES 2006000201 W;;ES 200500991 A,2005-04-25,UNIVERSAL RECONFIGURABLE SYSTEM AND METHOD FOR THE REMOTE READING OF COUNTERS OR EQUIPMENT COMPRISING VISUAL INDICATORS,"System (1) for remotely reading a meter (5) or equipment fitted with data visual indicators (6), which is  characterized in that  it is based on the use of reprogrammable logic devices (9) and the fact that it can be remotely reprogrammed. These two features make the system (1) universal, i.e., suitable for all types of meters (5), and adjustable to all types of variations in the installation or operation conditions of the meter (5) or the system (1) itself. Methods for reconfiguration, image capture, etc. are defined, having in common that some actions are carried out in parallel, with the use of queues, therefore requiring a small number of (or low-capacity) data storage memory components.",SERVICIOS INFORMATICOS KIFER S;;UNIV DEL PAIS VASCO UPV EHU;;SERVICIOS DE TXINGUDI S A;;UNIV AUTONOMA DE BARCELONA UAB;;CSIC CONSEJO SUP INVEST CIENTI,AYUSO RUBIO NESTOR;;PICO MACHO JESUS;;BENITEZ GALARZA NAGORE;;CARRABINA BORDOLL JORDI;;PONS MONTSERRAT ENRIC;;MARTINEZ HUERTA BORJA;;CASTELLS RUFAS DAVID;;MONTON MACIAN MARIUS;;TERES TERES LLUIS;;MERINO PANADES JOSE LUIS;;GONZALEZ BAZO ENRIQUE;;GUERENDIAIN OLIVER ALFONSO;;ALVAREZ BALBAS GONZALO;;AMUCHASTEGUI URIARTE CARLOS,"CSIC-CONSEJO SUP. INVEST. CIENTIFICAS (2012-08-15);;UNIVERSIDAD AUTONOMA DE BARCELONA-UAB (2012-08-15);;UNIVERSIDAD DEL PAIS VASCO (UPV-EHU) (2012-08-15);;SERVICIOS INFORMATICOS KIFER, S.L. (2012-08-15)",https://lens.org/198-568-762-737-360,Patent Application,yes,0,7,7,7,0,G01D4/008;;H04Q9/00;;G01D4/004;;G01D5/39;;H04Q2209/10;;H04Q2209/40;;H04Q2209/60;;Y02B90/20;;Y04S20/30;;G01D4/002;;G05B19/4185;;G01D4/004;;G01D4/008;;H04Q9/00;;G01D5/39;;H04Q2209/10;;H04Q2209/40;;H04Q2209/60;;Y02B90/20;;Y04S20/30,G01D4/00;;G01D5/39;;G05B19/042;;G08C17/02;;H04Q9/00,,0,0,,,,DISCONTINUED
164,MX,A,MX 2016016694 A,012-065-887-094-207,2020-02-07,2020,MX 2016016694 A,2016-12-08,MX 2016016694 A,2016-12-08,INSOLE FOR STATIC MEASUREMENT OF PLANTAR PRESSURE.,"The present disclosure is related to an insole for static measurement of plantar pressure, specifically, to the design of a mat to measure the plantar pressure of both feet in a static manner. Consists of pressure sensitive sensors that provide different signals that are acquired by an embedded system and transferred by means of a serial cable. Enabling a podiatrist, physiotherapist, physical therapy graduates, rehabilitation physicians, neurologists, orthopedic and trauma physicians and sports medicine, obtain the necessary data in diagnostic processes, evaluation treatment of foot conditions. The sensors are distributed in a insole for the right foot and another for the left foot, where the patient places the feet, allowing determining with certainty the type of foot that the patient has. The advantage of the present invention is that various foot sizes can be monitored.",ALEJANDRO MEDINA SANTIAGO,ALEJANDRO MEDINA SANTIAGO;;ARTURO CISNEROS GÓMEZ;;CESAR ROSALES MALDONADO;;CRUZ ELENA MEDINA SANTIAGO;;VICTOR MANUEL GUTIÉRREZ CORZO;;DARIO GONZALEZ GALINDO;;MIGUEL ANGEL RUIZ PINTO;;ALECTTE SELENE CHONG MONTOYA;;LUIS MANUEL SÁNCHEZ NIGENDA;;LUIS ALBERTO GARCÍA HERNÁNDEZ;;LORENA DEL ROSARIO ROJAS NUCAMENDI;;OEL GARCÍA HERNÁNDEZ;;KRISTEL RAMÍREZ URBANO;;LUIS ENRIQUE GÓMEZ AGUILERA;;NESTOR RODOLFO GARCIA CHONG;;MARIAMNNE VIRIDIANA MONTIEL HUERTA,,https://lens.org/012-065-887-094-207,Patent Application,no,0,0,1,1,0,,G01L1/00;;A61B5/107,,0,0,,,,PENDING
165,MX,A,MX 2016016691 A,129-094-323-032-073,2020-07-29,2020,MX 2016016691 A,2016-12-08,MX 2016016691 A,2016-12-08,UNIVERSAL ELECTRONIC SYSTEM BASED ON MULTI-INPUT FLOATING GATE TRANSISTORS.,"The present invention relates to an electronic system scheme for digital signal processing, allowing generating logic operations with a single circuit without modification of the internal circuit.",ALEJANDRO MEDINA SANTIAGO,MEDINA SANTIAGO ALEJANDRO;;CISNEROS GÓMEZ ARTURO;;ROSALES MALDONADO CESAR;;MEDINA SANTIAGO CRUZ ELENA;;GUTIÉRREZ CORZO VICTOR MANUEL;;GONZALEZ GALINDO DARIO;;RUIZ PINTO MIGUEL ANGEL;;CHONG MONTOYA ALECTTE SELENE;;SÁNCHEZ NIGENDA LUIS MANUEL;;GARCÍA HERNÁNDEZ LUIS ALBERTO;;ROJAS NUCAMENDI LORENA DEL ROSARIO;;GARCÍA HERNÁNDEZ OEL;;RAMÍREZ URBANO KRISTEL;;GÓMEZ AGUILERA LUIS ENRIQUE;;GARCIA CHONG NESTOR RODOLFO;;MONTIEL HUERTA MARIAMNNE VIRIDIANA,,https://lens.org/129-094-323-032-073,Patent Application,no,0,0,1,1,0,,H03K19/0948;;G06F7/50;;G06F7/503;;G11C16/10;;H03K19/173,,0,0,,,,PENDING
